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Abstract
Applying mathematical models to dynamic contrast enhanced MRI (DCE MRI) data
to perform quantitative tracer kinetic analysis enables the estimation of tissue char-
acteristics such as vascular permeability and the fractional volume of plasma in a
tissue. However, it is unclear to what extent modeling assumptions, particularly re-
garding water exchange between tissue compartments, impacts parameter estimates
derived from clinical DCE MRI data. In this work, a new model is developed which
includes water exchange effects, termed the water exchange modified two compart-
ment exchange model (WX-2CXM). Two boundaries of this model (the fast and no
exchange limits) were used to analyse a clinical DCE MRI bladder cancer dataset.
Comparisons with DCE CT, which is not affected by water exchange, suggested that
water exchange may have affected estimates of vp, the fractional volume of plasma.
Further investigation and simulations led to the development of a DCE MRI proto-
col which was sensitised to water exchange, in order to further evaluate the water
exchange effects found in the bladder cancer dataset. This protocol was tested by
imaging the parotid glands in eight healthy volunteers, and confirmed evidence of
water exchange effects on vp, as well as flow Fp and the fractional volume of ex-
travascular extracellular space ve. This protocol also enabled preliminary estimates
of the water residence times in parotid tissue, however, these estimates had a large
variability and require further validation.
The work presented in this thesis suggests that, although water exchange effects do
not have a large effect on clinical data, the effect is measurable, and may lead to
the ability to estimate of tissue water residence times. Results do not support a
change in the current practise of neglecting water exchange effects in clinical DCE
MRI acquisitions.
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Glossary
2CXM Two compartment exchange model, described by equations
3.10, 3.11
AIF Arterial input function - the concentration of contrast agent
in arterial plasma
AUC Area Under the Curve - the integrated area under the
concentration vs time curve for the first pass of tracer through
an artery of interest
B0 the static magnetic field
B1 the applied (radiofrequency) magnetic field
CO cardiac output - the net volume of blood pumped by the heart
per minute
CT Computed Tomography
DCE MRI Dynamic contrast enhanced MRI
DCE CT Dynamic contrast enhanced CT
Dotarem Gd-DOTA (gadoterate meglumine) - the contrast agent used
for the parotid DCE-MRI protocol
ECG electrocardiograph - a device using skin electrodes for monitoring
the electrical activity of the heart over time
EES extravascular extracellular space in a tissue
extended Kety A model of tracer kinetics described by equation 3.22
F The parameter describing flow of contrast agent into
the plasma in the 2CXM model
FXL The ‘fast exchange limit’ - the limit of water exchange modeling
in which water moves so quickly between different tissue
compartments that all water experiences the effects of the
tracer within the imaging period
Gd gadolinium
GE Gradient Echo
HU Hounsfield Units
IR Inversion Recovery
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Ktrans The transfer constant describing movement of contrast agent
between the plasma and extravascular extracellular compartments
in the Tofts and modified-Tofts models
kVp peak kilovoltage - the voltage accelerating electrons across an
X-ray tube
M the net magnetisation - the magnitude of the vector sum of the
magnetic moments of all spins in a system
mAs the product of X-ray tube current (in mA) and exposure time (in s)
MRI Magnetic Resonance Imaging
NXL The ‘no exchange limit’ - The limit of water exchange modeling in
which water does not move between different tissue compartments
Omnipaque (iohexol) The contrast agent used in the DCE-CT protocol
for this report
Omniscan Gd-DTPA-BMA (gadodiamide) - the contrast agent used in the
bladder cancer DCE-MRI protocol
p The probability of obtaining a test statistic which is at least as
extreme as the one observed, assuming that the null hypothesis
is true [4]
PC phase contrast
r or r1 The spin-lattice relaxivity - a constant used in T1-weighted DCE-MRI
to relating the change in tissue T1 to change in contrast
agent concentration
RF radiofrequency - a frequency of oscillation in the RF spectrum
SD Standard Deviation
SE Standard Error OR Spin Echo
SENSE Sensitivity Encoding - a parallel imaging technique used to remove
aliasing
SNR Signal to Noise Ratio
SPGR SPoiled GRadient echo
τ water residence time - the mean time which a water molecule spends
in a particular space or tissue compartment
T1 The relaxation time constant describing spin lattice (longitudinal)
relaxation
T2 The relaxation time constant describing the decay of the
transverse magnetisation due to spin-spin interactions
T ∗2 The relaxation time constant describing the decay of the transverse
magnetisation due to spin-spin interactions and magnetic field
inhomogeneities
TE The echo time of an MRI pulse sequence
TFE Turbo Field Echo
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TR The repetition time of an MRI pulse sequence
ve The fractional volume of extravascular extracellular space in a tissue
vp The fractional volume of plasma in a tissue
Venc The encoding velocity for phase contrast MRI
WX-2CXM The water exchange extended two compartment exchange model
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Chapter 1
Introduction
1.1 Motivation
One of the advantages of magnetic resonance imaging (MRI) over other imaging
modalities is the number of different types of contrast which can be produced simply
by varying the imaging parameters. Tissue characteristics which can be used to pro-
duce MR images with different types of image contrast include the relaxation rate
of protons in the tissue, the proton density, and diffusion characteristics. Each type
of image contrast provides insight into a different aspect of the tissue structure or
function, and many different MR pulse sequences have been developed to optimise
particular types of image contrast. The addition of an exogenous contrast agent
creates yet another type of MR image contrast. Intravenous injection of a bolus of
contrast agent is a technique used in dynamic contrast enhanced MRI to highlight
vascular characteristics, and will often aid in the discovery of breakdowns or irregu-
larities in the vasculature. It is becoming a common diagnostic aid in many clinical
fields including cardiology and oncology.
Dynamic contrast enhanced (DCE) imaging involves the repeated acquisition of im-
ages in a tissue before and after the injection of an exogenous contrast agent. This
technique can be used not only in MRI, but also in computed tomographic (CT)
imaging. Developments in both CT and MRI have reduced imaging scan times to the
point where DCE imaging is feasible in the clinic with temporal resolutions which
are fine enough to allow mathematical modelling of the signal changes produced by
contrast agent flow in tissues, allowing the extraction of parameters related to tissue
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blood flow, microvascular permeability, interstitial volume, and microvascular plasma
volume. However, as with any modeled process, assumptions must be made to create
a simplified model which still captures the relevant features of the system (in this
case, a living tissue). A variety of models have been used to analyse DCE MRI and
DCE CT data, with the ‘best’ model for a particular purpose being determined by
the tissue of interest, imaging protocol being used, and information required from
the data. As CT and MR hardware has advanced, better temporal resolutions and
signal to noise ratios (SNR) have allowed the use of more complex models. Good
practise requires that the simplifying assumptions made in these models should be
investigated for validity before any conclusions are drawn from the model parameters
extracted.
In this work, we set out to investigate tracer kinetic model assumptions related to
the diffusion of water between tissue compartments. It is known that the diffusion of
water across tissue boundaries, for example, between the intravascular and interstitial
spaces, can affect the MRI signal. The extent to which the signal is affected will
depend on the MRI acquisition, the contrast agent injection protocol, and the tissue
being imaged. However, given the present quality of typical clinical data, it is unclear
to what extent this effect is important in DCE MRI analysis. Because changes in the
DCE CT signal are directly related to attenuation of the beam by the contrast agent,
water exchange does not affect DCE CT, and thus the comparison of DCE MRI with
DCE CT data was one potential way to test hypotheses related to the effect of water
exchange on tracer kinetic modelling. This thesis sets out to investigate the impact
of water exchange effects on DCE MRI using clinical MRI and CT data, simulations,
and data from volunteers imaged using a specially designed MRI acquisition.
1.2 Hypotheses
It is known that the movement of water across tissue boundaries (termed ‘water
exchange’) can affect the signal intensities measured using T1 weighted DCE MRI.
However, much of the research which has been done into this effect has been ex vivo
work, or used specialised pulse sequences and techniques, or high doses of contrast
agent. Although these studies are valuable for exploring the effects involved and
establishing baseline values for measurable parameters, these protocols are not nec-
essarily applicable to clinical situations. The hypothesis of this study is that water
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exchange has a quantifiable effect on clinical T1 weighted DCE MRI tracer kinetic
parameter estimates which may allow measurements of the water residence times in
tissue. A secondary hypothesis is that the importance of water exchange in clinical
DCE MRI analysis can be gauged by comparing clinical DCE MRI data (which may
be affected by water exchange to an unknown extent) with clinical DCE CT data
(which are not affected by water exchange) and with a modified DCE MRI protocol
which is sensitised to water exchange.
Because the impact of water exchange on the DCE MRI signal depends on factors
including the MR acquisition parameters, contrast agent injection protocol, and tissue
characteristics, it is understood that no broad clinical recommendations can be made
from the investigations in this thesis. Rather, the goal of this work is to gain a better
understanding of water exchange effects by developing a suitable model and applying
it to real clinical data to estimate the effects involved in that situation, giving an
indication of which quantitative DCE parameters are most significantly affected, and
providing guidance and direction for future investigations using other T1 weighted
DCE MRI acquisitions in other tissues.
1.3 Overview
General background information relevant to the thesis is reviewed in chapter 2, in-
cluding an introduction to DCE CT, the DCE MRI and the MR pulse sequences
used in this work, as well as selected details regarding contrast agents and tissue
physiology which are relevant to future chapters. Chapter 3 contains a discussion of
the mathematical models used in this work, and develops a new tracer kinetic model
incorporating water exchange effects: the water exchange modified two compartment
exchange model (WX-2CXM). A clinical dataset consisting of both DCE MRI and
DCE CT data in 12 bladder cancer patients from a study which had recently closed
became available within the department, and so this dataset was used to test the
model developed in chapter 3. The results of applying two boundary conditions of
the WX-2CXM to the bladder cancer dataset, and comparing the DCE MRI results
with DCE CT are presented in chapter 4, providing an estimate of the impact of
water exchange in these clinical data.
The experience of analysing the clinical dataset in chapter 4 highlighted some experi-
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mental factors, separate to water exchange, which can impact tracer kinetic parameter
estimates. The simulations in chapter 5 explore the effects of tracer kinetic model
choice, manually defined vs automatically detected arterial input functions (AIFs),
contrast agent relaxivity, MR excitation pulse flip angle, TR, and precontrast tissue
T1 on tracer kinetic parameter estimates. These simulations helped to assess what
impact these factors each have on DCE MRI parameter estimates.
The analysis in chapter 4 also highlighted the potential impact of errors in the mea-
sured MR arterial input functions on DCE tracer kinetic parameter estimates. In
chapter 6, four AIF correction methods were applied, and their effects were evalu-
ated by comparison with CT and with AIF concentrations from the literature. Two
correction methods based on measurements of cardiac output were found to be par-
ticularly effective, and one of these methods is later used in chapter 8.
The water exchange effects observed in the data of chapter 4 were not sufficient to
allow measurement of tissue water residence times. However, if water exchange effects
are present in the data, they could potentially be used to measure related physiolog-
ical parameters, in particular, the residence times of water in tissue. In chapter 7,
simulations were run to help develop and optimise a protocol for the measurement
of water residence times in the parotid gland, assessing the best MR excitation pulse
flip angle, repetition time TR, and contrast agent injection protocol to enable the
measurement of tissue water residence times. The resulting protocol was run in 8
volunteers, and the results of fitting the WX-2CXM to these data are presented in
chapter 8. An AIF correction method tested in chapter 6 was incorporated in the
experimental protocol and analysis of these data, using measured cardiac output to
correct artefacts present in the MR AIFs. The thesis concludes with chapter 9 which
summarises the overall conclusions and suggests directions for future work.
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Background
This chapter presents a brief overview of the basics of DCE MRI, DCE CT, and water
exchange which are pertinent to the current investigation. Details of the imaging
techniques and MR pulse sequences used are summarised, and relevant MR artefacts
are discussed. Concepts related to the tracer kinetic modeling of the next chapter
are introduced, including contrast agents, quantitative vs qualitative analysis, and
arterial input functions. Finally, background information relevant to the tissues used
in this work is summarised.
2.1 DCE MRI
Clinically, dynamic contrast enhanced MRI (DCE MRI) is a technique which involves
the injection of contrast agent into a peripheral vein, and the use of MRI to capture
the movement of that contrast agent through a tissue of interest over time. By
applying mathematical models to the temporal change in the MR signal produced by
the contrast agent, DCE MRI can be used to examine the physiological characteristics
of the tissue, and in particular, is often used to characterise and monitor tumour
tissue microvasculature. The accuracy and physiological relevance of the information
obtained using DCE MRI depends to a large degree on the spatial and temporal
quality of the MR signal obtained.
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2.1.1 MRI signal generation
The signal in DCE MRI is produced when 1H protons in the water molecule are
exposed to applied magnetic fields. The way in which this signal arises is typically
described using a combination of quantum and classical physics, since each of these
descriptions is best suited to the explanation of certain aspects of MRI physics. This
tradition will be followed here. A more complete presentation of the basics of MR
physics can be found in a variety of introductory MR textbooks [5, 2, 6].
All elementary particles have an intrinsic spin quantum number s, which can take
on values of n/2 for any non-negative integer n. In particular, protons (our particle
of interest for 1H MRI) have a spin of 1/2. The spin angular momentum p has a
magnitude
p = ~
√
s(s+ 1) (2.1)
Or, for a proton with s = 1/2
p = ~
√
3/4 (2.2)
The z component of the spin angular momentum is
pz = ~sz for sz = {−s,−s+ 1, ...s− 1, s} (2.3)
Or, for a proton,
pz = ±~/2 (2.4)
This leads to a magnetic moment
µ = γpz = ±γ~
2
(2.5)
where γ is the gyromagnetic ratio; for 1H this constant is 42.6 MHz/T.
In the absence of an external magnetic field, the two possible states of a proton’s spin
angular momentum (±1/2~) have equal energies. However, if the proton is placed in
a static external magnetic field B0, the z component of the spin magnetic moment has
eigenstates which are parallel or anti-parallel to the external magnetic field. These
two states then acquire different energies:
E = −µB0 = ±~
2
γB0 (2.6)
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A slight excess of spins in the lower energy state is responsible for the MR signal.
2.1.2 T1 and T2 relaxation
To simplify explanations of the behaviour of single protons, all of the magnetic mo-
ments of the spins in a system can be considered to add together to form one net
magnetisation vector M . The remaining explanations in this section are based on
classical explanations of the behaviour of M . Although these classical explanations
are perhaps unsatisfactory from a quantum mechanical perspective, they are generally
accepted in MR physics, and can explain most MR experiments.
The net magnetisation can be perturbed from alignment with the B0 field by applying
a radiofrequency (RF) pulse with an effective field B1 oriented perpendicular to the
B0 field. The frequency of the RF pulse is related to the energy difference between
the high and low energy states ∆E.
ω0 = ∆E/~ = γB0 (2.7)
Absorption of this radiation causes the protons to transition between energy states.
Classically, we say that this causes the net magnetisation vector to ‘tilt’ away from
B0, precessing about B0 with a frequency ω0. M now has both a longitudinal compo-
nent parallel to B0, and a transverse component perpendicular to B0 (Mz and Mxy,
respectively). It is the transverse component of M that can be used to generate a
signal in the MR receiver coil.
If RF energy continues to be applied, the net magnetisation will tilt 90◦ to be perpen-
dicular to B0 (implying that there are equal populations in the two energy states).
This is called a 90◦ pulse. However, M will not remain here indefinitely, eventually
returning to alignment with B0 (the lower energy state) by a process called relaxation.
The parallel and perpendicular components of M relax by different processes and, in
general, at different rates. The perpendicular component relaxes via spin-spin or T2
relaxation, while the parallel component relaxes via spin-lattice or T1 relaxation. Be-
cause different environments within the body posses different properties which affect
the T1 and T2 relaxation rates, there is contrast in the signals produced by different
tissues; the ability to produce images with good contrast between tissue types has
motivated many of the clinical uses of MRI.
34
Chapter 2. Background
2.1.2.1 T1 relaxation
After the input of RF energy has perturbed the net magnetisation M away from B0,
the system will tend to return to its lowest energy state (alignment of M with B0) by
dissipating this energy to the environment or ‘lattice’ of surrounding particles. In the
same way that the applied RF field must be at the Larmor frequency ω0 to cause the
system to absorb energy, a proton must encounter a magnetic field fluctuating near
the Larmor frequency to allow the release of energy. In any substance, the random
motion and tumbling of nearby particles will produce local magnetic field fluctuations.
This energy release is termed T1, thermal, or spin-lattice relaxation, and the rate with
which T1 relaxation occurs is thus determined by the local distribution of frequencies
of magnetic field fluctuations.
Protons in different environments tend to move at different rates, affecting the local
magnetic field. For example, the free molecules in liquid water tend to move and
tumble in a way that produces fluctuations at a frequency much higher than the
Larmor frequency, while molecules in tissues tend to move at a slower rate which,
conveniently, produces more fluctuations near the Larmor frequency. For this reason,
T1 relaxation rates are faster in tissues than in liquid water, because protons in
tissues tend to encounter magnetic fields fluctuating at the Larmor frequency more
often than protons in water, allowing them to release energy more quickly. The T1
of a substance is defined as the time required for Mz to return to 63% (= 1− e−1) of
its equilibrium value. Bound molecules in solids tumble at much slower frequencies;
both free water and solids such as ice also have slow T1 relaxation rates and high T1
values.
The relaxation of Mz towards its equilibrium value of M0 after a 90
◦ pulse can be
described by the following Bloch equation [7]:
dMz
dt
=
M0 −Mz
T1
(2.8)
which has the solution
Mz(t) = M0(1− e−t/T1) (2.9)
Using this equation, we can verify that the time required for the magnetisation to
return to 63% (= 1− e−1) of its initial value is, by definition, T1:
Mz(T1) = M0(1− e−1) (2.10)
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2.1.2.2 T2 relaxation
After a pulse of RF energy with frequency ω0 is applied to the system, the net
magnetisation develops a transverse component with a coherent phase, meaning that
the individual magnetic moments are precessing at the same frequency and with the
same phase. However, phase coherence is difficult to maintain; individual protons
experience slightly different magnetic fields depending on the local magnetic fields
produced by neighboring particles as they randomly move and tumble. The differing
local magnetic fields induce changes in the precessional frequencies of the individual
spins, which results in individual phase differences. The vector addition by which
the individual components add to produce M thus dictates that, as the components
randomly dephase, Mxy approaches 0 exponentially. Unlike T1 relaxation processes
which dissipate energy, no energy is lost during T2 relaxation.
The loss of phase coherence occurs most rapidly in environments with slowly fluctu-
ating fields, such as large molecules and solids; these environments have very fast T2
relaxation times, and are effectively invisible to MR imaging due to the rapid signal
loss. In environments such as free water where increased motion causes rapidly fluctu-
ating fields, the field inhomogeneities experienced by a spin effectively average to zero
over short times, and dephasing takes longer to occur. For this reason, T2 relaxation
rates are much slower in free water than in membranes and macromolecules.
The exponential decay of Mxy can be described by the following Bloch equation:
dMxy
dt
= −Mxy
T2
(2.11)
This has the solution:
Mxy(t) = Mxy(0)e
−t/T2 (2.12)
The time required for the transverse magnetisation to return to 37 % (= e−1) of its
initial value is, by definition, T2.
Mxy(T2) = Mxy(0)e
−1 (2.13)
Although the same random motion of particles affects both T1 and T2, T1 is only
affected by Larmor frequency motions, while T2 is also affected by lower frequencies
of motion. For this reason, T2 is always less than or equal to T1.
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The dephasing of spins can also be caused by local static magnetic field inhomo-
geneities. Local inhomogeneities are any differences in the local magnetic fields caused
by static effects such as defects in the B0 field or susceptibility-induced field distor-
tions; these local differences cause nearby protons to precess at different rates. The
combined rate of dephasing due to spin-spin relaxation and dephasing caused by
static field inhomogeneities is called T ∗2 [2]:
1
T ∗2
=
1
T2
+
1
T ′2
(2.14)
where T ′2 is related to static field inhomogeneities. Because T
∗
2 is the combined rate
of dephasing, T ∗2 will always be less than or equal to T2.
T ∗2 ≤ T2 ≤ T1 (2.15)
2.1.3 Signal detection and image formation
Once an MR signal has been produced by the excitation of spins placed in the external
magnetic field B0, the signal must be received and processed if it is to be used
for MR analysis. In order to produce a three-dimensional image, the MR signal is
spatially encoded so that the changes in magnetisation can be spatially localised; this
is discussed in sections 2.1.3.2, 2.1.3.3, and 2.1.3.4.
2.1.3.1 Signal detection
By the process of electromagnetic induction, changes in the transverse magnetisation
can induce an electric current oscillating at the Larmor frequency in an appropriately
placed coil of wire. This coil is called the receive coil, and can be combined with the
coil which transmits the RF pulse, or can be a separate coil placed near the anatomy
of interest.
2.1.3.2 Frequency encoding
Without any spatial encoding, signal detected in this way will contain information
from all spins which have been excited. If a magnetic field is applied whose strength
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varies linearly with position, the Larmor frequencies of the spins will vary propor-
tionally, according to
ω(r) = γ(B0 +Bapplied(r)) (2.16)
A linearly varying applied magnetic field is called a ‘magnetic field gradient’. The
received signal from a volume which has been excited by an RF pulse and exposed
to a magnetic field gradient will contain a range of frequencies corresponding to
the strengths of the applied gradient. A Fourier transform can then be applied to
transform the signal from the frequency domain to the spatial domain. However,
in order to ensure each component of the signal corresponds to a unique point in
two dimensional space (and thus can form a two-dimensional image), an additional
dimension of spatial encoding is required.
2.1.3.3 Phase encoding
As seen in equation 2.16, the frequency of precession of the magnetisation depends
on the strength of the applied field gradient. A magnetisation vector exposed to a
stronger field will thus rotate more rapidly than one exposed to a weaker field. When
the equilibrium magnetisation is perturbed by an RF pulse, all spins have the same
phase angle. If a magnetic field gradient is then applied for a short time, the phase
angle of the spins will vary according to the position of the spins along the gradient.
The phase angle can be used to spatially locate the spins along the direction of the
gradient. Thus, if two perpendicular gradients are applied, the phase angle along
one direction and the frequency along the other direction can be used to resolve the
signal into a two-dimensional image.
2.1.3.4 Slice selection
Typically, in medical imaging, we want to visualise a specific area of tissue. In order
to ensure that an image is formed of a thin slice rather than a whole volume, an RF
pulse and gradient must be applied simultaneously. The slice selection gradient is
applied perpendicular to the plane of the desired slice, resulting in a linear variation of
Larmor frequency along the gradient direction, and then an RF pulse is applied with
a band of frequencies such that the central frequency matches the Larmor frequency
of the desired slice. In this way, only spins within the desired slice will be excited.
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This process is not exact, and the slice has a finite thickness determined by the
bandwidth of the RF pulse and strength of the gradient. If the signal received through
the plane of the slice is measured, this profile is never perfectly rectangular. The
sharpness of the edges of the plane of the slice is determined by the shape of the RF
pulse. Although pulses have been designed to give a profile which is as rectangular as
possible, it is important to be aware that some of the signal in each slice comes from
tissues which are slightly above and below of the expected slice region. If a volume
of tissue is imaged using a series of adjacent slices, the slice profiles overlap slightly
in an effect known as ‘slice cross-talk’. The technique of acquiring a series of slices
to image a volume of tissue is known as 2D imaging. When multiple slices are used,
a gap is often left between adjacent slices in 2D imaging to avoid cross talk effects,
resulting in non-contiguous slices.
An alternative to using slice selection to image a series of slices is 3D imaging. In a 3D
imaging experiment a whole volume of tissue is excited at once, and phase encoding
is appplied along the z-axis (perpendicular to the plane of the slices) to enable the
separation of slices. Although 3D imaging gives a better signal to noise ratio than
2D imaging, the imaging times are generally longer.
2.1.4 Basic pulse sequences
Any MR imaging sequence consists of a combination of RF pulses and magnetic
field gradients combined in different ways to produce different types of MR images.
Different pulse sequences may be designed to produce images where the signal depends
on different tissue characteristics such as T1, T2, proton density, etc. Pulse sequences
may also be designed to acquire images very quickly, or to eliminate signal from
certain tissues. A few of the most important pulse sequences used in the experiments
discussed in this thesis are summarised below, and the relevant signal equations given.
The basic gradient echo and spin echo pulse sequences form the basis for most other
advanced pulse sequences. The gradient echo and spin echo techniques will first be
summarised in sections 2.1.4.1 and 2.1.4.2 to introduce concepts and terms used later
to explain the SPGR and IR-TFE sequences in sections 2.1.4.3 and 2.1.4.6.
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2.1.4.1 Spin echo
If an RF pulse is applied with the correct amplitude and duration, the equilibrium
magnetisation M0 can be flipped into the xy plane; this is called a 90
◦ pulse. As in
section 2.1.2.2, the net magnetisation will decay by T ∗2 relaxation processes as the
spins dephase. If another RF pulse is then applied to flip the magnetisation by 180◦,
the spin dephasing will continue but in the reverse direction until, at a time TE after
the 90◦ pulse, the T ∗2 spin dephasing has reversed. Due to T2 relaxation processes, the
magnitude of the magnetisation at TE is less than M0, but the recovery of signal after
the reversal of the T ∗2 dephasing results in an increased magnitude of signal at TE
which creates a spin echo. In order to form an image using this signal, slice, phase,
and frequency encoding gradients are also applied. Figure 2.1 shows an example of a
simple spin echo pulse sequence. The sequence must be repeated at each level of the
phase encoding gradient.
2.1.4.2 Gradient echo
A gradient echo type pulse sequence begins with an RF pulse which perturbs the
magnetisation by an angle α◦ which is often less than 90◦. The application of the
frequency encoding gradient after the RF pulse will cause T ∗2 dephasing, but is neces-
sary to spatially encode the signal. This dephasing can be reversed by reversing the
direction of the frequency encoding gradient. The T ∗2 dephasing due to the frequency
encoding gradient will be completely reversed when the area under the positive and
negative gradient lobes (amplitude multiplied by time) is equal, and the spins rephase
to form a gradient echo at a time TE after the initial α◦ pulse. Note that the ac-
quired signal will still be subject to T ∗2 decay caused by static field inhomogeneities.
Throughout the time after the α◦ pulse, the longitudinal magnetisation has been
recovering via T1 relaxation processes. After sufficient recovery of the magnetisation
has occurred to allow enough signal for image formation, the sequence can be re-
peated for the next phase encoding step. The time interval allowed to pass before
the next α◦ pulse is called the repetition time TR. Figure 2.2 shows an example of a
simple gradient echo pulse sequence.
Gradient echo pulse sequences are often used in rapid imaging techniques, because
only one RF pulse is needed for each TR, and low flip angles can be used to allow short
TRs for rapid repetition of the sequence. Spoiled gradient echo (SPGR) techniques
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Figure 2.1: A pulse sequence diagram for a simple spin echo sequence using 90◦ and
180◦ RF pulses with echo time TE. The slice select, phase encode, and frequency encode
gradients are denoted GSS , GPE , and GFE , respectively. Pulse sequence diagram adapted
from [2, 3].
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Figure 2.2: A pulse sequence diagram for a simple gradient echo sequence using an α◦ RF
pulse, echo time TE and repetition time TR. The slice select, phase encode, and frequency
encode gradients are denoted GSS , GPE , and GFE , respectively. Pulse sequence diagram
adapted from [2].
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are one type of pulse sequence which take advantage of these characteristics of the
gradient echo pulse sequence.
2.1.4.3 Spoiled gradient echo (SPGR)
As in a gradient echo pulse sequence, a spoiled gradient echo (SPGR) -type sequence
begins with an initial α◦ pulse, producing a gradient echo at time TE. After a time
TR, the α◦ pulse is repeated. A short TR can be used in order to speed up the
acquisition, which often means that the magnetisation has not recovered to its equi-
librium value before the next pulse. After a number of such pulses, a steady state
will be achieved such that the longitudinal magnetisation reaches the same level after
each TR. Another consideration at short TRs is that T2 dephasing may not be com-
plete if TR is sufficiently short, leading to incomplete transverse relaxation. If the
transverse magnetisation reaches a steady state after each TR, the pulse sequence is
a steady state free precession (SSFP) type sequence. If the residual transverse mag-
netisation due to incomplete dephasing can be forced to zero prior to each α◦ pulse,
the pulse sequence is a spoiled gradient echo (SPGR) type sequence. This results in
the opportunity for the sequence to provide reduced T2 weighting and increased T1
weighting in the image, because the signal will depend strongly on the longitudinal
magnetisation [8]. The easiest way to achieve zero transverse magnetisation prior to
each pulse is to select a sufficiently long TR to allow the transverse magnetisation
to decay before the next pulse. However, if a faster sequence is desired, the residual
transverse magnetisation can be ‘spoiled’ by applying gradients or altering the phase
of consecutive RF pulses to ensure that the transverse magnetisation is zero prior to
each α◦ pulse. If spoiling is applied, the equation for the signal received in the steady
state is [2]:
S = S0sin(α)
1− e−TR/T1
1− cos(α)e−TR/T1 e
−TE/T ∗2 (2.17)
Here, S0 is the signal just prior to the α
◦ pulse, and incorporates various factors
including proton density and receiver gain. SPGR sequences often employ short TEs
such that at physiologically relevant T ∗2 s, the e
−TE/T ∗2 term approaches 1 so that the
signal depends minimally on T ∗2 . This was true for acquisitions used in this work,
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and so the form of the SPGR equation used is
S = S0sin(α)
1− e−TR/T1
1− cos(α)e−TR/T1 (2.18)
In choosing the flip angle, TR, and TE for a SPGR sequence, speed, SNR, and T1
weighting considerations must all be balanced. The flip angle, TR, and T1-weighting
of a SPGR acquisition are related by the Ernst equation, which gives the flip angle
αE producing the greatest signal for a given TR and T1 [2]
αE = arccos
(
e−TR/T1
)
(2.19)
Flip angles closest to the Ernst angle will maximise the SNR. Longer TRs also provide
greater SNR, due to a greater recovery of the longitudinal magnetisation.
For TRs less than the T1 of the tissues being imaged, SNR is maximised at longer
TRs, because of the greater recovery of the longitudinal magnetisation. Larger flip
angles will produce greater T1 weighting, but with a correspondingly lower SNR if the
flip angle is greater than the Ernst angle. Flip angles lower than the Ernst angle will
also produce lower SNR, and the signal intensity will be more dependent on proton
density or T ∗2 , depending on the TR and TE [8].
2.1.4.4 Spoiled gradient echo (SPGR) for multiple flip angle T1 measure-
ment
When a spoiled gradient echo type sequence is used for T1 measurement, it can be
repeated at several different flip angles. If each of these flip angles is used as a point
on a curve, equation 2.18 can be used to fit for T1. This is a relatively fast method
of T1 measurement, because the SPGR using short TRs can be made reasonably
fast, and a large number of flip angles can be acquired in a short time. Although
this is a popular method of T1 measurement because of its speed, the technique is
vulnerable to errors. The failure of magnetisation to reach its equilibrium state before
measurement, incomplete spoiling, B1 field inhomogeneities, and insufficient SNR can
all contribute to inaccurate T1 calculations using this technique [9, 10].
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2.1.4.5 Inversion recovery (IR)
In a spin echo type inversion recovery sequence, an initial 180◦ pulse is applied to
invert the magnetisation. After a delay of length TI, a 90◦ pulse is applied, at which
point there is some transverse magnetisation available to produce a signal.
The length of the inversion time TI will affect the amount of longitudinal magneti-
sation available to be flipped into the transverse plane. No RF pulse is perfect; the
inversion efficiency denoted by λ represents the proportion of the initial magnetisa-
tion which is inverted by the 180◦ pulse. A perfect pulse would have λ = 1. For a
spin echo type inversion recovery, the signal is given by:
S = S0
(
1− 2λe−TI/T1 + (2λ− 1)e−TR/T1) e−TE/T2 (2.20)
After each inversion pulse, a time TR is allowed to pass before the next inversion
pulse to allow recovery of the longitudinal magnetisation. The echo time TE is the
time between the 90◦ pulse and the centre of the readout.
If a series of images is acquired using different TIs, equation 2.20 can be fitted to the
the signal to estimate T1, λ, and S0. If many different TIs are used, this can be a
very accurate way of measuring T1 (at least three TIs are required to fit for the three
free parameters).
2.1.4.6 Turbo field echo inversion recovery (IR-TFE)
The inversion recovery sequence is the gold standard for accurate T1 measurement in
MRI [11]. However, the use of this sequence for T1 measurement is time consuming
to the extent that it can be difficult to include with the other necessary experiments
in a clinical protocol in the time available. In order in decrease the time required
for IR T1 measurement, an inversion recovery sequence can be incorporated into a
turbo field echo -type experiment, as explained below, to form an IR-TFE sequence
[12, 13].
In an IR-TFE experiment, an initial inversion pulse is applied which flips the mag-
netisation from Meq to −Meq. After a time TI following the inversion pulse, a series
of N low flip angle β◦ RF pulses are applied to tip a small portion of the magnetisa-
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Figure 2.3: The magnetisation for an IR-TFE pulse sequence produces a signal described
by equation 2.21. An initial inversion pulse is applied at time = 0, flipping the magnetisation
from Meq to −Meq; this is followed by a series of β◦ pulses separated by time tr. During
this time, the magnetisation continues to relax towards Meq. After the last β◦ pulse, there
is a delay of TD before the next inversion pulse.
tion into the transverse plane while T1 relaxation occurs. Each β
◦ pulse is separated
by a repetition time tr. One phase encoding step (see section 2.1.3.3) is collected
after each β◦ pulse. After the final β◦ pulse, there is a delay of TD to allow full
recovery of the longitudinal magnetisation to Meq. In a multi shot sequence, a shot
interval of time TR is the time between consecutive inversion pulses. A schematic of
the evolution of the magnetisation during such an experiment is shown in figure 2.3.
The signal acquired from an IR-TFE sequence is described by:
S = S0sin(β)
[
b
1− a(1− a
N/2−1)+
e−TI/T1aN/2−1λ
(−D (bA− 1/cos(β) + C)− 1
1 + λBD
)
+ (1− e−TI/T1)aN/2−1
] (2.21)
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In this equation,
a = cos(β)e−tr/T1
b = 1− e−tr/T1
C = aN−1
(
1− e−TI/T1)
A =
1− aN−1
1− a
D = cos(β)e−TD/T1
B = aN−1e−TI/T1
(2.22)
A full derivation of this equation is given in [3].
As with a standard inversion recovery sequence, if images are acquired at several TIs,
equation 2.21 can be fitted to the signal to estimate T1, S0, and λ.
2.1.5 Contrast agents
Endogenous contrast in MRI can be related to tissue parameters including T1, T2, and
proton density. Each of these parameters can lead to a different type of MR image
contrast depending on the MR pulse sequence used; many different pulse sequences
have been developed to maximise particular types of image contrast. The addition of
an exogenous contrast agent creates yet another type of contrast, producing contrast
enhanced MR images. Contrast enhancement can be used to highlight highly vascu-
larized tumour tissues or reveal breakdowns in the blood-brain barrier. If the flow
of the contrast agent is monitored over time, quantitative analysis can be used to
extract functional information about tumours such as blood flow and plasma volume.
A number of different exogenous contrast agents, providing different types of image
contrast, are being used and investigated for use in MRI. Some contrast agents are
designed to remain within the vasculature, while others diffuse out of the vasculature
and into the tissue interstitium. Intravascular contrast agents are gaining popular-
ity for angiographic and DCE MRI applications, but often provide less signal than
contrast agents which diffuse out of the blood pool. The contrast agents which are
most commonly used in the clinic are low molecular weight gadolinium chelates such
as Gd-DTPA (gadopentate dimeglumine, Magnevist, Schering, Berlin, Germany),
Gd-DOTA (gadoterate meglumine, Dotarem, Guerbet, Aulnay-sous-Bois, France),
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Gd-DTPA-BMA (gadodiamide, Omniscan, GE Healthcare, Oslo, Norway), and Gd-
HP-DO3A (Gadoteridol, Prohance, Bracco, Milan, Italy) [14]. These contrast agents
readily diffuse out of vasculature in most tissues outside of the brain, and have been
extensively studied as reflected in the DCE MRI literature. Omniscan and Dotarem
were the MR contrast agents used to acquire the data for the bladder cancer (chapter
4) and parotid datasets (chapter 8), respectively.
At clinically relevant concentrations of contrast agent, a linear relationship exists
between the concentration of contrast agent C and the change in T1 and T2 that the
contrast agent induces [15]. The constant of proportionality is called the longitudinal
or transverse relaxivity, r1 or r2, respectively [6]:
C =
1
r1
(
1
T1 post contrast
− 1
T1 pre contrast
)
C =
1
r2
(
1
T2 post contrast
− 1
T2 pre contrast
)
(2.23)
Note that, because contrast agent molecules do not enter red blood cells, the concen-
tration of contrast agent in plasma Cp is related to the concentration in whole blood
Cb by the haematocrit Hct (see subsection 2.5.3):
Cp =
Cb
1−Hct (2.24)
2.1.5.1 Clinical use of gadolinium-based contrast agents
Gadolinium is a paramagnetic contrast agent. Due to the toxicity of the gadolinium
ion, it is always used in its chelated form in vivo. The tracer molecules themselves
are not MR visible, but affect MRI signal intensity by shortening the T1 and T2
relaxation rates of adjacent water molecules [16]. The reduction of tissue T1 occurs
via dipole-dipole interactions between water molecules and Gd ions. These dipole-
dipole interactions have a shorter range than the susceptibility gradients which lead
to T ∗2 related dephasing [16]. While both T1 and T2 effects can be measured, it is the
T1 effects which are of primary concern in this project. Because of the T1-weighted
imaging protocol used, T ∗2 effects are considered negligibly small compared to T1
effects in these data.
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Although gadolinium-based MR contrast agents were once thought to be completely
benign, some contrast agents have recently been associated with nephrogenic systemic
fibrosis (NSF) in patients experiencing renal dysfunction (defined for this purpose as a
glomerular filtration rate of less than 30 ml/min/1.73m2) [17]. The incidence of NSF
seems to have decreased since its discovery and the subsequent identification of risk
factors and implementation of strategies to minimise the risk to patients [18]. Such
strategies include avoiding the use of gadolinium based contrast agents in patients
with glomerular filtration rates less than 30 ml/min or in neonates with immature
renal function, minimising the dose of contrast agent agent given to at risk patients,
ensuring that patients on dialysis receive dialysis soon after contrast agent admin-
istration, and not exceeding the recommended dose of contrast agent [19]. Another
strategy to minimise the risk of NSF is to use a more stable contrast agent prepara-
tion. Many centres have switched to the use of cyclic, ionic gadolinium chelates such
as gadoterate (Gd-DOTA), which are more stable than their linear, non-ionic coun-
terparts gadoversetamide (Gd-DTPA-BMEA) and Gd-DTPA-BMA (gadodiamide)
[17].
In the bladder cancer dataset used in chapters 4, 5, and 6, the tracer Gd-DTPA-
BMA (gadodiamide) (Omniscan, GE Healthcare, Oslo, Norway) was used. This is
a non-ionic linear tracer, and this tracer has in the past been associated with some
cases of NSF [17]. In the later parotid dataset, used in chapter 8, the ionic cyclic
tracer Gd-DOTA (gadoterate) (Dotarem, Guerbet, Aulnay-sous-Bois, France) was
used. Both of these are low molecular weight tracers, with molecular weights of 574
Da and 754 Da, respectively [20].
2.1.6 Quantitative vs Qualitative DCE MRI analysis
MR techniques used for the qualitative assessment of enhancement after contrast
agent injection were probably the first clinical use of contrast enhancement in MRI
(for reviews, see [21, 22]). For example, the brightness of a lesion after contrast
injection can be used as a qualitative measure of tumour vascularity. Qualitative
techniques can be useful in lesion identification and delineation within an individual
patient, but comparisons between scans and between different patients undergoing
the same scan are fraught with difficulties. The primary difficulty is that there is a
non-linear relationship between MR signal intensity and underlying tissue parameters
such as T1, T2, temperature, and contrast agent concentration [23]. Because a change
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in signal intensity depends on the intrinsic characteristics of a tissue as well as on
the imaging parameters used, analyses based solely on signal intensity cannot be
compared in situations where these parameters are likely to vary.
If equations specific to the MRI pulse sequence are used and some baseline parame-
ters are known, the concentration of contrast agent in the tissue can be calculated.
Empirical parameters such as the initial area under the contrast-time curve (IAUC)
can be used to measure the delivery of contrast agent to tissue [24]. Because they
should not depend on imaging parameters, empirical parameters based on contrast
agent concentration are easier to compare between scans than qualitative measures;
however, qualitative and empirical parameters share the disadvantage of having an
uncertain relationship to the underlying physiological characteristics of the tissue.
If a tracer kinetic model is used to analyse the change in contrast agent concentra-
tion over time, it is possible to calculate quantitative measurements of physiological
characteristics such as blood flow and volume, vessel density and permeability, and
the volume of the extravascular extracellular space [25]. The reliability of these mea-
surements depends on the use of a model which accurately describes the relationship
of contrast agent concentration to the underlying physiological parameters. There is
some debate about where the compromise should be made between the accuracy of
the model and the ability to collect data which contain sufficient information about
all parameters in the model [26, 27]. For example, effects such as water exchange
have often been ignored in order to simplify quantitative analyses. In this report,
the extended Kety model [28] will be compared with the two compartment exchange
model (2CXM), a model which has more parameters but more completely describes
the tissue physiology in most situations.
2.1.7 Arterial input functions
The arterial input function (AIF) is the concentration vs time curve that describes
the changing concentration of contrast agent in the arterial plasma in the tissue.
The AIF is a fundamental part of most quantitative models in DCE MRI. However,
because of the relatively small diameter and fast blood flow in arteries, it can be
difficult to get accurate MR measurements of the arterial concentration and there are
several different theories on the best AIF for use in DCE MRI. Some investigators
use an AIF measured in a large artery feeding the tissue of interest. Such AIFs
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can be used directly, or smoothed by fitting a measured AIF using a theoretical or
functional form to the data [29], or averaged together over a number of patients
to form a group averaged or population AIF [30]. Other investigators derive the
AIF in the tissue of interest by using one or more nearby reference tissues [31] or
techniques which assume a form for the AIF and optimise the parameters using the
tissue data [32]. In this work, an AIF measured in a nearby artery feeding the
tissue of interest is used in all analysis. Because of its fundamental importance to
DCE MRI modelling, and because of its known patient-to-patient variability, the AIF
should ideally be measured individually wherever possible. However, as mentioned,
a variety of MR-related artefacts can affect the accuracy of individually-measured
AIFs. Issues relating to AIF measurement, and the impact of AIF characteristics on
tracer kinetic parameter estimates are discussed throughout the thesis, particularly
in chapter 6 and sections 5.3 and 7.2.
2.1.8 Artefacts
A variety of imaging artefacts can affect the MRI signal. The most important of
these in DCE MRI are partial volume effects, inflow, B0, and RF field (B1) effects.
2.1.8.1 Partial volume effects
With any pulse sequence used to produce MR images, there is a finite signal produced.
This signal must be used efficiently, and considerations about the speed of imaging
(temporal resolution) must be balanced with spatial resolution to produce a final
image with an acceptable signal to noise ratio [33]. Partial volume effects occur in
a voxel when that voxel contains a mixture of tissues. This is most often seen at
the interface between two tissues, and is problematic because it is then unknown
what proportion of the signal is being produced by each tissue. In AIF measurement,
partial volume effects occur at the edges of arteries where voxels contain a mixture of
tissue and arterial plasma. This is problematic in small vessels because, although it
may appear from visually examining contrast enhanced images that a particular voxel
is wholly contained within an artery, within- or through-plane partial volume effects
may mean that voxel contains signal produced by both the arterial contents and the
surrounding tissues. Some investigators attempt to correct for partial volume effects
in AIFs using a simple multiplicative rescaling of the signal [33]. A more effective
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solution (which is not always possible) is to image at a high enough spatial resolution
to ensure that purely arterial voxels can be found.
2.1.8.2 Inflow effects
Blood is constantly moving and circulating through vessels and tissues, delivering
oxygen and nutrients to all parts of the body. When a fixed 3D imaging volume
is used, this means that blood is moving into and out of the imaging volume while
static tissues remain in the imaging volume throughout the experiment. During
the course of an imaging experiment, static tissues will experience all RF pulses
applied to that volume, and acquire a known Mz according to the pulse sequence
applied (see section 2.1.4). Using a T1-weighted 3D sequence, the tissue in the field
of view will have a signal which has been reduced or saturated by the RF pulses to
a known value. However, the magnetisation acquired by blood in an artery passing
through an imaging volume is much more complicated to calculate. Blood within the
artery which enters the imaging volume from the side proximal to the heart may not
have been subjected to any RF pulses and will thus contain only fresh unsaturated
spins with maximal longitudinal magnetisation (Mz), resulting in a higher signal
than the surrounding tissue containing saturated spins. As it moves through the 3D
imaging volume, the blood will experience RF pulses which will reduce its Mz so that
blood leaving the volume has experienced a different number of pulses and acquired
a different Mz to that entering the volume.
One would ideally like to acquire an AIF using blood which has acquired a known
magnetisation identical to that of the surrounding tissue. In a 3D imaging volume
oriented perpendicular to the direction of arterial blood flow, this is most likely to be
achieved in the last slice of the imaging volume (the slice distal from the heart, where
the magnetisation of the flowing blood is most likely to have reached saturation).
However, the outermost slices in the 3D volume are those most likely to suffer from
B1 effects (see section 2.1.8.4), and so in practice the last slice is usually not chosen.
For the purposes of designing a T1-weighted sequence which is robust to inflow effects,
using higher flip angles and shorter TRs cause the magnetisation in the flowing blood
to reach saturation more quickly [34, 35]. If the inflow effect is present in the data and
not properly accounted for, it can affect measurements of the baseline magnetisation
M0, and T1 values, which will subsequently affect the calculated AIF concentrations
[35]. For further discussion of the impact of inflow effects on DCE MRI, see [36]
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2.1.8.3 Signal saturation
Signal saturation refers to the effect in T1 weighted DCE MRI which occurs when
the signal becomes unresponsive to a change in tissue T1 due to nonlinearities in the
relationship between signal and contrast agent concentration.
In DCE MRI, there is a linear relationship between contrast agent concentration and
the change in 1/T1, and a nonlinear relationship between 1/T1 and the change in the
signal; the precise relationship depends on the pulse sequence used. For a SPGR type
sequence, the relationship between signal and 1/T1 is roughly linear at long T1s, such
as those usually seen in the absence of contrast agent. However, contrast agents are
designed to shorten the tissue T1, and at high doses of contrast agent, the relationship
between signal and T1 flattens for SPGR type sequences: the slope decreases, causing
the signal to ‘saturate’. At T1s where the signal is saturated, a large change in T1
causes a minimal change in the signal. This is problematic for accurate conversion of
signal to contrast agent concentration [37].
Saturation effects are most likely to occur in the arterial blood, where the concen-
trations of contrast agent are highest. This is problematic for the measurement of
individual arterial input functions. Potential solutions include the use of lower doses
of contrast agent, higher flip angles, or pulse sequences which are less prone to signal
saturation effects at the anticipated T1 values [37]. Performing direct measurements
of T1 (effectively avoiding the nonlinear conversion from signal intensity to T1) avoids
this problem altogether, as noted in [37].
2.1.8.4 B1 and flip angle
The RF field (B1) is used to manipulate the spins within the imaging volume to
produce signal. In the case of an imaging volume filled with a uniform cylinder of
water, the signal received should, ideally, be uniform. However, due to technical
challenges related to imaging gradients and coils, this is often not the case. Some B1
inhomogeneity is to be expected throughout the coil volume and at the edges of the
imaging volume on the outermost slices; a variety of different techniques have been
investigated for reducing B1 inhomogeneity [38]. Imperfections and inhomogeneities
in the B1 field will result in unexpected variations in magnetisation and signal in-
tensity, and can lead to errors in any quantitative measurements based on signal
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or proton density. Although tailored RF pulses and B1 mapping techniques can be
used to minimise and correct for field inhomogeneities [39], this process can be time
consuming and is often neglected.
2.1.8.5 B0 inhomogeneities
The strength of the static magnetic field B0 determines the equilibrium magnetisa-
tion of the sample (M0). Variations and inhomogeneities in B0 across the imaging
volume can result in geometric distortion of the image and signal voids. Imperfect
shimming of the magnet, susceptibility effects at air-tissue interfaces, and the pres-
ence of metallic implants or jewellery can all contribute to static field inhomogeneities
[40]. The impact on quantitative calculations due to geometric distortion and partial
volume effects related to B0 inhomogeneities can be significant [40, 41].
2.2 Phase contrast MRI
Although the magnitude of the MR signal is typically displayed in many MR images,
the MR signal is inherently complex, including both magnitude and phase informa-
tion. Phase contrast MRI produces images whose contrast depends on the accumu-
lated phase of the received signal, which can be used to detect phase accumulations
such as those caused by spins in arterial blood moving through a magnetic field gra-
dient. A phase contrast method was used to measure cardiac output in chapter 8;
the relevant background material for understanding phase contrast measurements of
flow will be summarised in this section.
2.2.1 Phase imaging
As noted in section 2.1.3.3, if a linear gradient is applied for a period of time τ , each
spin experiences a phase shift ∆φ as the the phase angle of the spin varies according
to its position along the gradient. If a gradient with the opposite magnitude is then
applied for the same period of time, the phase angle of the spin should vary in the
opposite way, such that after the second gradient is switched off, the total phase
shift is zero for stationary spins. The combination of two gradients with opposite
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Figure 2.4: A square bipolar read gradient of length τ and strength G.
magnitudes applied consecutively for the same length of time is referred to as a
bipolar gradient pulse.
The phase shift of a stationary spin after a bipolar gradient pulse is zero. However,
if the spin has moved during the pulse, the phase shift will be nonzero. An arterial
proton moving along the gradient direction will accumulate a positive phase shift,
while a proton moving in the opposite direction will accumulate the opposite phase
shift [2]. If an MR image is acquired after the bipolar gradient pulse (shown in
figure 2.4), and the phase information displayed rather than the typical magnitude
information, this is called a phase image, and the signal intensity is proportional to
the accumulated phase of the magnetisation.
As will be discussed in section 2.2.3, bipolar gradient pulses applied to moving spins
are not the only thing which causes a phase shift to appear in phase images. Anything
which causes an accumulated phase will affect the appearance of phase images, in
particular, magnetic field inhomogeneities, and RF penetration and pulse errors can
introduce phase shifts. However, the use of bipolar gradients and other techniques
can be used to separate out phase shifts caused by moving spins, and use these to
produce velocity maps.
2.2.2 Calculating flow using PC MRI
If a square bipolar read gradient of length τ and strength G is applied (as in figure
2.4), spins moving with a constant velocity, v, in the read direction will develop a
phase at time TE of:
φv± = φv(TE) = ∓γGvτ 2 (2.25)
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The ± sign in equation 2.25 denotes the fact that the phase changes sign if the
read gradient is applied with the opposite polarity (first the negative lobe, then the
positive lobe) [5]. In theory, using equation 2.25 with a single phase image should be
sufficient to calculate the velocity for every voxel. However, a number of effects can
cause phase errors, such as field inhomogeneities and RF penetration effects. These
effects are independent of the bipolar gradients and can be largely eliminated by
taking the difference of two images taken using bipolar gradients of opposite polarity
[5]. Subtracting the phases between two such images gives
∆φv = 2γGvτ
2 (2.26)
The image formed is called a phase difference image. The velocity in the read direction
can be calculated for any voxel in the phase difference image using equation 2.26,
allowing velocity maps to be easily constructed using PC MRI.
Assuming that the flow is perpendicular to the imaging plane, the flow (F) is the
through-plane velocity of the blood (vz) integrated over the area of the vessel (A) [5]:
F =
∫
vzdA (2.27)
2.2.2.1 Calculating cardiac output from flow
As will be noted in section 2.6, cardiac output can be calculated as the product of
stroke volume and heart rate. If phase contrast measurements of flow are taken over
a cardiac cycle, the area under the flow vs time curve will give the stroke volume.
A typical curve is shown in figure 2.5; in this example, 75 measurements of flow are
plotted over one cardiac cycle. The integrated area under this curve represents the
total flow over one cardiac cycle, or the ‘stroke volume’. This can be multiplied by
the heart rate to give cardiac output.
2.2.3 Artefacts
A number of artefacts can cause inaccuracies in phase contrast calculations of veloc-
ity. These include partial volume effects, eddy current effects, concomitant gradient
effects, and phase wrapping.
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Figure 2.5: A typical flow vs time curve with 75 measurements taken over one cardiac
cycle. The integrated area under this curve can be multiplied by the heart rate to give the
whole-body cardiac output. Net flow is shown on the y axis in ml/s, while the elapsed time
through the cardiac cycle is shown on the x axis in ms.
As seen in equation 2.27, phase-contrast based calculations of flow involve both the
velocity of the blood and the area of the vessel. Partial volume effects at the edge
of a vessel can be problematic for flow calculations, as such effects can introduce
errors in both velocity and area estimates, leading to potentially major errors in
small vessels. The use of lower flip angles and higher spatial resolutions can help
reduce flow calculation errors related to partial volume effects [2].
Eddy currents are charge currents induced in objects which are electromagnetically
conductive. Eddy currents depend on the specific hardware involved, and are not
easily predicted. Because the eddy currents induced by the two toggles of a bipo-
lar gradient are not generally the same, the magnetic fields induced by these eddy
currents are not generally subtracted out in a phase difference image, and can cause
errors in phase contrast measurements of velocity [2]. One way to measure these
effects is to acquire a phase subtraction image in stationary tissue; areas of non-zero
phase in such an image are likely related to eddy current effects caused by the bipolar
gradient, since all other gradient pulses are the same between the two acquisitions.
One may choose to use pixels from the chest wall for stationary tissue measurements
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in a thoracic phase contrast image, or alternatively image a static water or gel phan-
tom separately from the patient for such measurements [42].
Concomitant gradients are nonlinear gradients which occur as a result of Maxwell’s
equations whenever a linear gradient is activated. For example, if a linear gradient
Gx is used to create a variation of the z component of the magnetic field with respect
to x, there will be other (concomitant) gradients produced concurrently, such as
the variation of the x component of the magnetic field with respect to z. These
concomitant gradients can be calculated analytically using Maxwell’s equations [2].
They are not typically strong enough to cause artefacts in most applications, but
will cause errors in phase contrast imaging if not corrected for [43]. Because they
can be calculated using Maxwell’s equations, the concomitant gradient effects can be
analytically predicted and are easily corrected. Most major scanner manufacturers
should provide analytical corrections for such effects [43].
The encoding velocity (Venc) is the maximum velocity that can be imaged using a
phase contrast sequence. A proton moving at Venc will experience a phase shift of
180◦. Phase wrapping occurs when velocities in the image exceed Venc; a proton
moving with a speed slightly exceeding Venc (say, with a phase shift of 181◦) will
appear to have a phase shift of −179◦, or a speed of slightly more than −V enc on the
phase contrast image. Phase wrapping can be avoided by choosing a Venc slightly
higher than the maximum expected velocity. For example, a Venc of 200 to 250 cm/s
is typically used in the aorta.
2.3 DCE CT
Exogenous contrast agents are used in X-ray computed tomographic imaging (CT)
for many of the same reasons as in MRI: to highlight vascularized tumours, and pro-
vide information about tumour morphology and tissue physiology. However, unlike
in MR, tracer molecues are directly visible using CT. Because there is a linear rela-
tionship between contrast agent concentration and attenuation of the X-ray beam,
signal intensity in CT is linearly proportional to contrast agent concentration [44].
This simplifies the relationship between signal intensity and the biological parame-
ters derived from tracer kinetic models in CT data, as compared to the non-linear
relationship in MR.
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The ability to directly image the contrast agent, and the linear relationship between
signal intensity and concentration greatly simplifies the acquisition of an accurate
arterial input function (AIF) using CT. When the bolus of contrast agent makes its
first pass through the arteries, it is highly concentrated and moving very quickly (in
humans, up to 60 cm/s [45]). These two factors mean that the arterial measurement
of contrast agent concentration using MRI can be complicated by flow effects, and also
by non-linearities between signal and concentration caused by high concentrations of
contrast agent [46, 37]; these effects are not seen in CT.
However, there are several disadvantages to DCE CT as compared to DCE MRI.
Because contrast agent molecules are directly imaged, CT images are relatively in-
sensitive to the presence of the contrast agent, and higher doses of tracer are typically
required for DCE CT than DCE MRI [46, 47]. The iodinated contrast agents com-
monly used in CT are known to have the potential to cause allergic reactions and
nephrogenic toxicity, which can become problematic at higher doses [48]. As well,
mechanical restrictions imposed by the design of some older CT scanners mean that
only a limited number of CT slices can be imaged in a dynamic acquisition: many CT
scanners acquire sufficient slices to image a large volume by moving the patient later-
ally through the scanner; because of the need to monitor the same voxel throughout
contrast enhancement, this procedure cannot be used in DCE CT for older scanners
which do not allow synchronised continuous table movement. Repeated CT imaging
of the same volume during a dynamic acquisition also means that ionising radiation
burden is a significant consideration. So, despite the fact that CT has the advantage
of a linear signal to contrast agent relationship, there are several reasons for choos-
ing DCE MRI over DCE CT, motivating the refinement of MR-based tracer kinetic
models.
2.3.1 CT signal generation
A conventional X-ray image consists of a two-dimensional image which is formed when
X-rays are fired through the patient from a stationary source, and received on the
detector forming a projection image. Multi-slice X-ray computed tomography (CT)
images are based on the same principle, but have the advantage that tomographic
slices through a 3D volume are created by acquiring X-ray images at multiple angles
around the patient, and employing filtered back projection reconstruction to construct
an image of the volume. In both conventional X-ray and in CT imaging, the intensity
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of the signal in the image is related to the attenuation of the X-rays as they pass
through the volume. If the signal intensity at the surface of a piece of material of
thickness ∆x with a linear attenuation coefficient µ closest to the source is denoted
I0, the signal intensity I at the surface closest to the detector is given by [49]:
I = I0e
−µ∆x (2.28)
Materials such as bone that have a higher linear attenuation coefficient (µ) will at-
tenuate the X-rays to a greater degree than materials such as air with a lower µ,
creating contrast in medical CT images. This is a fundamentally different contrast
mechanism than in MR; the fact that many of the body’s soft tissues have a similar
µ is the reason why CT has relatively poor soft tissue contrast as compared to MR.
It should be noted that the X-ray spectrum produced by the tube in CT is not
mono-energetic, but rather, consists of a broad spectrum. The linear attenuation
coefficient depends on both the properties of the material and the frequency of the
X-rays being attenuated. In fact, the spectrum of the beam changes as it passes
through the patient as the different frequencies of X-rays are attenuated to different
degrees. The process whereby X-rays that are attenuated more (generally, those with
lower energy) are preferentially filtered out of the beam, leaving a spectrum with a
greater proportion of more penetrating X-rays (generally, higher energy) is generally
known as ‘beam hardening’ [50].
2.3.1.1 CT number: HU
CT signal was originally measured in terms of µ, but is now usually displayed in terms
of CT numbers or Hounsfield units (HU). The HU is simply the linear attenuation
coefficient of the material of interest scaled to that of water:
HU =
µmaterial − µH20
µH20
1000 (2.29)
The HU of water is 0. Materials that attenuate less than water, such as air, have
negative CT numbers (HUair = −1000), whilst materials that attenuate more than
water have positive CT numbers (HUbone ≈ 1000) [51]. It should be noted that
the HU for a particular tissue is not absolute, and depends on the X-ray spectrum
being used for imaging. Thus, the HU can change for different tube voltages (kVp),
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scanners, and even different X-ray tubes in the same scanner.
2.3.2 Radiation dose
The energy dose is defined as
D =
absorbed energy
tissue mass
(2.30)
in units of Gray = J/kg = Gy. In living organisms, an effective dose (E) is frequently
reported alongside or instead of dose. Effective dose accounts for the fact that the
biological impact of radiation dose differs by tissue. Empirically determined weighting
factors for different tissue types (wT ) can be applied to calculate an effective CT dose
E =
∑
T
wTDT (2.31)
Effective dose is measured in units of Sievert Sv = J/kg [51, 49].
Dose considerations must always be taken into account when designing a CT protocol.
Dynamic CT protocols will tend to have a much greater dose than single CT images,
because images must be acquired repeatedly over the time of the dynamic acquisition.
CT protocols imaging a large volume will also tend to be associated with a greater
dose than protocols imaging a single slice. In addition, the number of follow-up scans
which a patient will require should be taken into consideration, as dose is cumulative.
2.3.2.1 Scan settings: kVp and mAs
The product of the X-ray tube current and time (mAs) and the tube voltage (kV p)
are two important settings affecting CT image quality and patient dose. These pa-
rameters can be adjusted to alter the characteristics of the X-ray beam.
Dose is proportional to the mAs, which is proportional to the square of the image
signal to noise ratio (SNR). Thus, the mAs used should be monitored to ensure that
the dose is minimised while leaving sufficient SNR for a useful image.
Dose ∝ SNR2 ∝ mAs (2.32)
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Larger patients will, of course, attenuate more than smaller patients, and so the mAs
must be increased to achieve the same SNR in a larger patient as a smaller one.
Another way of increasing SNR in a CT image is to increase the slice thickness.
However, this must be balanced with partial volume considerations [51].
SNR ∝
√
slice thickness (2.33)
The intensity and penetration of the X-rays tends to increase with increasing tube
voltage, with the increase in intensity leading to an increase in both SNR and dose.
However, because alterations in the tube voltage change the characteristics of the
beam spectrum, there is no simple equation for the generalised relationship between
kV p, dose, and SNR.
2.3.3 Iodinated contrast agents
Iodine-based contrast agents are the most popular type of contrast agent used for
DCE CT. Iodine has a high linear attenuation coefficient (higher than most tissues),
and thus an influx of iodinated contrast agent tends to produce an increase in the CT
number of a tissue. If the pre-contrast HU for a tissue is subtracted, the resulting
HUs for a DCE CT timeseries are linearly related to iodine concentration [52].
Iohexol is the contrast agent used in the CT studies in this thesis. Iohexol is a
non-ionic iodinated contrast agent with the chemical formula C19H26I3N3O9 and a
molecular weight of 821 Da [52]. It has a low osmolarity (g of substance per L
of solution); osmolarity is important as significantly fewer negative side effects are
associated with low osmolar contrast agents as opposed to high osmolar contrast
agents [53].
Iodinated contrast agents are not metabolised; after circulating around the body
they are filtered by the kidneys and excreted by passive glomerular filtration. While
generally safe, there is a risk of negative effects, particularly in patients with impaired
kidney function. Contrast induced nephropathy is a condition associated with an
acute decline in renal function and glomerular filtration rate (GFR) soon after the
administration of iodinated contrast media, typically within 48 hours. The incidence
of contrast induced nephropathy is estimated at 2-7% in the general population, and
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7-24% in chronic kidney disease patients with a GFR of less than 60 ml/min/1.73m2
[53].
2.3.4 DCE CT calibration
As noted previously, the background subtracted DCE CT signal is directly propor-
tional to the concentration of contrast agent present in the tissue. Because the
concentration of contrast agent in the blood and tissue are related to the CT sig-
nal by the same proportionality constant, the calculation of absolute contrast agent
concentration is not necessary for quantitative DCE CT analysis or the calculation
of tracer kinetic model parameters. Most DCE CT analysis uses the background
subtracted DCE CT signal rather than the absolute contrast agent concentration.
However, absolute tracer concentrations were used for some calculations in chapter 6
of this work, and so a CT calibration was required.
In order to find the absolute concentration of tracer in CT, it is necessary to find
the proportionality constant between signal and concentration by performing a cali-
bration measurement with all of the same scan settings to be used in the DCE CT
protocol (see 6.4.1). As noted in section 2.3.1.1, the CT number depends on the
precise beam spectrum, which is affected by patient weight, X-ray tube condition,
and other factors. For this reason, Miles et al. [54] recommend that calibration to
find the proportionality constant should be performed prior to every DCE CT for
accurate quantification of CA concentration.
2.4 Water exchange basics
The high natural abundance of H2O in the human body is one of the reasons why
in vivo 1H-based MR imaging is so useful. Water molecules exist in many different
states and conditions in the body, for example, bound or associated with macro-
molecules, flowing through the arterial and venous systems, freely diffusing through
the extracellular space, and experiencing restricted diffusion in the intracellular space.
Individual water molecules are not restricted to any one of these states, and are con-
stantly diffusing and being pumped around the body.
For the purposes of monitoring contrast enhancement, the movement of contrast
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agent through the arterial and venous systems is perhaps the most important of
these processes. However, as mentioned in section 2.1, it is not the contrast agent
itself but rather its effect on the surrounding water molecules which causes a change in
MR signal intensity. There are differences between the behaviour of water molecules
and contrast agent molecules in vivo, for example, water molecules diffuse across
cellular membranes while contrast agent molecules cannot enter intact cells. Cellular-
interstitial exchange is the passage of water molecules across cellular membranes,
between the intracellular space and the extravascular extracellular space. The amount
of time that a water molecule spends inside a cell is affected by the volume and surface
area of the cell, as well as the type and health of the membrane [55]. For example, red
blood cells have a high surface area to volume ratio with permeability of 5×10−3 cm/s
[56]; Herbst et al. found a mean residence time of 11 ms in erythrocytes [57]. Squid
axons are much larger, and have membranes which are less permeable (0.14 × 10−3
cm/s) [58], leading to longer water residence times; Villegas et al. found a mean
intracellular residence time of 45 s [58] in squid axons.
Vascular-interstitial exchange is another type of water exchange which affects contrast
enhanced MRI, referring to the passage of water between the intravascular and ex-
travascular extracellular (interstitial) compartments. Most models of contrast agent
kinetics are designed to measure the rate of contrast agent passage from capillaries
into the interstitium. However, even if the contrast agent remains entirely intravas-
cular, changes in the MR signal intensity of the tissue can be observed because in-
travascular water molecules whose T1 and T2 rates have been affected by contact with
contrast agent will diffuse out of the vasculature, complicating the determination of
tissue concentration of contrast agent [35].
Because of this dependence of contrast enhancement on water exchange, the relative
speed with which water exchange occurs can have a significant effect on DCE MRI
calculations. If water exchange between two compartments is sufficiently fast relative
to the difference between the T1s of the compartments, the effects of the contrast
agent will be experienced by all water molecules in the system within the time of the
MR experiment, regardless of which compartment the contrast agent resides in.
Figure 2.6 illustrates a two pool model of water exchange which will be further dis-
cussed in section 3.2.1. For two compartments, say p (blood plasma) and e (ex-
travascular extracellular), exchange can be considered fast when the exchange rate
is much greater than the difference in T1s between the two compartments [59]. The
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Figure 2.6: The rate of water exchange between the two pools (say p (plasma) and e
(extravascular extracellular)) is described by the inverse of the average length of time which
a water molecule spends in each compartment (τ). Whether the water exchange is described
as fast or slow depends the magnitude of the difference between the compartmental T1s
relative to the sum of the exchange rates.
exchange rate between compartments i and j is 1
τi
if τi is the water residence time in
compartment i. If T1i is the longitudinal relaxation time in compartment i, the two
compartments are considered in fast exchange if the following inequality is satisfied:
1
τi
+
1
τj

∣∣∣∣ 1T1i − 1T1j
∣∣∣∣ (2.34)
If the fast exchange assumption in equation 2.34 holds, the two pool water exchange
model illustrated in figure 2.6 can be simplified by the fact that the whole tissue
relaxes with one T1 which is the weighted sum of the T1s for each compartment [13].
This is called water exchange in the fast exchange limit (FXL). The compartmental
T1 is weighted by the probability of a water molecule residing in that compartment,
which will be taken to be vi, the fractional volume of water in compartment i per
unit volume of tissue. In the fast exchange limit, the T1 of the tissue as a whole is
given by T1FXL:
1
T1FXL(t)
=
vp
T1p(t)
+
ve
T1e(t)
(2.35)
For example, water exchange across the red blood cell membrane is likely to be in the
FXL most situations [60, 61, 59]. This is due to the high permeability of red blood
cells; the mean residence time of water inside a red blood cell is approximately 9.8 to
14 ms [62] which is much shorter than typical plasma T1 values [63]. If there are only
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two compartments (red blood cell and plasma), detailed balance (see section 3.2.1)
dictates that the residence time in plasma is 14ms × (1 − 0.42)/0.42 = 19ms for a
haematocrit of 0.42. If we consider a red blood cell intracellular T1 of 670 ms [64],
a blood plasma precontrast T1 of 1650 ms, and a peak tracer concentration of 4.66
mM [1] with a relaxivity of 4.5 /mM/s, the post-contrast plasma T1 is
1
T1 contrast
= rCcontrast +
1
T1 pre−contrast
= 4.5/mM/s× 4.66mM + 1/1.65s
= 22/s (2.36)
and we see that the difference in the inverse of the erythrocyte intracellular and
plasma T1s is ∣∣∣∣ 10.670s − 22/s
∣∣∣∣ = 20/s (2.37)
which is much less than the sum of the inverse of the τ ’s (1/9.8ms+1/19ms = 154/s).
In the case of exchange which is not fast enough to satisfy 2.34, each compartment
relaxes with its own apparent T1, which depends upon the size and intrinsic relaxation
rate of each compartment, as well as the exchange rates between compartments [59].
If there is no exchange between the compartments, the total signal intensity S is the
volume weighted sum of the signal intensity from each compartment, simplifying the
two pool model of water exchange to the no exchange limit (NXL) [13]. In the no
exchange limit, the signal intensity of the tissue is given by SNXL:
SNXL(t) = vpSp(T1p(t)) + veSe(T1e(t)) (2.38)
In most tissues it seems likely that the true rate of exchange lies somewhere between
the ‘fast exchange’ and ‘no exchange’ extremes, depending on the amount of contrast
agent present [35]. While vascular-interstitial exchange is typically believed to be
much slower than cellular-interstitial exchange [59], it is not usually the case that
there is no exchange at all [35, 61]. The case of intermediate exchange is mathemat-
ically more complicated, since no approximations can be made.
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2.4.1 The effect of water exchange on DCE MRI
The most commonly used models of tracer kinetics do not take water exchange into
account - they effectively assume that water exchange is in the fast exchange limit.
This assumption is likely more accurate for some tissue types than for others. Some
investigators suggest that assuming fast exchange for all tissue types could cause
significant systematic errors in the calculation of relaxation times [65] and tracer ki-
netic parameters [26, 55]. However, other investigators argue that the fast exchange
assumption is valid for current clinical acquisitions [66]. Experiments involving in-
travascular contrast agents are potentially more sensitive to water exchange effects
than experiments in which the contrast agent can freely diffuse into the intersti-
tial space [67]. This is because the difference in T1s between the intravascular and
extravascular spaces is larger for a contrast agent which remains intravascular, cre-
ating a large change in the T1 of the vascular compartment but leaving the T1 of the
extravascular compartment unchanged.
If water exchange is assumed to be fast but is actually slow or intermediate, simula-
tions indicate that estimates of both perfusion and blood volume will likely be affected
[26, 35, 59, 61]. Because the difference in compartmental T1s is greatest when all of
the contrast agent is intravascular, some flattening or smoothing of the first-pass
peak is likely to occur, since water exchange is more likely to be intermediate when
intercompartmental T1 differences are greater, and intermediate water exchange will
lead to reductions in signal intensity relative to fast water exchange [65]. See figures
5.13 and 5.14 in section 5.4 for illustration of this effect. Yankeelov et al. found that
analysing DCE MRI data using a model which neglects water exchange effects led
to up to a 10% underestimation in contrast agent concentration in rat gliosarcomas
when compared with a model which these investigators suggest may account for water
exchange more fully [26]. The failure to account for water exchange when calculat-
ing contrast agent concentrations in this study resulted in significant underestimates
in tracer kinetic parameters: up to 45% in the transfer constant (Ktrans), and up to
30% in the fractional volume of the interstitial space (ve) [26]. Other investigators
suggest that the use of FXL models neglecting water exchange effects are sufficient
for analysis of clinical data [66]. The differences in parameter estimates produced by
analysis including and excluding water exchange effects are dependent on the type of
MR acquisition and models used; however, work such as [26, 35, 59, 61] suggests that
further investigation is warranted to come to firm conclusions and recommendations
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on how to determine when water exchange effects must be modelled, and when FXL
assumptions are valid.
2.5 Physiology
The wide variation in appearance of different tissue types in MRI, and the sensitivity
of MRI to tissue function are among the reasons why MRI has become so clinically
useful. Quantitative DCE MRI attempts to separate the differences in signal intensity
amongst different tissue types from underlying characteristics such as plasma volume,
vascular permeability, and plasma flow. However, tissues still vary widely in their
anatomical and physiological characteristics, and very different parameter estimates
can be derived from different tissues. In this section, the physiological characteristics
relevant for DCE MRI of the tissue types examined in the data used in this thesis
will be briefly discussed. The analysis in chapter 4 involves ROI analysis of bladder
tumours, chapters 7 and 8 involve analysis of the parotid gland, and all of the AIFs
require an understanding of the characteristics of arterial blood.
2.5.1 Bladder cancer
The bladder is the organ in the pelvis responsible for storing urine produced by the
kidneys. It is made up of four layers: the transitional epithelium, the lamina propria,
the muscularis propria, and the perivesical soft tissue.
The transitional epithelium is the thin layer which lines the bladder; most bladder
cancers originate in the cells of this layer. The lamina propria is a layer of connective
tissue, blood vessels, and muscle tissue underlying the transitional epithelium. Stage
T1 cancers are cancers which have invaded the lamina propria, but have not spread
to the muscularis propria or lymph nodes. Underlying the lamina propria is the
muscularis propria, a layer of smooth muscles forming the wall of the bladder. Stage
T2 cancers are cancers which have invaded the muscularis propria, but have not
spread beyond the bladder. The outermost layer of the bladder is the perivesical
soft tissue, consiting of fat, blood vessels, and fibrous tissue. Stage T3 tumours have
invaded through the muscularis propria to involve the soft tissues around the bladder.
Stage T4 tumours have spread beyond the bladder to the pelvic or abdominal wall,
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or have spread to lymph nodes and/or other distant sites in the body [68].
Bladder cancer is a relatively homogeneous cancer. The cancers studied in the dataset
introduced in chapter 4 were stage T2-T4 muscle invasive bladder tumours, which are
generally uniformly solid and show relatively uniform contrast enhancement. These
tumours rarely have cystic areas or areas of necrosis [69]. This makes these tumours
well suited to ROI analysis, as pixels within the ROI can be expected to show rela-
tively little variation, indicating that little information could be gained (and signal
to noise lost) by performing a pixel-by-pixel rather than ROI analysis. The pelvic
location of bladder tumours presents another advantage for ROI analysis, as the tu-
mours are relatively stationary, and are less susceptible to motion than abdominal
tumours. The homogeneity and pelvic location of bladder tumours are two of the
primary reasons these tumours were chosen as the target for the study detailed in
section 4.2. Bladder cancers present one difficulty for DCE MRI analysis, which is
the delayed presence of contrast agent in urine after it has been filtered out from the
blood plasma via the kidneys and excreted into the bladder. Thus, any DCE MRI
analysis must be careful to exclude tissue which borders on urine and may experience
a delayed enhancement due to contrast agent in the urine. In this work, this was
accomplished by carefully trimming the ROIs to avoid any tissues which might be
susceptible to this effect.
2.5.2 Parotid gland
The parotid gland is the largest of the three paired major salivary glands which
secrete saliva into the oral cavity and pharynx. Saliva from the parotid drains into
the oropharynx via Stensen’s duct, which is attached the the anterior border of the
gland and enters the oral cavity near the upper second molar. The size and position
of a typical parotid gland are shown in figure 2.7 in a healthy male. Blood is supplied
to the parotid gland by the external carotid artery, which branches into the maxillary
artery and superficial temporal artery as it passes through the gland [70].
The parotid gland is composed mainly of serous secreting acini which secrete a watery
saliva. The acinar cells are surrounded by connective tissue and, in adults, fat, and the
cells themselves are clustered around acinar lumen and ducts. Water is transported
into the acinar cells from the surrounding capillaries [71]; the acinar cells then secrete
a salivary mixture containing more than 90% water into the acinar lumen (figure
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Figure 2.7: A coronal slice showing the parotid gland (white outline) in a healthy male
volunteer
2.8). Upon initial secretion, the saliva is isotonic with the blood plasma. However,
the acinar ducts are relatively impermeable to water, and so when salivary flow rates
are low, the saliva within the acinar lumen and ducts is gradually modified by the
surrounding cells to become hypotonic, with decreased concentrations of Na+ and
Cl−, and decreased concentrations of K+ and HCO−3 [72]. The pH of secreted saliva
ranges from 6-7.4, and varies with flow rate as the acinar cells have less time to modify
the ion concentrations. In addition to inorganic ions, saliva secreted by the parotid
gland also contains cholesterol, mucin, and enzymes such as L-amylase, lingual lipase
and lysosyme [72].
The parotid gland is not entirely composed of acinar cells and ducts, and also con-
tains arteries, veins, intraglandular ducts, lymphatic vessels and intraglandular lymph
nodes, which can be visualised using some MR pulse sequences [71]. Previous DCE
MRI analyses using a Kety-style model has found a small but detectable fraction
(3− 4%) of the parotid gland is vascular plasma, and a significant portion ( 20%) is
extravascular and extracellular [73]. However, it should be noted that these results
have not been validated.
There is nearly a 45% variation in normal salivary flow rates, which are dependent on a
variety of factors including circadian rhythms, hunger, emotional state, physical activ-
ity, and hydration [74, 71]. Salivary flow rates can reach up to 1 ml/min/g of tissue,
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Figure 2.8: A schematic drawing showing the acinar cells surrounding the acinar lumen,
where saliva is secreted, stored, and modified.
which may be significant for DCE MRI. The rate of salivary flow is paralled by the
rate of blood flow through the gland; the maximum rate of blood flow is thought to
be approximately 10 times the rate in actively contracting skeletal muscle [71].
For the purposes of DCE analysis, it should be remembered that the blood flow
and salivary flow to the gland can vary widely for a variety of reasons. Ideally, tissue
parameters such as blood flow and the volume of the extravascular-extracellular space
should remain constant during a DCE data acquisition in order to allow accurate
estimates of these parameters. Thus, steps should be taken to minimise any variation
in factors which could affect the rates of blood flow and salivary production during
the DCE acquisition.
It is hoped that the DCE MRI protocol in chapter 8 will eventually be used in oncology
patients. However, for preliminary testing and development this protocol was run in
healthy volunteers. The parotid gland was chosen as the tissue of interest for this
volunteer study because it possesses DCE MRI characteristics which mimic tumour
tissues in the sense that the parotid gland experiences good tracer uptake and leakage,
and possesses a measurable plasma and interstitial space. These characteristics are
important for the type of DCE MRI analysis that could potentially be transferred to
tumours if patient data are acquired with this protocol in the future.
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2.5.3 Arterial blood
Arterial blood consists of a number of different components suspended in plasma. Red
blood cells, leukocytes, platelets, plasma proteins, nutrients, electrolytes, metabolic
by-products, hormones, and other substances are all present in different proportions.
Red blood cells (erythrocytes) normally compose about 42% of the total volume of
arterial blood sampled in a major artery; this percentage is called the haematocrit.
Plasma typically forms the bulk of the remaining volume, with leukocytes, platelets,
and other elements forming less than 1% of the volume[75].
Arterial blood is propelled around the body by contractions of the heart. The velocity
of arterial blood flow is roughly proportional to the diameter of the vessel. It is fastest
in the aorta (40-50 cm/s), and slowest in the capillary bed (0.03 cm/s) [76], where
the slow flow allows time for exchange of nutrients and waste products between the
blood and tissue. The velocity of venous blood flow is slower (10-30 cm/s in the
vena cavae), because blood is being pumped not by the heart but by the action of
the skeletal muscles, squeezed along the vessels through unidirectional valves which
prevent gravity from pooling the venous blood in the lower extremeties.
For the purposes of acquiring an arterial input function for quantitative DCE analysis,
it is advantageous to image in a larger vessel to avoid partial volume effects with the
surrounding tissue. However, to avoid temporal undersampling of the fast-flowing
arterial concentration, and MRI inflow effects, it is better to acquire in a smaller
diameter vessel with slower flow. In addition, it must be noted that in order for the
arterial input function to be relevant, it should be acquired in an artery which supplies
blood to the tissue of interest if the AIF is to be used for quantitative analysis. Thus,
all of these considerations must be balanced with the available spatial and temporal
resolution of the data acquisition protocol for the optimal acquisition of a relevant
arterial input function.
2.6 Cardiac output
Cardiac output is a measure of the net volume of blood pumped by the heart per
minute. Cardiac output depends on a number of factors such as age, body size,
general health, and posture (upright or prone). Cardiac output generally decreases
72
Chapter 2. Background
with age [77], and increases with weight [78]. Cardiac output increases when a person
is prone rather than upright [79]. One metastudy has estimated the average cardiac
output in healthy adults at rest as (6.5± 1.46)L/min [80], although there is likely a
broad range of what can be considered a ‘normal’ cardiac output. Values between 4
and 8 L/min for an adult are considered normal by some sources [81], and examples
at either end of the range can be cited: Fagard et al. found a mean cardiac output
of (7.8 ± 1.8) L/m in men aged 16-24 in the supine position [77], while Sugawara et
al. found a mean of (4.1 ± 1.3) L/min in healthy subjects during semisupine resting
[82]. This ‘normal’ range may be broadened when considering factors such as age,
body size, general health and fitness, and the measurement technique used.
Total cardiac output can be simply calculated as the product of the cardiac stroke
volume with the heart rate.
CO = stroke volume× heart rate (2.39)
Phase contrast MRI can be used to map the velocity of blood flow in L/min in the
ascending aorta. The stroke volume of the left ventricle is given by the integral of
flow in the ascending aorta over one cardiac cycle; this can be multiplied by the heart
rate to give an accurate estimate of cardiac output [83].
Alternatively, dynamic contrast enhanced MRI can be used to estimate cardiac output
using the indicator dilution principle (also known as the Stewart Hamilton principle),
which states that the cardiac output is related to the injected dose of contrast agent
D divided by AUC, where AUC is the area under the curve of the the concentration
of contrast agent vs time on its first pass through the artery of interest [84, 85, 86, 87].
The Stewart Hamilton equation is:
CO =
D
AUC
(2.40)
This can be seen by considering an injection of contrast agent into a system of constant
flow and constant volume. Consider a dose D of contrast agent injected into the
system at time zero. The concentration of contrast agent C(t) measured at the exit
of the system is related to the mass of contrast agent m present in a volume V :
C = m/V (2.41)
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The flow F of a cylinder of fluid is given by its area A multiplied by its velocity. For
a constant velocity given by the distance travelled by the fluid x in a time t:
F = A
x
t
= V/t (2.42)
The volume V from equation 2.41 can be used in equation 2.42 to find
F =
m
tC
(2.43)
If we integrate the area under the flow curve to obtain the cardiac output CO, this
equation implies that the cardiac output is equal to the total dose of tracer D divided
by the area under the concentration curve over time AUC, and we arrive back at
equation 2.40 [88, 85].
The concentration should be calculated in whole blood where the tracer used does
not enter the red blood cells [89]. Equation 2.40 assumes that the bolus injection of
contrast agent can be measured without recirculation effects, and that the contrast
agent and plasma mix completely. This equation also assumes that the system has
a single inflow and outflow; this assumption may be violated in cases where there
is considerable tracer leakage between the point of injection and the point of mea-
surement. Additionally, equation 2.40 assumes that the system is stationary, and
possesses constant volume and flow [85]. Assumptions and applications of this equa-
tion are discussed in section 6.9, and in [85].
2.7 Summary
In this chapter, we have summarised the basics of DCE MRI, DCE CT, and water
exchange that are relevant to the investigation of the effect of water exchange on DCE
MRI in this thesis. Other background information relevant to the tissues imaged in
the datasets used in this work and the pulse sequences and imaging techniques used
was also introduced. In the next chapter, the tracer kinetic modelling techniques
used are presented, and the development of a model incorporating water exchange
effects (the WX-2CXM) is presented.
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Developing a tracer kinetic model
incorporating water exchange: the
WX-2CXM
3.1 Introduction
In the previous chapter, background details of DCE MRI and DCE CT were reviewed.
In order to investigate whether water exchange has an impact on the tracer kinetic
parameters estimated using current clinically relevant DCE MRI techniques, it is
necessary to use a model which includes water exchange effects. Ideally, in order to
compare DCE MRI results with DCE CT results, the same model should be used to
analyse both MR and CT.
In this chapter, models for performing quantitative DCE analysis will be discussed,
leading to the development of a new model incorporating water exchange effects
which will be used for the analysis of MR and CT data in this thesis. First, the
diffusion Bloch equations are introduced for modeling water diffusion. Next, the two
compartment exchange model of tracer kinetics (2CXM) is introduced, and combined
with the diffusion Bloch equations to form the new model which accounts for the
effects of water exchange on tracer kinetics: the water exchange modified 2CXM (WX-
2CXM). The two mathematical limits of this model representing fast (FXL) and no
(NXL) water exchange are introduced; both the full WX-2CXM and its mathematical
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limits will be important in the analyses in chapters 4 through 8. Finally, to close
this chapter, restrictions of the 2CXM including the one compartment model (1CM),
extended Kety, and uptake models are reviewed. These restrictions of the WX-2CXM
will be important in justifying the use of the 2CXM in sections 5.1 and 8.4.1.
3.2 The diffusion Bloch equations
The protons in water molecules are the dominant source of signal in most 1H MRI.
Water molecules are not stationary, but are constantly flowing, diffusing, and being
pumped around the body. The diffusive motion of the water molecules can be modeled
using the diffusion Bloch equations, which describe the effects of water diffusion on
the magnetisation M in a homogeneous magnetic field [90, 91].
d
dt
(
Mxy(r, t)
Mz(r, t)
)
=
[
O •D(r)−
(
iω0 − 1/T2(r)
1/T1(r)
)](
Mxy(r, t)
Mz(r, t)
)
(3.1)
Here D(r) is the local diffusion coefficient of water, Mxy(r, t) and Mz(r, t) are the
local transverse and longitudinal magnetisations with relaxation rates T2 and T1, and
ω0 is the Larmor frequency. Equation 3.1 describes unrestricted diffusion. However,
in tissues, water often encouters semi-permeable barriers. By defining spatially de-
pendent diffusion coefficients and relaxation rates, these equations can be used to
describe the diffusion of water between an arbitrary number of compartments. Equa-
tion 3.1 can be simplified by eliminating the transverse magnetisation; for the spoiled,
short TE, T1- weighted DCE MRI sequences being considered, only the longitudinal
magnetisation equation is needed [91]:
d
dt
Mz(r, t) =
(
∇D(r)∇− 1
T1(r)
)
Mz(r, t) (3.2)
The solution to a multi-compartment version of equation 3.2 is not exact, but is found
using methods such as a generalised moment expansion, finite difference approxima-
tion, Newtons method [91], shooting method, or Simpsons method [92]. Both Barsky
[91] and Bauer [92] found piecewise solutions using cylindrical coordinates with re-
flective boundary conditions. Bauer et al. have applied this model to study water
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exchange between intracapillary and extracapillary compartments, with the capillary
wall included as a barrier between the two compartments [92]. Barsky applied a
similar model to study water exchange between spherical liposomes and extracellular
water, as well as between the intracapillary and extracapillary space [91].
3.2.1 Two compartments
Instead of solving equation 3.2 directly, one can define a series of compartments with
an associated set of exchange equations describing the flow of magnetisation between
the compartments. In this paradigm, the spatial localisation of magnetisation within
each compartment is lost, since magnetisation is localised only in terms of being ei-
ther inside or outside a particular compartment. This model is illustrated in Figure
2.6. The rate of water exchange between the two pools is described by the inverse
of the average length of time which a water molecule spends in each compartment
(τ). Whether the water exchange is described as fast or slow depends on the mag-
nitude of the difference between the compartmental T1’s relative to the sum of the
exchange rates. The average length of time it takes for a water molecule to cross
from compartment i to compartment j is the water residence time τi, while the rate
at which molecules move between compartments i and j is the transfer constant kij.
The transfer constant is the inverse of the water residence time.
The introduction of separate equations for each compartment simplifies the mathe-
matics considerably, allowing an analytical solution to be calculated. Consider two
compartments: the intravascular blood plasma p and the extravascular extracellu-
lar space (EES), e. The system of equations describing longitudinal magnetisation
between the two compartments is sometimes called the two-site exchange equations
(TSEE) [91, 57]. The TSEE are [93, 94]:
d
dt
(
Mp(t)
Me(t)
)
=
(
−Rp − 1/τp 1/τe
1/τp −Re − 1/τe
)(
Mp(t)
Me(t)
)
(3.3)
Where Mi is the magnetisation in compartment i, Ri = 1/T1i is the longitudinal
relaxation rate in compartment i, and τi is the average time that a molecule spends
in compartment i before crossing to compartment j. Since one particle must enter
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compartment i for each particle that exits, detailed balance requires [94]:
vp
τp
=
ve
τe
(3.4)
Where vi is the fractional volume of compartment i. In addition to equation 3.3, the
normalisation of initial magnetisation is commonly specified [95]:
Mp(0) +Me(0) = 1 (3.5)
After comparing the spatially dependent two-compartment set of exchange equations
with the exact solutions of equation 3.2, Barsky finds that for uniform initial condi-
tions and simple geometries the simplified compartmental solution (3.3) agrees well
with the full spatially dependent solution (3.2), and the spatial information provided
by the more spatially-dependent exact solution provides no significant advantage [91].
3.2.2 Greater than two compartments
To the above system of equations (equation 3.3), Stanisz adds a third (decoupled)
equation describing the magnetisation of protons associated with macromolecules
(M), with the assumption that they do not exchange with water inside the other
compartments [95].
dMM(t)
dt
= −RMMM(t) (3.6)
The normalisation condition is thus modified to
Mp(0) +Me(0) +MM(0) = 1 (3.7)
While the macromolecular pool is necessary to fit the ex vivo CPMG data acquired
by Stanisz et al. (Carr-Purcell-Meiboom-Gill or CPMG sequences are spin echo type
MRI pulse sequences), it is unclear whether this pool would have a significant im-
pact on the SPGR sequences commonly used in T1-weighted DCE MRI experiments
in vivo. It seems more likely that the addition of an intracellular pool exchanging
with the extravascular-extracellular pool would have a greater impact on the mod-
elling of T1-weighted DCE MRI data. An intracellular pool can easily be added as
a third compartment in the TSEE (equation 3.3). In this way, a description of wa-
ter exchange between the intravascular, intracellular, and extravascular-extracellular
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compartments can be formulated. This is illustrated in Figure 3.1.
Figure 3.1: A linear three pool model of water exchange including the intravascular plasma
(p), intracellular (ic), and extravascular-extracellular (e) pools.
The equations describing the three pool system are a simple extension of the two pool
system [27], where compartment i has been added in exchange with compartment e.
The three pool equations have similar constraints to those for the two pool system:
normalisation of initial magnetisation, and detailed balance [27]:
Mp(0) +Me(0) +Mic(0) = 1
ve
τe
=
vic
τic
+
vp
τp
(3.8)
Note that in this case, equation 3.8 shows that due to detailed balance, the exchange
rate between compartments e and p is given by vp/(veτp) = 1/τe − vic/(veτic), while
the exchange rate between e and ic is given by vic/(veτic) = 1/τe − vp/(veτp).
The three pool system is shown in equation 3.9 [27]:
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d
dt
 Mp(t)Me(t)
Mi(t)
 =
 −R1p − 1/τp 1/τe −
vic
veτic
0
1/τp −R1e − 1/τe 1/τic
0 1/τe − vpveτe −R1ic − 1/τic

 Mp(t)Me(t)
Mic(t)

(3.9)
These three-pool equations are the basis for the description of water exchange used
in the models developed in the current project: pool p is the intravascular plasma
space, pool e is the extravascular extracellular space, and pool ic is the intracellular
space.
3.3 The 2CXM of tracer kinetics
The tracer kinetic model described in this section has some similarities to the diffusion
Bloch equations used to model water exchange in the previous section. Both types
of model describe the same process, which is the movement of molecules between dif-
ferent tissue compartments. Water exchange and tracer movement are two processes
which occur simultaneously in a DCE scan. The primary difference between the two
processes is that contrast agent arrives as an arterial bolus which diffuses out into
the extravascular extracellular space but cannot enter the intracellular space, while
water is always present in all compartments.
The movement of tracer from the plasma to the extravascular extracellular space
can be described using the two compartment exchange model (2CXM), a two com-
partment model of tracer kinetics based on linear and stationary systems theory
[96, 97, 98, 99]. This model (shown in Figure 3.2) consists of two compartments sep-
arated by a permeable membrane, described by a system of two coupled differential
equations. The first compartment experiences an externally generated flow of plasma
and contrast agent Fp which diffuses into the second compartment. For the purposes
of in vivo tracer kinetics, the two compartments are typically assigned to be the in-
travascular plasma and the extravascular extracellular space, with concentrations Cp
and Ce of contrast agent respectively. The concentration of tracer in arterial plasma
is Ca. The concentration of tracer is defined as the number of tracer particles in
a compartment divided by the volume of that compartment. Tracer can only enter
or leave the system via the flow through the plasma compartment, and because the
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Figure 3.2: The two compartment exchange model is a two pool model of tracer kinetics
derived from linear and stationary systems theory. The arterial input function Ca is an
input into the plasma compartment. The plasma compartment and extravascular compart-
ment undergo symmetric bidirectional exchange, described by the permeability surface area
product PS. The fluxes into and out of the intravascular plasma p and EES e compartments
are indicated with arrows.
system is stationary, the flows of tracer entering and leaving the plasma compartment
must be equal. The flux of tracer out of a compartment is proportional to the average
concentration inside the compartments, so that the flux of tracer into the system is
proportional to FpCa, and out of the system is FpCp, with units of mmol/min (these
fluxes will be normalised to volume, so the units become mmol/min/ml). The fluxes
into and out of the EES are PSCp and PSCe, respectively..
Combining these expressions for fluxes with the principle of conservation of (tracer)
mass to each of the plasma and EES compartments gives the system of two coupled
differential equations which define the 2CXM:
vp
dCp
dt
= PSCe + PSCp − FpCp + FpCa (3.10)
ve
dCe
dt
= PSCp − PSCe (3.11)
These equations can be solved for Ce and Cp. The solutions are given by the convo-
lution of the arterial concentration with a residue function Re(t) or Rp(t) [100]:
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vpCp = FpRp ⊗ Ca
veCe = FpRe ⊗ Ca
(3.12)
where the expressions for the residue functions Rp and Re are given by the following
equations [101, 102]:
Rp = (1− E−)K+e−tK+ + E−K−e−tK−
Re =
e−tK− − e−tK+
K−1− −K−1+
E− =
K+ − Fpvp
K+ −K−
K± =
1
2vevp
(
veFp + PS(ve + vp)±
√
(veFp + (ve + vp)PS)
2 − 4PSFp
)
(3.13)
The tissue concentration is defined as the weighted sum of the compartmental con-
centrations
Ct = veCe + vpCp (3.14)
where vi is the fractional volume of water in compartment i relative to the total
volume of water in the region of interest. Because vi are fractional volumes, they
are constrained by ve + vp ≤ 1: the extracellular volume must be less than the total
volume of the region. If the solutions to equations 3.10 and 3.11 are summed in
this way and combined with equations 3.12, these equations can be used to find a
biexponential form for the residue function for the tissue [101]:
Ct = R(t)⊗ FpCa(t)
= Fp
∫ t
0
R(t− u)Ca(u)du
(3.15)
In equation 3.15, the residue function for the tissue R is given by the following
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expression [102]:
R(t) = (1− E−) e−tK+ + E−e−tK− (3.16)
Note that in the 2CXM, the concentration in plasma Cp is defined separately from
the concentration entering the system through the feeding artery Ca. This leads to
the introduction of the time dependent AIF Ca in equation 3.10, providing a means
to directly estimate Fp.
This can also be more compactly written as a matrix exponential, which allows Ce
and Cp to be separated from the total concentration Ct using equations 3.12 and 3.13:
(
Cp
Ce
)
= Fp e
−Xte1 ⊗ Ca (3.17)
Here, e−Xt is a matrix exponential and e1 is the unit vector [10]. X is the matrix of
coefficients controlling exchange between the compartments, and is given by:
X =
(
Fp + PS −PS
−PS PS
)
(3.18)
The 2CXM contains a number of assumptions. Firstly, as the name suggests, it as-
sumes that the tracer is distributed over two tissue compartments (typically, the EES
and vascular space). This assumption holds for most low molecular weight tracers
and most tissues; however, it may break down in areas of necrosis or intracellular
leakage; the 2CXM, and indeed most tracer kinetic models, are not suited for quanti-
tative analysis of such tissues. The 2CXM also assumes that the tracer is uniformly
distributed in the capillary bed, that there is a single inlet into the vascular space,
that there is symmetric exchange across the boundary between the EES and vascular
compartments, and that tracer can only enter or leave the EES via exchange with
the vascular compartment. These assumptions mean that the 2CXM must be used
with caution in the liver and kidneys. Although the liver has a dual blood supply
for the vascular compartment, Sourbron et al. suggest that the 2CXM can still be
applied in the liver with the use of an appropriate input function [103]. The 2CXM
must be modified for use in the kidneys, where tracer cannot re-enter the vascular
compartment once it has entered the EES, or where the tracer leakage is sufficiently
slow that it does not begin to re-enter the vascular compartment within the time
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of the imaging experiment. In situation with slow tracer leakage, restrictions of the
2CXM may be used (see section 3.4).
Further exploration of the 2CXM, and its matrix form are given in [96, 103].
3.4 Restrictions of the 2CXM: the 1CM, uptake,
and extended Kety models
Although the 2CXM itself is a general and widely applicable model of tracer kinetics,
there are several restricted or reduced versions of the 2CXM that may be useful
in situations where the full 4 parameter model is not appropriate, for example, for
short DCE acquisitions, or in tissues where one of the compartments is negligibly
small. The 1CM, uptake, and extended Kety models are each useful restrictions of
the 2CXM. These models and their relationship to the 2CXM will be summarised
here.
We will begin from equations 3.11 and 3.10, state the restrictions, and derive the
restricted models from these equations. For reference, these equations are:
vp
dCp
dt
= PSCe − (Fp + PS)Cp + FpCa
ve
dCe
dt
= PS(Cp − Ce)
As before, in these equations ve and vp are the fractional volumes of plasma and
EES in the tissue. Ce, Cp, and Ca are the concentrations of contrast agent in the
EES, tissue plasma, and arterial plasma, defined as the amount of contrast agent
divided by the volume of the compartment. Fp is the flow of plasma, and PS is the
permeability surface area product, both normalised to the tissue volume, in units of
ml/min/ml.
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3.4.1 The extended Kety model
The extended Kety model is one of the most commonly used models in T1 weighted
DCE MRI analysis. It was developed for use in the brain with lower temporal res-
olution data [104], and can be derived from the 2CXM by assuming that flow is
unlimited. This can be seen by dividing equation 3.10 by Fp and setting 1/Fp = 0.
This has the result that the plasma concentration is equal to the AIF:
Cp(t) = Ca(t) (3.19)
Equation 3.11 then becomes:
ve
dCe
dt
= PS(Cp(t)− Ce)
= PS (Ca(t)− Ce) (3.20)
One can solve this equation for Ce to find
Ce(t) =
PS
ve
e
−PS
ve
t ⊗ Ca(t) (3.21)
In the literature, the system of equations 3.19 and 3.21 are typically summed together
to give the total concentration C = vpCp + veCe
C(t) = vpCa(t) + PSe
−PS
ve
t ⊗ Ca(t) (3.22)
This is typically called the extended Kety or modified Tofts model, to distinguish it
from the Kety model (section 3.4.2, below) which assumes a negligible vp.
The extended Kety model does not allow for the measurement of plasma flow Fp.
Instead, the three fitted parameters are the fractional plasma volume vp, fractional
EES volume ve, and PS. The extended Kety model is only applicable in tissues with
a high flow. In tissues with intermediate or low flows, or highly permeable vessels,
the extended Kety model may produce parameter estimates with an ambiguous rela-
tionship to the underlying physiology which will be vulnerable to misinterpretation.
The use and interpretation of the extended Kety model is discussed in detail in [103].
85
Chapter 3. Developing a tracer kinetic model incorporating water
exchange: the WX-2CXM
3.4.2 The one compartment model (1CM)
If vp is set to 0 in the 2CXM, the result is a single compartment model which we
will call the 1CM (also commonly called the Kety or Tofts model). The elimination
of one of the 2CXM compartments may be useful, for example, in muscle. Many
muscle tissues have a very small vp compartment such that model fitting fails to
return reasonable values for vp. Because the one compartment model was developed
for use in the brain [104], and is suitable for use in tissues with a negligible vascular
pool [103] the 1CM could be tried in such situations. If vp = 0, equation 3.10 can be
solved for Cp:
Cp =
1
PS + Fp
(FpCa + PSCe) (3.23)
This can then be substituted into equation 3.11 to create a differential equation in
terms of Ce and Ca
ve
dCe
dt
=
PSFp
PS + Fp
(Ca − Ce) (3.24)
This can be solved for Ce. Again with vp = 0, the solution to equation 3.24 can be
substituted into equation 3.14 to give the tissue concentration C(t):
C(t) =
PSFp
PS + Fp
e
−PSFp
ve(PS+Fp)
t ⊗ Ca(t) (3.25)
If we let Ktrans = PSFp/(PS + Fp) [103], the parameter K
trans can be used to write
the 1CM model (which is also known in the literature as the Kety or Tofts model) in
the commonly used form [25]:
C(t) = Ktranse
−Ktrans
ve
t ⊗ Ca(t) (3.26)
As can be seen from the derivation, this equation only applies in tissues with negli-
gible vp. The 1CM cannot be used to separately estimate Fp or PS, and the com-
bination of the two, Ktrans, is generally estimated in 1CM fitting. Because Ktrans
is a combination of Fp and PS, its interpretation varies depending on the perfusion
and permeability characteristics of the tissue [25]. For example, Ktrans ≈ Fp when
PS  Fp, and Ktrans ≈ PS when Fp  PS [103, 25].
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Further discussion of the 1CM and its relationship with the 2CXM and extended
Kety model are given in [25, 103].
3.4.3 The uptake model
The uptake model is derived from the 2CXM by setting the backflow from the EES
to the plasma equal to zero. As the rate constant for the transfer of contrast agent
from the EES to the plasma is equal to PS/ve, setting the backflow to 0 is equivalent
to an effectively infinite ve. Because the tracer appears to be diffusing into a limitless
reservoir in the absence of backflow from the EES to the plasma, the uptake model
thus cannot be used to estimate ve. This model is useful in situations where the data
acquisition is not long enough to allow the concentration of tracer in the vascular and
extravascular-extracellular spaces to stabilise, meaning that the tissue concentration
of CA continues to rise through to the end of the acquisition. Although contrast agent
may still be diffusing out of the EES, this cannot be modelled if the concentration of
CA is still rising at the end of the acquisition. When the outflow of tracer from the
EES is set to 0, the 2CXM simplifies to [101]:
vp
dCp
dt
= − (Fp + PS)Cp + FpCa (3.27)
ve
dCe
dt
= PSCp (3.28)
Which can be solved for Cp and Ce. If we sum these solutions, C = vpCp + veCe:
C(t) =
(
(1− E)e−t
Fp+PS
vp + E
)
⊗ FpCa (3.29)
where
E =
PS
PS + Fp
(3.30)
3.5 Combining the 2CXM with the diffusion Bloch
equations: the WX-2CXM
Having considered the models that can be derived by restricting the 2CXM, an ex-
pansion of the 2CXM will now be developed. The WX-2CXM is a model of tracer
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kinetics which accounts for water exchange effects on DCE MRI, and incorporates
two additional fitting parameters to the four parameters used in the 2CXM. In order
to account for the effects of water exchange on DCE MRI, the diffusion Bloch equa-
tions are used to modify the relationship of signal to the concentration calculated
using the tracer kinetic models described above.
For any quantitative DCE MRI sequence, there exists an equation describing the
relationship between the magnetisation M (which is proportional to signal intensity
S) and the T1 or T2 properties of the tissue. DCE MRI sequences are typically T1
or T2 weighted: the contrast in a MR image is primarily due to either the T1 or T2
properties of the tissue. One commonly used sequence in DCE MRI is the spoiled
gradient echo sequence (SPGR), where the signal is described by [2]:
S = S0sinα
(
1− e−TRR1
1− cosα e−TRR1
)
e−TE R
∗
2 (3.31)
Here, R1 = 1/T1 and R
∗
2 = 1/T
∗
2 are the longitudinal and transverse relaxation rates.
If the echo time TE is short relative to T ∗2 , then the exponential term e
−TE R∗2 is
approximately 1. For example, the spin-spin relaxivity of Gd-DTPA-BMA in plasma
at 37◦C is 5.2 /mM/s at 1.5 T [105]. Fritz-Hansen et al. took arterial measurements
of Gd concentration in a peripheral artery, and found a maximum plasma concen-
tration of 4.66 mM [1]. Assuming a T2 relaxivity of 5.2/mM/s for Omniscan and a
pre-contrast plasma T2 of 416 ms [106], this gives a post contrast T2 of 60.8 ms. The
TE used in the bladder cancer study was 0.8 ms. If T ∗2 = T2, e
−TE R2 = 0.99. Even
for a T ∗2 much shorter than T2, for example 20 ms, e
−TE R2 = 0.96, indicating that
any T2 effects in these data negligible.
Thus, in the limit TE  T ∗2 , the signal intensity S produced by an SPGR pulse
sequence is related to the longitudinal relaxation rate R1 [107]:
S = S0sinα
1− e−TRR1
1− cosα e−TRR1 (3.32)
Since MR signal is proportional to magnetisation, this equation can be used in con-
junction with the solutions to the coupled Bloch equations describing water exchange
(equation 3.9) to relate signal intensity to T1 (and hence to water exchange). At clin-
ically relevant doses of contrast agent, the change in tissue T1 is related to contrast
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agent concentration by the spin-lattice relaxivity r1. Because the spin-spin relaxivity
r2 is not needed in the equations in this thesis, the spin-lattice relaxivity will be
denoted by r.
We can use the 2CXM in combination with equation 3.32 to describe the change
in DCE MRI signal intensity over time, and include water exchange effects. This
equation is simplest at the fast limit of water exchange (FXL: see section 2.4 for a
discussion of water exchange limits), and in fact, no modifications to the equation are
needed in the fast exchange limit, where the relaxation rate R1 = 1/T1 in the FXL
is the sum of the rates from all tissue compartments weighted by the probability of
a water molecule being in the compartment. Equation 2.23 can be used to relate the
relaxation rate to the concentration of contrast agent C via the longitudinal relaxivity
r. For a tissue made up of plasma p, intracellular ic, and extravascular extracellular
e compartments, with precontrast relaxation rates R1,0p, R1,0ic, and R1,0e, the total
relaxation rate is:
R1 = vicR1ic + vpR1p + veR1e
= vicR1,0ic + vp (rCp +R1,0p) + ve (rCe +R1,0e)
= R1,0tissue + r (vpCp + veCe) (3.33)
The concentrations in the plasma Cp and interstitial compartments Ce are calculated
using the 2CXM equations 3.15. Substituting equations 3.16 and 3.33 into equation
3.32 gives:
S = S0sinα
1− e−TR(R1,0tissue+rvpCp+rveCe)
1− cosα e−TR(R1,0tissue+rvpCp+rveCe)
= S0sinα
1− e−TR
(
R1,0tissue+rFp
R t
0 [(1−E−)e−(t−u)K++E−e−(t−u)K− ]Ca(u)du
)
1− cosα e−TR
(
R1,0tissue+rFp
R t
0 [(1−E−)e−(t−u)K++E−e−(t−u)K− ]Ca(u)du
)
(3.34)
In these equations,
E− =
K+ − Fpvp
K+ −K− (3.35)
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In these equations, R1,0i is the baseline R1 (= 1/T1) of compartment i in the absence
of contrast agent. As before, vi is the fractional volume of compartment i.
The FXL and NXL are the two extreme cases of water exchange. Although equations
3.34 and 3.37 may appear algebraically complicated, they are simplifications of the
full three-pool model for water exchange. In the full model, the signal S is again the
sum of the signal from all three compartments:
S = Sp + Se + Sic (3.39)
For a spoiled gradient echo acquisition where steady state is attained at each time-
point, the signal in each compartment is given by [108, 27]: SpSe
Sic
 = I − eTR X
I − cosαeTRX
 vpve
vic
S0 sinα (3.40)
Where I is the 3×3 identity matrix, eTR X is a matrix exponential, and X is the
transfer coefficient matrix of the three-site water exchange equation, as previously
seen in equation 3.9
X =

−R1v − 1/τp 1/τe − vicveτic 0
1/τp −R1e −
(
1/τe − vpveτic
)
1/τic
0 1/τe − vpveτe −R1ic − 1/τic
 (3.41)
Here, R1i is calculated separately for each compartment, similar to equation 3.36.
These expressions for R1i should then be substituted into the exchange matrix (equa-
tion 3.41) to calculate the total signal using equations 3.39, 3.40, and 3.41.
This full WX-2CXM is a new model of DCE MRI tracer kinetics incorporating water
exchange effects using 6 free fit parameters: the four 2CXM parameters Fp, PS, ve,
and vp plus the water residence times τp and τic. The third compartmental residence
time τe is calculated from the other two compartmental residence times via equation
3.8 for τe:
τe =
ve
vp
τp
+ vic
τic
; (3.42)
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The full 6 parameter WX-2CXM is more versatile than the 2CXM in the sense that
it can be used to fit MRI data which shows evidence of water exchange effects.
However, fitting a 6 parameter model requires high quality data with good temporal
resolution and minimal bulk motion. Caution must be used to ensure that the data is
of sufficient quality to allow informative fitting of the full model; the use of a decision
criteria such as an F-test (for nested models) or the Akaike Information Criterion
(for non-nested models) can aid in the decision as to whether a particular dataset
is appropriate for fitting with a 6 parameter model, or whether a model with fewer
parameters would be more suitable. The use of F-tests to examine the suitability
of various models for fitting individual datasets will be demonstrated in sections 5.1
and 8.4.1.
3.6 Discussion
The 2CXM of tracer kinetics has 4 free parameters: Fp, PS, vp, and ve. When water
exchange effects are added, the WX-2CXM has 6 free parameters: the 4 parameters
of the 2CXM (Fp, PS, vp, and ve), plus two additional parameters describing the
residence time of water in the vascular (τp) and intracellular compartments (τic).
The restrictions of the 2CXM discussed in this chapter have 3 and 2 parameters: the
extended Kety model can be fit to estimate the three free parameters vp, PS, and
ve. The uptake model also has three free parameters: Fp, vp, and PS, while the one
compartment model has two free parameters, ve and K
trans.
The use of each of these models in DCE analysis depends on the tissue being imaged,
the information required from the analysis, and the protocol used for data acquisi-
tion. The tissue being imaged will influence the model which should be used for the
analysis because, for instance, tissues with a negligible vp, such as muscle, or with no
tracer leakage, such as healthy brain, will require different models than leaky tumour
tissue with a large ve and vp. The type of results required from the analysis will
also fundamentally influence the choice of model. If quantitative information about
tissue physiology is not of interest, a model may not be required at all, while if the
intracellular residence time of water is desired, the 6 parameter WX-2CXM must
be used. The acquisition protocol will also influence the ability to use a particular
model for the analysis because of the influence of the acquisition on data quality and
sensitivity. A high dynamic temporal resolution, good SNR, and sufficient acquisition
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length to allow tracer backflow into the vascular compartment are required for the
use of the 6 parameter WX-2CXM model. If the acquisition protocol has a lower
temporal resolution or SNR, or a short acquisition time, one of the restricted models
with fewer parameters may be more appropriate. F-tests can be used to select the
most appropriate model out of several nested models for DCE analysis; this tech-
nique will be explored in sections 5.1 and 8.4.1. Nested models are models which
are related by a restriction of parameters. For example, the 1CM is a nested model
for the 2CXM because it can be derived from the latter by setting vp = 0. All of
the models in this chapter are nested; the 6 parameter WX-2CXM can be considered
the ‘parent’ model, which can be restricted to derive the 4 parameter 2CXM, the 3
parameter uptake or extended Kety models, or the 2 parameter 1CM.
The FXL and NXL are restrictions of the WX-2CXM which involve assuming that
water exchange is fast (occurring when the net exchange rate 1/τ is much greater
than the difference between the compartment relaxation rates 1/T1) or negligible.
The magnitude of the difference between the two limits of the WX-2CXM can be
considered as an indication of the maximum possible impact of water exchange on
a tracer uptake curve, or on a set of parameter estimates. This can be useful for
deciding whether water exchange may be having an impact on a dataset, since in
most tissues, the rate of water exchange is neither infinitely fast nor infinitely slow
but rather some (often unknown) intermediate rate. Given a set of input parameters
(flip angle, TR, signal, tissue compartmental T1s) calculating the difference between
the extremes of the FXL and NXL will give some indication of the upper and lower
bounds of water exchange effects. This technique of using the FXL and NXL to
estimate potential water exchange sensitivity will be used in chapters 4, 5, and 8 to
estimate the potential impact of water exchange on a clinical bladder cancer dataset,
simulated data, and a parotid dataset, respectively.
3.6.1 Summary
In this chapter, the 2CXM of tracer kinetics and the diffusion Bloch equations were
introduced as the roots of the WX-2CXM, and restrictions of the 2CXM including the
Kety and extended Kety models, the 1CM, and the uptake model were introduced.
These models will be applied in subsequent chapters to clinical data (chapters 4 and
6), simulated data (chapters 5 and 7), and volunteer data (chapter 8). The influence of
acquisition parameters on the shape of the tracer uptake curves and on the sensitivity
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of the data to water exchange is explored in chapters 5 and 7. The use of F-tests and
the effect of model choice on DCE MRI analysis will be discussed in sections 5.1 and
8.4.1.
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4.1 Introduction
In the previous chapter, the WX-2CXM was developed. In this chapter, the model
and its mathematical limits the FXL and NXL are used to investigate whether water
exchange has a measurable effect on clinical DCE MRI data; the next chapter (chapter
5) expands upon the analysis in this chapter, examining the effects of various factors
including model choice, AIFs, flip angle, TR, precontrast T1, and contrast agent
relaxivity. The subject of this analysis is a dataset with matched DCE CT/DCE
MRI in bladder cancers that had been acquired as part of another project and was
made available to the author. This dataset was well-suited for this analysis because
DCE CT is not affected by water exchange, and so can serve as a ‘gold standard’
for comparison with MRI for the evaluation of water exchange effects. These data
were acquired as part of a study investigating whether the typical clinical protocols for
DCE MRI and DCE CT produced comparable estimates of tracer kinetic parameters,
as such the standard CT and MR protocols were used, resulting in differences in
terms of spatial resolution, temporal resolution, and contrast agent injection protocols
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between the two modalities. The tumours in this dataset were well suited to ROI
analysis because of their homogeneity, minimising any signal changes lost by averaging
together signals from all voxels in the ROI to increase the SNR. The homogeneity
of the tumours also ensured that any mismatches in the CT and MR fields of view
would not change the results dramatically. Some of the tumours in this dataset were
quite large, and did not fit entirely within either the CT or MR fields of view. Naish
et al. performed an investigation into the impact of this mismatch by analysing only
the MR data which matched with the CT data, and found no significant changes
in the parameter estimates produced [109]. An ROI analysis was chosen for this
investigation in an attempt to obtain sufficient signal-to-noise for the full WX-2CXM
6 parameter fit. However, attempts to fit the WX-2CXM proved unsuccessful [110].
4.2 Materials and Methods
Twelve male patients aged 53 - 80 years old (mean: 69 years) with stage T2 to T4
primary bladder cancer underwent DCE CT followed by DCE MRI within one week
with a mean interscan interval of (4.1 ± 2.2) days.
4.2.1 DCE MRI
DCE MRI was performed on a Philips Intera 1.5 T system using a 3D T1-weighted RF
spoiled gradient echo sequence (known as a fast field echo (FFE) technique for Philips
scanners) with a flip angle/TR/TE of 20◦/4 ms/0.8 ms, FOV of 375×375×100 mm,
and a matrix of 128×128×25. Axial volumes were acquired every 5 s for a total
scan time of 6 minutes. 0.1 mmol/kg gadodiamide (Omniscan, GE Healthcare, Oslo,
Norway) was injected after the sixth dynamic timepoint using a power injector at
3 ml/s followed by a saline flush of the same volume. Pre-contrast tissue T1 was
calculated using a 3D T1-weighted SPGR variable flip angle technique [111], which
used flip angles of 2◦, 10◦ and 30◦ with TR/TE = 4 ms/0.8 ms and 4 signal averages.
In all patients, the DCE MRI volume encompassed the DCE CT volume.
96
Chapter 4. Investigating water exchange effects in a clinical DCE
MRI dataset by comparison with DCE CT
4.2.2 DCE CT
DCE CT was performed on a GE Lightspeed Plus scanner. Prior to dynamic imaging,
a conventional CT pelvic scan was performed to locate the tumour. The DCE CT
acquisition was performed at 120 kV p, 80 mAs, using a single slab passing through
the tumour with 4×5 mm collimation. Images were acquired every 1 s for the first 60
s, then every 30 s for a further 4 minutes, giving a total scan time of 5 minutes. This
temporal sampling scheme was chosen to minimise radiation dose while providing
sufficient temporal resolution over the first pass of the contrast agent through the
tissue; the technique of sampling the first pass more densely than the later data is
commonly used in DCE CT [97, 112, 113]. A standard dose bolus (100 ml) of the
iodinated CT contrast agent iohexol (Omnipaque 300, GE Healthcare, Oslo, Norway)
was injected immediately before the start of the dynamic scans at a rate of 5 ml/s.
Four 5 mm slices (FOV 340 to 380 mm) were reconstructed at each time point with a
512×512 matrix. The effective dose from these scans was approximately 16-24 mSv
(depending on the organ), with an estimated dose to the bladder of approximately
150 mGy.
4.2.3 Post-processing
For this analysis, the MR arterial input function was automatically extracted using
the MaDyM software as described in [30]. This software selects the 5% of timecourses
with maximal signal change which reach peak concentration within 10 s of contrast
agent injection. The MaDyM software is routinely used for the analysis of clinical
trials data by the QBI lab in the department (www.qbi-lab.org). The impact of this
automated AIF selection technique versus a manual AIF definition is examined in
section 5.3. The automated AIF selection was performed in a slice selected in the
inferior half of the imaging volume, intersecting the iliac arteries at the distal end
to minimise inflow effects [114]. The outermost slices were not used, to avoid RF
inhomogeneities. A haematocrit of 0.42 and tracer relaxivity of 4.5 /mM/s were
assumed in all concentration calculations [30, 106]. The FXL and NXL of the 2CXM
were fitted to the MR signal intensity data; conversion to contrast agent concentration
is required to obtain parameter estimates using equations 3.34 and 3.37.
The MaDyM software discussed above was designed for MR AIF extraction and did
not perform well on the CT data; CT arterial input functions were therefore extracted
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manually by averaging the signal from a small region of pixels in the centre of the iliac
artery to avoid partial volume effects. In order to convert CT signal intensity to a
signal proportional to contrast agent concentration, the mean precontrast signal was
subtracted from all images [44]. The precontrast signal was determined by averaging
together all precontrast images; the number of precontrast images was determined
by visually inspecting the mean signal enhancement curves.
Tumour regions were outlined on T1 and T2 weighted MR images and on postcontrast
CT images by an experienced radiographer (Yvonne Watson). To create the final
regions used in analysis, these tumour regions were then trimmed by the author to
remove voxels which might be susceptible to partial volume effects or contamination
with urine due to patient motion or bladder filling.
4.2.4 Analysis
The 2CXM model was fitted to the baseline subtracted CT data, and the FXL and
NXL limits of the WX-2CXM were fitted to the MR signal intensity data. This
produced CT estimates of Fp, PS, ve, and vp, as well as MR FXL and NXL estimates
of the same parameters. All fitting was performed in MATLAB (The MathWorks Inc.,
Natick, MA, USA) using a bounded simplex based nonlinear optimisation where the
sum of squares of the residuals was used as a minimisation function. In the MR fitting,
mean pre-contrast T1s for the tumour regions were calculated using the multiple flip
angle data, and a precontrast T1 of 1.35 s was assumed for blood [115, 116] as the
multiple flip angle data did not give accurate T1s in arterial blood.
4.2.4.1 Statistics
Comparisons of MR and CT, and MR FXL/NXL estimates of Fp, vp, and PS were
performed using two-tailed paired t-tests (see figure 4.4 and table 4.3). Due to fitting
issues, only 5 of the datasets produced estimates of ve (see section 4.4.1). This was
primarily due to the fact that, due to slow tracer uptake in these patients, the tissue
concentration of contrast agent continued to increase beyond the end of the CT ac-
quisitions in these datasets, which means that it is not possible to estimate ve using
the 2CXM. Additionally, one of the datasets (patient 9) was compromised by patient
motion. Two-tailed paired t-tests were used to test for parameter differences. A 3
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test Bonferroni correction can be applied to all p-values to correct for multiple com-
parisons (3 comparisons for each parameter: FXL with CT, NXL with CT, and FXL
with NXL); for example, a p-value of 0.01 would be 0.03 after Bonferroni correction.
The Bonferroni correction is an adjustment that can be applied when multiple tests
have been performed on the same data. It is based on the idea that, if the null
hypothesis is true, and a series of statistical tests is performed on a dataset each
with a significance level α, then there is a probability of α of observing a significant
difference purely by chance. This is a type I error. One way to correct for this is
to divide the significance level by the number of tests performed; equivalently, one
can multiply the p-values by the number of tests performed [117]. The Bonferroni
correction is thus a way of decreasing type I errors (false positives). However, this
comes at the cost of increasing type II errors (false negatives). There is some debate
about the appropriate use of the Bonferroni correction, with some arguing that it
has been too widely adopted and is overly conservative in many situations, resulting
in the loss of potentially significant results [118]. Throughout this thesis, the raw p-
values have been reported, and a moderate Bonferroni correction, correcting not for
the total number of tests, but for the number of tests performed on each parameter
or the number of ‘questions’ being asked, applied. The reader is encouraged to
consider consider both the raw p-values and the Bonferroni correction when reading
conclusions presented.
Bland-Altman plots were produced for MR and CT estimates of Fp, vp, and PS to
examine whether there was any relationship between the mean and difference of the
MR and CT estimates of each parameter (see figure 4.5, section 4.3).
4.3 Results: CT/MR parameter comparison
The CT and MR AIFs, tissue uptake curves, and tumour outlines in a sample slice
from a typical patient are shown in figure 4.1. Of the 12 patients imaged, it was not
possible to fully analyse the MR data from 4 of the patients using the 2CXM. In
one case, the fits to the data were compromised by patient motion. In 3 cases there
was slow tracer uptake, meaning that the data was not well suited for fitting using
the 2CXM (see section 5.1). An example is shown in figure 4.3. These datasets are
excluded from the results discussed here, and only the results from those 8 patients
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Figure 4.1: Representative slices of a) CT and b) MR images are shown with tumour
outlines shown as white overlays. The tumour region used has been trimmed to exclude
pixels containing non-tumour tissues due to urine filling or patient motion. The arterial
input functions from the iliac artery are shown for c) CT and d) MR. The mean signal
intensity in the tumour is shown for the duration of the DCE imaging session (e CT, f
MR). 2CXM fits to the data are shown as solid lines (for MR, the NXL fit is shown as a
dashed line). Figure previously published in [110], reproduced with permission of ISMRM
journals.
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fully analysed with the 2CXM are presented.
Good fitting of the models to the data were observed in all 8 patients (see figure 4.2
for an example), without any observable systematic fitting errors. In the MR data,
the FXL fits had a lower sum of squared residuals than the NXL fits in 7 of 8 patients.
The ratio of the FXL/NXL sum of squared residuals was (0.92 ± 0.10), however the
difference was not significant (p=0.08).
In several datasets, the CT tissue uptake curves showed noticeable peaks during the
first pass of the contrast agent through the tissue (“first pass peaks”) which were
not present in the MR uptake curves from the same patient. Examples of paired
CT and MR uptake curves showing this effect are given in figures 4.2 and 4.3. A
counterexample, in which both the CT and MR uptake curves show small first pass
peaks, is shown in figure 4.1. The suppression of the first pass peak in the MR
uptake curves may be related to non-FXL water exchange between the vascular and
EES compartments, as it occurs during the first pass when there is likely the greatest
difference in T1s between the two compartments, and thus the greatest likelihood for
non-FXL water exchange effects [65, 13]. The suppression of the first pass peak in
the MR uptake curves supports the hypothesis that the significant difference between
CT and MR estimates of vp may be related to water exchange (discussed below).
Figure 4.4 shows the FXL and NXL MR and CT parameter estimates for all patients.
The mean values of these parameters, and the MR-CT differences are given in table
4.3. Figure 4.5 shows the Bland-Altman plots for these parameters. Generally, the
mean and difference shown in the plots of figure 4.5 appear to be unrelated. The
large confidence limits for PS are skewed by one outlier.
When the FXL and NXL MR parameter estimates were compared, Fp, vp, and PS
differed significantly (the NXL estimates of vp and Fp were greater than the FXL
estimates, while the reverse was true for PS), implying that these are the parameters
most sensitive to water exchange in these tumours, because they show the greatest
difference between the two limits of water exchange. When the MR parameters
were compared with CT, MR NXL estimates of vp were significantly higher than CT
estimates (p = 0.0002 after a 3 test Bonferroni correction), and FXL estimates of Fp
were lower than CT, with p = 0.02 after Bonferroni correction. The fact that the
potential for water exchange sensitivity as shown by the MR FXL-NXL difference
was supported by an MR-CT difference for vp and Fp suggests that the differences
for vp and Fp may be related to water exchange.
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Figure 4.2: Typical CT (crosses) and MR (circles) mean uptake data are shown from a
whole-tumour ROI. FXL and NXL fits to the MR data are shown as solid lines. A clear
first-pass peak is visible in the CT data, but is absent in the MR data, which is a possible
indication of limited vascular-EES water exchange. Figure previously published in [110],
reproduced with permission of ISMRM journals.
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Figure 4.3: CT (crosses) and MR (circles) mean uptake data are shown for a tumour which
had slow tracer uptake; tracer concentration was still rising at the end of the acquisition.
As a result, the 2CXM was not used to analyse this dataset (see section 5.1). As in figure
4.2, a clear first-pass peak is visible in the CT data, but is absent in the MR data, which
is a possible indication of limited vascular-EES water exchange.
Figure 4.4: CT and MR parameter estimates for all patients are shown with group means
(solid horizontal lines). FXL and NXL estimates are shown for MR. Fp and PS are in units
of ml/min/ml, while vp is unitless. The asterisk denotes a significant difference between
the CT and NXL MR estimates of vp, and between MR FXL and NXL estimates of vp, Fp
and PS.
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4.4 Discussion and Conclusions
No significant differences were seen between CT and MR FXL parameter estimates
after a 3 test Bonferroni correction, although the difference between CT and FXL
MR estimates of Fp had a p-value of 0.06, which is borderline significant. When
the fast and no exchange limits of the model were applied to the DCE MRI data,
a significant difference was present between the CT and the NXL MR estimates of
vp. The fact that no definitively significant differences were observed between the
CT and FXL MR parameter estimates after Bonferroni correction support the use of
FXL models to fit clinical data, as is currently common practise. However, MR FXL
estimates of Fp were lower than CT estimates, with a p-value of 0.06 after Bonferroni
correction, and so further investigation into the impact of water exchange effects on
Fp are needed.
The observation of a difference between the CT and MR estimates of vp suggests that
there is the potential for water exchange to affect the MR data. It is possible that
this difference could be related to factors other than water exchange. However, MR
FXL and NXL estimates of vp were also significantly different, implying that, if water
exchange were to impact the MR data, it would likely affect vp. The same may also
be true for Fp, as a marginally significant (p=0.06 after a 3 test Bonferroni correc-
tion) difference between CT and MR FXL estimates of Fp was observed, combined
with a significant difference between MR FXL and NXL Fp estimates (p=0.02 after
Bonferroni correction). In addition, a comparison of the first pass of some CT and
MR uptake curves, shown in figures 4.2 and 4.3, reveals that a clear first pass peak is
present in the CT (which, paradoxically, had a longer and slower injection of contrast)
but is absent in the MR curve. This lends further support to some water exchange
effect being present in the MR data, because water exchange which deviated from
the FXL would be expected to reduce the intensity of the MR curve, and would have
the largest effect during the first pass when the difference in compartmental contrast
agent concentrations (and thus in T1s) is greatest. Effects which affect the first pass
of the contrast curve through the tissue could be expected to be related to flow and
vascular parameters (Fp and vp), lending further support to a relationship between
water exchange effects and the observed CT-MR differences in Fp and vp.
Water exchange between the vascular and EES compartments is expected to impact
F and vp, while EES-intracellular water exchange is expected to affect PS and ve.
As shown in figure 4.4 and table 4.3, the differences between the FXL and NXL MR
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Figure 4.5: Bland-Altman plots showing the mean and difference between the CT and
MR parameter estimates for all patients. The left column (A,C, and E) shows MR FXL
estimates while the right column (B, D, and F) shows MR NXL estimates. The top row
(A, B) shows vp, the middle row (C, D) Fp, and the bottom row (E, F) PS. 95% confidence
limits are shown as dashed lines.
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estimates, and between the MR and CT parameter estimates were seen in vp (signif-
icant differences) and Fp (borderline significant differences). Although a difference
between MR FXL and NXL estimates of PS was observed (p = 0.05 after a 3 test
Bonferroni correction), this was not supported by a difference between MR and CT,
and no significant differences were seen for ve. This implies that any water exchange
effect in these data was likely due to vascular-EES exchange (impacting Fp and vp),
and that EES-intracellular water exchange had a negligible effect. This absence of
intracellular-EES exchange effects may have been partly responsible for the difficulty
in fitting the full 6 parameter model to the data, as a lack of information about this
type of exchange could make it more difficult to fit for the EES and intracellular
residence times τe and τic.
Although several other studies have investigated the role of water exchange in DCE
MRI analysis, a consensus has not yet been achieved about the significance of water
exchange effects in clinical practise [119, 60, 13, 120, 121]. Huang et al.. [121] suggest
that their method of water exchange correction results in a significant change inKtrans
and kep values when applied to an MR protocol with significantly lower temporal
resolution in breast tumours; however, this study uses a number of assumptions in
the tracer kinetic modeling that differ from the present study. Landis et al. [119]
found significant underestimates in peak contrast agent concentration when water
exchange was ignored; however, as this work was done in rats using a specialised
pulse sequence, it is unclear whether the results are clinically relevant.
Other investigators suggest that water exchange may not have a significant impact on
clinically relevant DCE MRI protocols in cancers with extravasating contrast agents
[60, 13, 120]. Larsson et al. observed a significant decrease in flow estimates in
the brain (where the contrast agent remained intravascular) which was attributed to
water exchange, but no such effect was observed in the myocardium where there was
extravasation of the contrast agent [13].
This work has investigated the potential impact of water exchange on a clinical DCE
MRI protocol by calculating parameter estimates at the two extremes: the FXL and
NXL. Significant differences were found between MR NXL and CT estimates of vp,
and between MR FXL and NXL estimates of vp, Fp, and PS. The difference between
the FXL and NXL estimates suggests a potential for water exchange effects which is
supported by a significant difference between the CT and the MR NXL estimates for
vp only. However, while this suggests the potential for water exchange effects, these
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results do not support the use of a non-FXL model in clinical DCE analysis.
In practice, water exchange likely lies somewhere between the two extremes of the
FXL and NXL. However, the data were not suitable for analysis with the 6 parameter
WX-2CXM, and preliminary attempts to use this model resulted in large variability
and imprecision for the two additional parameters τe and τic. In chapter 8, the full
WX-2CXM, allowing for intermediate exchange, will be fitted to volunteer data which
were acquired with greater water exchange sensitivity.
4.4.1 Study limitations
It must also be noted that water exchange is only one explanation for the differences
between CT and MR parameter estimates observed here. Differences in the temporal
and spatial resolution, length of data acquisition, contrast agent injections, and ROI
coverage between the CT and MR protocols are important to consider.
The temporal resolution of the MR protocol (5 s) was low relative to CT (1 s); as a
result, temporal undersampling effects were observed in many of the MR AIFs, but
in none of the CT AIFs. However, previous studies [116] suggest that the temporal
resolution used in this MR acquisition is adequate, and the general agreement between
MR and CT results support the validity of the MR/CT comparison, despite the
differing temporal resolutions. The work in chapter 8 uses an increased temporal
resolution in the MR acquisition in an attempt to reduce the temporal undersampling
observed here in the MR AIFs.
Another potentially important difference between the CT and MR protocols was
the shortened period of CT data acquisition relative to the MR; this difference was
exacerbated by the longer contrast agent injection time and larger bolus volume used
in the CT. In many cases, the CT acquisition ended before the concentration of
contrast agent in the vascular and EES compartments had equilibrated; as a result,
it was not possible to obtain ve estimates in 7/12 datasets. However, the other
parameter estimates should not have been affected, and the comparisons between
MR and CT for these parameters remain valid. The results of the simulations in
section 7.2 support the statement that good estimates of Fp, PS, and vp can be
obtained in the absence of a good ve estimate (0 < ve < 1). This is also seen in the
results of analysing the volunteer data in section 8.4. In future comparisons between
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the DCE MRI and DCE CT, it would be advantageous to increase the length of the
CT acquisition to allow estimates of ve. However, the increased acquisition length
would necessarily need to be balanced with radiation dose considerations.
There were differences in the spatial resolution and coverage of the CT and MR
acquisitions: the CT acquisition consisted of four 5 mm slices with an in-plane spatial
resolution of better than 0.74×0.74 mm, while the MR resolution consisted of twenty-
five 4mm slices with an in-plane spatial resolution of 2.9×2.9mm. For tumours which
were larger than the CT volume in the z-direction, the MR volume thus covered more
of the tumour than the CT volume, but at a lower spatial resolution. The tumour
regions for the MR and CT were drawn separately, so there may have been other
coverage differences due to differences in region drawing on the two modalities as
well. However, in a separate study by Naish et al. [109], the tumour regions were
matched between MR and CT and the CT data were downsampled to the MR spatial
resolution on this same dataset. A comparison of the voxelwise analysis revealed no
significant differences as a result of matching the regions and spatial resolutions. This
is likely related to the homogeneity of these tumours, which showed very uniform
parameters throughout.
The two different contrast agents used for the two modalities (Omnipaque for the CT
imaging and Omniscan for the MR imaging) is also a limitation of this study, as ideally
the same contrast agent would have been used in both modalities. However, although
there are differences in viscosity and osmolarity [122], the two contrast agents used
both have low molecular weights (821 Da for iohexol and 574 Da for Omniscan),
and similar pharmacokinetics in vivo [123]. The temporal separation of the MR and
CT acquisitions by several days is another limitation of the study, as it means that
there may have been physiological differences in hydration, food intake, and patient
wellbeing between the two scans. However, had the MR and CT scans been scheduled
on the same day, stress to the patient by two contrast enhanced examinations on one
day may also have affected the results, and it is not expected that the separation of
the scans by a few days could have caused any systematic differences between the
MR and CT.
As discussed below, there are no known estimates of Fp, PS, ve, and vp in bladder
tumours available in the literature. The lack of validation for the parameters obtained
in the present analysis is another limitation of this study. It would be valuable to
compare these parameter estimates with those obtained in another patient group
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using DCE MR, CT, or PET methods
A final note on the limitations of this study should be made regarding the assumptions
that were made in the data analysis. In the absence of the relevant values, it was
assumed that the precontrast T1 and relaxivity were the same in the intracellular and
EES compartments. The spin density was assumed to be equal in all compartments,
which meant that the fractional water pool sizes were assumed to be equal to the
fractional compartmental sizes in all compartments [60]. If the above assumptions do
not hold, the resulting parameter estimates would be biased accordingly. However,
the final impact of such a bias is expected to be small relative to other effects.
4.4.2 Comparison with literature values
Several comparisons between DCE CT and DCE MRI have recently been published,
using different models for tracer kinetic analysis [124, 125, 126]. However, the agree-
ment between the CT and MR results in these studies is variable, which may be
related to the various acquisition protocols, tracer kinetic models, and tumour het-
erogeneities in each of these studies. Kierkels et al. found agreement between MR
and CT for Ktrans, with MR giving higher ve and vp than CT using the extended
Kety model [124]. Yang et al. also used the extended Kety model but with lower
temporal resolution DCE MRI data, and found correlations between MR and CT for
Ktrans, kep, and vp, with MR giving lower values than CT [125]. Using T2 weighted
dynamic susceptibility contrast MRI and a distributed parameter model, Bisdas et
al. found “poor to moderate agreement” between MR and CT; MR estimates of F ,
vp, and PS were higher than CT [126]. Although it is difficult to draw broad conclu-
sions from this mix of results, the recent interest in comparing DCE MRI with CT is
encouraging, and should serve to promote discussion of the issues surrounding DCE
analysis, and improve understanding of both modalities.
Due to the variable nature of tumour physiology, it is ill advised to compare tracer
kinetic parameter estimates from DCE analysis between any tissues which are not
known to be the same grade and type of tumour. To the knowledge of the author,
there is no available literature on quantitative estimates of tracer kinetic parameters
in human bladder tumours for comparison with these results. However, the estimates
for PS, ve, vp, and Fp shown here in figure 4.4 are within the broad limits defined by
the PET and CT literature for other extracranial tumours [127, 128, 129, 130].
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4.4.3 Conclusions
No significant differences were seen between the DCE CT and DCE MRI parame-
ter estimates presented in this chapter, aside from the difference between CT and
NXL MR estimates of vp. The hypothesis that this differenc may be related to water
exchange effects is supported by the observation that significant differences between
MR FXL and NXL estimates of vp were also seen, suggesting that vp is the parameter
most likely to be affected by water exchange in these data. The differences seen in
vp also support the results of previous studies which suggested that water exchange
between the intracellular and EES had a negligible effect on clinical DCE MRI, while
exchange between the EES and vascular space may be more significant. As no sig-
nificant differences between the MR FXL and CT parameter estimates were seen,
there is no evidence to recommend the use of a non-FXL model in typical clinical
DCE MRI. However, further investigation into water exchange effects for Fp should
be made, as the difference between CT and MR FXL estimates of Fp was borderline
significant (p=0.06).
The results presented in this chapter are the result of a specific DCE acquisition
protocol and analysis process, and compare a clinical DCE MRI acquisition with
unknown water exchange effects with DCE CT, which is not affected by water ex-
change. Subsequent chapters explore the impact of different acquisition parameters
or choices in the analysis on the final parameter estimates. Chapter 5 discusses the
influence of model choice, AIF differences, and variations in the assumed MR se-
quence parameters on the results of tracer kinetic parameter analysis. The impact
in variations of measured AIF concentration is also investigated in section 7.2, and
chapter 6 presents the results of testing four methods of MR AIF correction. In
chapter 8, a DCE MRI protocol which is sensitised to water exchange is developed
and analysed, giving further insight into the results in the present chapter.
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In any DCE MRI analysis, there are assumptions made, and decisions to be taken.
One set of assumptions and decisions is presented for the analysis of the bladder
cancer dataset in chapter 4. The investigations in this chapter inform the work
leading to the development of a water exchange sensitised protocol in chapter 8. This
work is also linked with the simulations and analysis of chapters 6 (exploring methods
for correcting errors in MR AIFs) and 7 (selecting an optimal flip angle and contrast
agent injection parameters for the protocol in chapter 8).
In the present chapter, the influence of some of these decisions and assumptions on
the final results will be examined in greater detail. The choice of model to use for
the analysis is explored, and the use of nested F-tests to statistically select the best
model for fitting the data is discussed. The results of using manually defined AIFs
are compared with automatically detected AIFs. A series of simulations investigating
the impact of variations in input parameters such as TR, flip angle, compartmental
T1 relaxivities, and pre-contrast T1 is presented. These simulations are informative
because they present the impact of variations on the analysis process, suggesting that
the data are more sensitive to errors or variations in some parameters than others in
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a way that depends upon the flip angle used for the acquisition.
5.1 Model selection using nested F-tests
In order to ensure that both the MR and CT data could be fitted to obtain estimates
of the same parameters for comparison, all bladder cancer patient datasets were
first analysed using a piece of code which performed model selection. The models
included in this assessment were: the 2CXM, 1CM, uptake, and extended Kety. The
free parameters for each of these models, as well as the restrictions by which they are
derived from the WX-2CXM are summarised in table 5.1. The FXL of all models
were fitted to the bladder cancer data to obtain these parameter estimates. A series
of nested F-tests was used to determine which model best fit the data [131]. Given
a sum of squared residuals SSp for the fit of a parent model with p parameters to n
datapoints, and SSr for the fit of a restricted model with r parameters, the F-ratio
of a comparison of two models is calculated by [132]:
F =
SSr−SSp
p−r
SSp
n−p
(5.1)
This F-ratio has an F distribution with p− r degrees of freedom for the numerator,
and n − p degrees of freedom for the denominator. The null hypothesis is that the
restricted model provides a better fit to the data, and the alternative hypothesis is
that the parent model provides a better fit. The p-value for a given F-ratio is found
using the F distribution, and the parent model was selected if the p-value associated
with the F-ratio is less than or equal to 0.05.
The nested F-tests were carried out as follows: if the 2CXM did not have the lowest
summed squared residuals, the first question is whether the simplest model can be
used to describe the data. If the 2 parameter 1CM had the lowest summed squared
residuals, this was selected as the best model for fitting the data. If one of the 3
parameter models had the lowest summed squared residuals, the 2 and 3 parameter
models were compared to decide whether a 3 parameter model is justified over a 2
parameter model: if the 3 parameter uptake model had the lowest summed squared
residuals, an F-test was carried out between the 1CM and the uptake model to
determine whether the 3 parameter model was justified. If the 3 parameter extended
Kety model had the lowest summed squared residuals, an F-test was carried out
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model number of fitted restriction
parameters parameters on 2CXM
WX-2CXM 6 Fp, PS, vp, ve, τic, τp –
2CXM 4 Fp, PS, vp, ve τic = τp = 0
extended Kety 3 PS, vp, ve 1/Fp = 0
uptake 3 Fp, PS, vp 1/ve → 0
1CM 2 Ktrans, ve vp = 0
Table 5.1: Five nested models are summarised here: the water exchange modified two
compartment exchange model (WX-2CXM), the 2CXM, extended Kety, uptake, and one
compartment model (1CM). The fitting parameters are given for each, as well as the re-
strictions which enable the derivation of the simpler models from the more complex models.
For further discussion, see chapter 3.
between the 1CM and the extended Kety model.
If the 4 parameter 2CXM had the lowest summed squared residuals, F-tests were
carried out between the 2CXM and each of the uptake, extended Kety, and 1CM.
If all three of these tests indicated that the 4 parameter model was justified, the
2CXM was selected as providing a significantly better fit to the data than the other
models. If the tests indicated that the 2CXM was superior to the 1CM and one of
the 3 parameter models, the 3 parameter model with the lowest summed squared
residuals was selected. If the tests indicated that the 2CXM was superior to the 3
parameter models but not the 1CM, F-tests were carried out between the 1CM and
each of the 3 parameter models to indicate whether the 3 parameter models provided
a significantly better fit than the 1CM, where again, the summed squared differences
were used to choose between the 3 parameter models if the F-tests indicated that one
of the two provided a significantly better fit than the 1CM.
Figure 5.1 shows the data from patient 1 with the 1CM, uptake, extended Kety, and
2CXM fits overlaid. F-tests indicated that the 2CXM provided a significantly better
fit to this dataset, which is confirmed by the low summed squared residuals and good
fitting of the 2CXM to the data shown in figure 5.1. The dataset shown in figure 5.2,
meanwhile, is more difficult to judge. All of the models appear to provide acceptable
fits to the data, but F-tests selected the uptake model for fitting these data, likely
due to the rising tail which indicates that tracer concentration has not yet had time
to equilibrate between the EES and vascular compartments.
As shown in table 5.2, the 2CXM provided a significantly better fit to MR and CT
datasets 1, 3, 5, 10, and 11. However, datasets, 4, 6, and 8 were best fit with the
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Figure 5.1: A typical dataset (patient 1) for which the 2CXM provides a significantly
better fit than the 1CM, uptake, or extended Kety models, with all four fits overlaid.
Figure 5.2: A dataset is shown with the 1CM, uptake, extended Kety, and 2CXM fits
overlaid. This dataset (patient 2) was best fitted with the uptake model.
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patient CT best model MR best model
1 2CXM 2CXM
2 uptake uptake
3 2CXM 2CXM
4 uptake 2CXM
5 2CXM 2CXM
6 uptake 2CXM
7 uptake 1CM
8 uptake 2CXM
9 1CM 1CM
10 2CXM 2CXM
11 2CXM 2CXM
12 Ext. Kety 1CM
Table 5.2: Nested F-tests were used to select which of the 2CXM, 1CM, uptake, or
extended Kety models provided the best fit for each of the 12 bladder cancer datasets.
uptake model in the case of CT, and 2CXM for MR. This is likely because the CT
data acquisition ended before the concentration of contrast agent in the tissue had
stopped rising. The fact that this occurred in the CT and not the MR data is likely
due to the shorter acquisition (5 minutes vs 6 minutes), coupled with the longer
bolus duration due to the larger volume of the bolus of CT contrast agent (100 ml
vs (15 ± 4) ml). In the case of CT datasets 4, 6, and 8 which were best analysed
using the uptake model, there was sufficient data to estimate all 2CXM parameters
except for ve. This should be expected, as the uptake model is derived from the
2CXM by setting the extravasation of tracer from the EES to 0, and does not allow
the measurement of ve (see section 3.4). Thus, the results of the model selection
indicated that it should be possible to use the 2CXM to analyse data from datasets
4, 6, and 8, so long as estimates of ve were not required.
Datasets 2, 7, 9, and 12 were excluded from the 2CXM analysis because it was not
possible to accurately estimate PS or ve (see equation 3.4.2); F-testing revealed that
the 2CXM was not the best model for fitting either the CT or MR datasets for these
patients. The F-tests indicated that a 1CM was significantly better at fitting MR
datasets 7, 9, and 12, and CT dataset 9 (estimates of PS, ve were not obtained),
while an uptake model was selected for MR dataset 2 and CT datasets 2 and 7
(estimates of ve were not obtained), and an extended Kety model was selected for
CT dataset 12 (estimates of ve and vp not obtained). Dataset 7 is shown in figure 4.3,
demonstrating rising tracer concentrations at the end of the CT and MR acquisitions
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which meant that the 2CXM was not the most appropriate model for analysing this
dataset; estimates of PS and ve were not obtained from the CT and MR fits, and vp
was not obtained for MR.
It may seem contradictory that, having selected the best model for each dataset,
analysis was not performed using the optimal model for each dataset. However,
because the goal of the project was to eventually apply the WX-2CXM, and also
because it was felt that it would be confusing to present results analysed using several
different models each with different numbers of parameters, the decision was made
to analyse as much of the data as possible using just one model - in order to do this,
the parent (2CXM) model was chosen, rather than one of its restrictions. The 2CXM
was applied to datasets 1, 3, 4, 5, 6, 8, 10 and 11.
5.2 Preliminary comparison of 2CXM and extended
Kety models
Due to the popularity of the extended Kety model in the literature, preliminary fits
were performed using this model on the bladder cancer dataset in order to assess
the suitability of this model and investigate the differences between the 2CXM and
extended Kety fits. However, the fit quality using a extended Kety model was poor,
with systematic misfitting of tumour ROI data observed, particularly around the first
pass of the tracer through the tissue. A typical example of the type of systematic
fitting errors observed is shown in figure 5.3. This figure also demonstrates that the
2CXM provides much better fits, without any noticeable systematic errors. This
information, together with the results given in section 5.1, indicated that the 2CXM
should be used for all further analyses of the 8 datasets for which this model was
appropriate, and the preliminary results found using the extended Kety model are
included here simply for completeness.
The mean parameter estimates of PS, ve, and vp found using the extended Kety
and 2CXM models are shown in table 5.3. Significant differences were seen between
CT, MR FXL, and MR NXL estimates of vp, and between MR FXL and MR NXL
estimates of ve using the extended Kety model as compared with the 2CXM model.
The systematic misfitting of the first pass of tracer through the tissue observed with
the extended Kety model as exemplified in figures 5.1 and 5.3 could be expected to
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Figure 5.3: A typical dataset (patient 3) which is best suited to 2CXM fitting is shown
with the 1CM, uptake, extended Kety, and 2CXM fits overlaid.
affect vp, and the systematic misfitting of the tail of the extravasation of the tracer
from the tissue could be expected to affect ve. The types of fitting errors observed
in figures 5.1 and 5.3 likely account for these differences between the 2CXM and
extended Kety model estimates of vp and ve.
As discussed in [103], the extended Kety model (referred to in [103] as the extended
Tofts model) is only valid in situations where vp is negligible or Fp is infinite. In the
case of negligible vp, the Kety model (with no vp term) could be used, while if vp is
not negligible, the tissue must be highly perfused for this model to apply [103]. Thus,
fitting errors should be expected for tissues with moderate flow and vp. These fitting
errors are related to values of vp and Fp which are outside of the scope of the extended
Kety model, and could be expected to affect the fitting of the first pass peak. This
effect is observed in figure 5.3, showing data from patient 3 with a noticeable first past
peak, which were best fit with the 2CXM. In these data, the 2CXM and extended
Kety estimate vp at 0.08 and 0.04 respectively (non-negligible), and the 1CM and
extended Kety models produce systematic fitting errors. None of the MR datasets
are best fit by an extended Kety model. However, the data from patient 12 in figure
5.4 are best fit by the 1CM, which is equivalent to the extended Kety model with
vp = 0. In this figure, the 1CM, extended Kety, and 2CXM all produce similar fits
to the data. This may be because the data in figure 5.4 have no noticeable first pass
118
Chapter 5. The effect of model choice, AIF selection, and input
parameter errors on quantitative DCE MRI analysis
Figure 5.4: A typical dataset (patient 12) which is best suited to 1CM fitting is shown
with the 1CM, uptake, extended Kety, and 2CXM fits overlaid.
peak, perhaps due to a very small vp in this tissue within the realm of validity for the
1CM and extended Kety models. For these data, which are best fit with the 1CM,
the 2CXM estimates vp at 0.12 (perhaps incorrectly - recall that these data are best
suited for 1CM analysis), while the extended Kety estimates vp as negligible (10
−10).
5.3 Comparison of manually and automatically se-
lected AIFs
Since preliminary analysis had already been done on the bladder cancer dataset by
another group in the department prior to the start of this project, there were some
pre-processing steps available such as automatically detected patient AIFs found us-
ing in house departmental software, referred to here as Manchester Dynamic Modeling
(MaDyM). These automatically detected AIFs were used for the analysis in chapter
4, and the results published in [110]. However, it is interesting to note the differ-
ences that occur when a manually defined AIF is used rather than an automatically
detected AIF. Figure 5.5 shows an example of a manually defined and automatically
detected AIF in the same patient. The tracer concentrations in this automatically de-
119
Chapter 5. The effect of model choice, AIF selection, and input
parameter errors on quantitative DCE MRI analysis
PS [ml/min/ml] ve vp
CT mod Kety 0.087 0.27 0.023
2CXM 0.14 0.27 0.063
p-value 0.47 0.79 0.0019
MR FXL mod Kety 0.089 0.21 0.011
2CXM 0.10 0.16 0.079
p-value 0.64 0.0023 0.0002
MR NXL mod Kety 0.097 0.25 0.029
2CXM 0.064 0.18 0.14
p-value 0.16 0.0012 0.0002
Table 5.3: Mean estimates of PS, ve, and vp found using the 2CXM and extended Kety
models. 8 datasets gave useable estimates of PS and vp, 5 datasets for ve. Significant
differences between the two models were found for parameters highlighted in bold. P-values
are shown without Bonferroni correction.
Figure 5.5: An example of manually (∗) and automatically (◦) defined AIFs from a typical
patient. The automatically defined AIF shows artificially high peak concentrations of tracer
(over 20 mM), while the manually defined AIF shows concentrations which are closer to
literature values [1].
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Figure 5.6: Manually defined AIFs are shown here for the 12 bladder cancer patients.
Figure 5.7: Automatically detected AIFs are shown here for the 12 bladder cancer patients.
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tected AIF are over 20 mM , which is high compared to literature values [1], perhaps
indicating artefacts affecting the AIF. The observation of artificially elevated AIF
concentration curves in datasets such as this were the motivation to create manually
defined AIFs, which showed more realistic tracer concentrations (less than 8 mM for
all bladder datasets) [1].
Similar effects can be seen when comparing the manually defined and automatically
detected AIFs for all 12 patients, shown in figures 5.6 and 5.7, respectively. The
automatically detected AIFs had significantly higher peak concentrations (p = 0.0008,
paired 2 tailed t-test) and variance (p=0.001, 2 tailed squared ranks equality of
variance test) than the manually defined AIFs. The mean (±SD) peak concentration
for the manually defined AIFs was (4.1 ± 2.3) mM (range: 0.90 to 7.9 mM), while
the mean peak concentration for the automatically detected AIFs was (14.7 ± 8.0)
mM (range: 5.4 to 31 mM).
Because the MaDyM software does not restrict the voxels used for AIF creation,
voxels throughout the FOV can be selected, making it unclear which artery (or other
tissue) contributed to the AIF. The small size of the iliac arteries (as compared with
a larger artery such as an aorta) may have increased the difficulty of the automated
detection. The MaDyM software also uses T1 values from the multiple flip angle data
to provide pre-contrast T1s for arterial blood. Investigation revealed a large range
of measured arterial T1s, with physiologically unrealistic values suggesting that these
measured T1s may be experiencing artefacts. After performing the analysis in chapter
4, it was decided to use manually defined AIFs with an assumed precontrast T1 of
1.35 s for arterial blood, to eliminate the possibility of AIFs calculated using voxels
outside of the feeding artery for the tissue, and unphysiological T1s.
Manual AIFs were defined by the author in slice 5 of all 12 bladder cancer MR
datasets in the iliac arteries. These ROIs consisted of a few (generally 2-5) pixels
which were centrally located in the artery, and judged to be likely to suffer minimal
partial volume effects. Slice 5 was chosen as the optimal slice for AIF definition as
it is distal from the heart (minimising inflow effects) but also far enough in from the
edge of the volume to avoid B1 effects [116]; slices more proximal to the heart (slices
6-25) would be more likely to suffer inflow effects, while more distal slices (slices 1-4)
are closer to the edge of the imaging volume, and thus more likely to suffer slice
profile/B1 effects.
Figure 5.8 is similar to figure 4.4, showing the analogous results over 8 patients for
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Figure 5.8: CT and MR parameter estimates for analysis using manual AIFs. Results for
all patients are shown with group means (solid horizontal lines). FXL and NXL estimates
are shown for MR. Fp and PS are in units of ml/min/ml, while vp is unitless. Aster-
isks denote a significant difference using two-tailed paired t-tests, p ≤ 0.05 after a 3 test
Bonferroni correction.
a manually defined (rather than an automatically detected) AIF. The use of a man-
ual AIF gave similar results to the use of the automatically detected AIF in section
4.3: there was a significant difference between the CT and NXL MR estimates of
vp and Fp (p = 3×0.0046 = 0.014 for vp and p = 3×0.012 = 0.036 for Fp after a
3 test Bonferroni correction), which was supported by an MR FXL-NXL difference
(p = 3×0.0040 = 0.012 for vp and p = 3×0.00007 = 0.0021 for Fp after Bonferroni
correction). The difference between CT and FXL MR estimates of Fp was marginally
significant (p = 0.051 after Bonferroni correction). Additionally, there was a sig-
nificant difference between FXL and NXL estimates of PS (p = 3×0.0057 = 0.017
after Bonferroni correction), but no significant difference with CT. Table 5.4 gives
the mean 2CXM parameter estimates for the parameter estimates found using the
manual AIF (individual patient estimates are shown in figure 5.8).
Figure 5.9 shows the difference between parameter estimates made using the manually
defined and the automatically detected AIFs. In general, the manual AIFs gave
higher parameter estimates than the automatically detected AIFs (see table 5.5).
However, the conclusions of the analysis remained similar; using both manually and
automatically detected AIFs, vp and Fp remained the parameters most likely affected
by water exchange, as these parameters showed a significant difference between both
the FXL and NXL estimates and the CT and MR estimates. Using an automatically
detected AIF, there was a borderline significant difference between FXL and CT
estimates of Fp (p=0.02); using a manually defined AIF there was a difference between
both FXL and NXL MR, and CT estimates of Fp. The FXL MR - CT difference for
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Fp vp PS ve
[ml/min/ml] [ml/min/ml]
mean value CT 0.21 0.063 0.14 0.25
MR FXL 0.48 0.157 0.19 0.26
MR NXL 0.59 0.18 0.17 0.26
MR - CT difference MR FXL 0.27 0.094 0.053 0.012
MR NXL 0.38 0.12 0.028 0.0097
MR-CT p-value MR FXL 0.039 0.017 0.24 0.89
MR NXL 0.012 0.0046 0.53 0.83
MR p-value FXL-NXL 0.0007 0.0040 0.0057 0.62
Table 5.4: Parameter means, MR-CT differences, and p-values for the MR - CT difference
are shown for the MR FXL and NXL fits using a manually defined AIF (8 patient datasets).
P-values are from two-tailed paired t-tests and are not corrected using the Bonferroni
correction. Significant p-values after a 3 test Bonferroni correction are shown in boldface.
Fp using a manual AIF was significant before (p = 0.039) but not after Bonferroni
correction, and the difference between NXL and CT estimates of Fp was significant
both before (p = 0.012) and after correction. There was a significant difference
between NXL and CT estimates of vp using either a manually defined (p = 0.0046)
or an automatically detected (p = 0.0002) AIF. Additionally, there was a borderline
significant difference between FXL and CT estimates of vp using a manually defined
AIF (p = 0.017). The conclusions in chapter 4 involving automatically detected
AIFs hold for the use of manually defined AIFs. All further results in this thesis are
calculated using manually defined AIFs, except where noted. Note that manually
defined AIFs were used in the fits described in sections 5.1 and 5.2 above.
5.4 The effect of input parameter variation on quan-
titative DCE MRI: simulations
A variety of errors are commonly present (or may be suspected to be present) in DCE
MRI acquisitions which cause input parameters to differ from their assumed values.
Errors in AIF concentration estimates, compartmental T1 relaxivities, precontrast
T1 (also referred to as T1(0)), and assumed flip angle are among those most likely
to affect DCE MRI analysis. While the repetition time TR should be assumed to
be accurate as reported by the scanner, TR may be forced to vary between scans to
accommodate changes in the field of view and slice position. Although the exact value
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Figure 5.9: Difference between MR parameter estimates for analysis using manually and
automatically defined AIFs using the 2CXM FXL and NXL. Results for 8 patient datasets
are shown with group means (solid horizontal lines). Fp and PS are in units of ml/min/ml,
while ve and vp are unitless.
Fp vp PS ve
[ml/min/ml] [ml/min/ml]
FXL auto 0.14 0.079 0.10 0.16
manual 0.47 0.15 0.19 0.23
difference 0.33 0.078 0.089 0.089
p-value 0.0099 0.034 0.053 0.17
NXL auto 0.21 0.14 0.064 0.18
manual 0.59 0.18 0.17 0.23
difference 0.38 0.047 0.10 0.084
p-value 0.0065 0.13 0.037 0.20
Table 5.5: Parameter means are shown for analysis using a manually defined and au-
tomatically detected AIF for MR FXL and NXL model fitting. The difference between
the parameter estimates from the manual AIF and automatic AIF analysis is also given.
P-values are from two-tailed paired t-tests comparing manual and automatic AIF analysis,
and are not Bonferroni corrected. Significant p-values after a 3 test Bonferroni correction
are shown in boldface.
125
Chapter 5. The effect of model choice, AIF selection, and input
parameter errors on quantitative DCE MRI analysis
of TR should be used in any analysis, variations in TR will affect the characteristics
of the signal curve just as variations in other parameters will. The combined effect of
these errors and variations on the final tracer kinetic parameter estimates is usually
assumed to be small. However, for the purposes of applying the WX-2CXM model
to detect the effect of water exchange on our data (which we also suspect is small),
we wanted to investigate the impact of each source of error to determine which errors
were most likely to affect the analysis, and thus which errors were most important to
minimise.
5.4.1 Sources of variation in input parameters
The factors causing variations in concentration, compartmental T1 relaxivities, T1(0),
flip angle, and TR are different for each parameter. If a very short TR is set in a
given acquisition protocol, TR may be forced to increase for certain patients or scans
to accommodate variations in slice angle and position, or field of view. While the
nominal flip angle applied by the scanner should not vary between scans, the actual
flip angle in the tissue is known to differ from the nominal value, both generally and
spatially, due to factors such as imperfections in RF pulse shapes and slice selection
gradients, off resonance RF excitations, and B0 nonuniformities, and may also vary
between scans [2, 39]. As both TR and nominal flip angle are under the control
of the scanner and can be optimised for a given protocol, these two parameters are
examined in more detail in this section than parameters for which the true value may
be unknown: compartmental relaxivities, T1(0), and estimated AIF concentration.
Errors in calculated AIF concentrations relative to the actual concentration can arise
from a variety of sources, including inflow, partial volume, undersampling, and B1
effects. As very high AIF concentrations were observed in the automatically detected
AIFs in section 5.3, a variation of 2× the AIF concentration was simulated. A
common T1 relaxivity (r1) is assumed for all calculations (as is standard in DCE MRI
analysis). However, variations in r1 can occur due to local magnetic field variations,
and it is possible that the intravascular, intracellular, and EES compartments could
have slightly differing T1 relaxivities [133, 134]. While it is likely that the EES
relaxivities are similar to the vascular (plasma) relaxivity, a perturbation of ± 0.5
/mM/s was simulated [134]. The pre-contrast T1 value for the arterial plasma may
differ from the calculated or assumed value due to inflow and partial volume artefacts
in the case of calculated T1(0), or due to individual physiological variation in the
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case of an assumed T1(0), particularly in oncology patients undergoing treatment.
Differences between the calculated and actual tissue T1(0) are also possible, due to
partial volume effects and B0 and B1 imperfections. Intracellular T1s may differ from
both the intravascular and EES T1(0). However, as it is not typically feasible to
measure intracellular T1 using standard clinical DCE protocols, intracellular T1 was
set equal to EES T1(0) in all simulations. A variation of ± 0.6 s of precontrast T1
was simulated.
5.4.2 Methods
To investigate the impact of these errors on DCE MRI parameter estimates and tracer
uptake curves, simulations were run with varying compartmental relaxivities, AIF
concentration, baseline T1, flip angle, and TR, producing simulated data. Simulated
curves were produced for all of these parameters, using the WX-2CXM. Additionally,
because TR and flip angle were to be optimised for the sequence in chapter 8, a small
amount (1%) of normally distributed random noise was added to the simulated curves,
and WX-2CXM fits to the noise-added curves were performed for 100 iterations.
Baseline and perturbed (raised and lowered) inputs were used, and the DCE MRI
parameter estimates resulting from using these baseline and perturbed inputs were
compared. Note that, since AIF concentration is also adjustable in a DCE MRI
protocol, further noise-added simulations were performed and the results discussed
in section 7.2.
The shapes of the uptake curves produced are broadly indicative of the resulting vari-
ations in the parameter estimates, and sample uptake curves are shown and discussed
for each of the parameters simulated in the subsections below, both for those with
fits to noise-added data (TR and flip angle), and those with only simulated uptake
curves produced (T1(0), r1, AIF concentration).
The values used in these simulations are listed in table 5.4.2. Values for T1 relaxivity
and arterial T1(0) were set to the values used in data analysis (4.5 /mM/s and
1.35 s respectively). TR was set to 6 ms as it was anticipated that a value of
approximately 6 ms might be feasible for a dynamic acquisition with 1-2 s temporal
resolution. A typical T1(0) of 1.35 s was estimated using the bladder cancer data. A
selection of small flip angles (3, 5, and 10◦) were tested, as well as a larger value (20◦)
used in clinical protocols in this department. A MaDyM-derived patient AIF was
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input variable initial value perturbation
flip angle [◦] 3, 5, 10, 20 ±5%
TR [ms] 6 ±5%
AIF [mM ] patient concentration 2 x patient concentration
relaxivity [/mM/s] 4.5 4.0, 5.0
arterial T1(0) [s] 1.35 1.95, 0.75
tissue T1(0) [s] 1.3 1.9, 0.7
Table 5.6: Six input variables were tested for their impact on DCE MRI parameter es-
timates. The variable, its initial (baseline) value, and perturbed value used to produce
simulated uptake curves are listed.
used to produce simulated uptake data via the WX-2CXM model with the following
parameters: Fp = 0.26 ml/min/ml, PS = 0.067 ml/min/ml, ve = 0.14, vp = 0.10,
τp = 0.1s, τic = 0.5s. These parameters were selected by taking the parameter
estimates resulting from fits to the CT data of the same patient as the MR AIF which
was used (patient 1). The values for the intracellular and intravascular water residence
times were selected based on literature suggesting intracellular water residence times
were typically 0.1-1.5 s in tumour tissue [27], less than 0.12 s in myocardium [133],
and approximately 0.55 s for in vivo brain [135]. Intravascular water residence times
in rat myocardium were found to be on the order of 0.1-0.3 s [133, 67]. Water
residence times are likely influenced by factors such as cell size, type, and health, and
should be expected to vary by tissue type.
5.4.3 Simulation results - flip angle
Baseline data were simulated for flip angles of 3, 5, 10, and 20◦. Variations of ±5%
were tested to determine their impact on the uptake curves and tracer kinetic param-
eter estimates. The parameter estimates resulting from 100 fits to simulated curves
with noise are given in tables 5.7 (WX-2CXM), 5.8 (FXL), and 5.9 (NXL). Mean
estimates of ve and τic are vulnerable to outliers, as seen in tables 5.7 and 5.9. Figure
5.10 shows the simulated uptake curves generated using the baseline and perturbed
flip angles. The impact of these variations is most pronounced in the NXL (middle
column of figure 5.10) and at lower flip angles (see first and second rows of figure 5.10,
and table 5.9), and so, to minimise the impact of errors in flip angle on estimates of
Fp, PS, ve, and vp, a larger flip angle should be selected for the DCE acquisition.
Due to the scatter in mean estimates of τv and τic, perhaps caused by outliers, it is
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Figure 5.10: Simulated MR signal uptake curves are shown for simulations using assumed
flip angles of 3, 5, 10, and 20◦ versus using flip angles which are raised and lowered by 5%.
The effect of this variation on three water exchange regimes (FXL, NXL, WX-2CXM) is
shown, with the lowered flip angles shown as solid lines, and the elevated flip angles shown
as dashed lines.
difficult to draw any conclusions about the impact of variations in flip angle on these
parameters.
A 5% variation in the assumed flip angle is a relatively small variation, and variations
of this magnitude could easily occur in typical DCE MRI protocols. Such a variation
does have a small impact on the tracer uptake curves and parameter estimates (table
5.7), however, as indicated, the impact is greatest for smaller flip angles.
The shape of the curves appears to vary with flip angle (variation with row in figure
5.10). In order to better see this, figure 5.11 shows a comparison of the small and
large flip angle (3 and 20 ◦) timecourses, where the curves have been shifted to the
same baseline, and scaled to the same amplitude so that the differences in shape can
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Figure 5.11: Simulated MR signal uptake curves are shown for simulations using flip
angles of 3 and 20◦ for the FXL, NXL, and WX-2CXM. Curves have been shifted to the
same precontrast baseline, and scaled to the same peak value in order to aid the comparison
of the shapes of the two curves with different flip angles in each of the model limits.
be better compared. By comparing the small (◦) and large (•) flip angle curves in
figure 5.11, it can be seen that the two curves differ primarily in their initial shape
after injection, although the tail of the curves are also slightly different.
These types of differences in the shape of the tissue uptake curves are related to
the differences in sensitivity of SPGR DCE MRI data to water exchange at different
flip angles; acquisitions using lower flip angles are generally more sensitive to water
exchange than acquisitions using higher flip angles [120]. This can be seen by plotting
the difference between the signal from the FXL and NXL equations: at lower flip
angles, there is a greater difference between the FXL and NXL. See figure 7.1 for
an illustration of this effect. As T1 differences between compartments become more
pronounced after contrast agent injection, the signal behaviour deviates further from
the FXL. This leads to a characteristic flattening of the signal intensity-time response
at lower flip angles which can be observed in figure 5.11, and is also indicative of the
increased water exchange sensitivity. This is particularly noticeable in the first pass
because water exchange between the EES and vascular compartments is most likely
to deviate from the FXL due to the increased difference in the T1s of the vascular and
EES compartments caused by the high vascular contrast agent concentration present
before significant tracer leakage has occurred.
5.4.4 Variations in TR
Baseline data were simulated for a TR of 6 ms. Variations of ± 5% were tested to
determine their impact on the uptake curves and tracer kinetic parameter estimates.
The parameter estimates resulting from 100 WX-2CXM fits to simulated curves with
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TR +5% TR −5% angle +5% angle −5%
3◦
Fp [ml/min/ml] -12 -9.4 -9.7 -0.30
PS [ml/min/ml] 23 26 -2.3 9.2
ve 1.0 -3.2 -1.9 -40
vp -25 -23 -28 -22
τp 43 32 19 36
τic 82 53 67 -1161
5◦
Fp [ml/min/ml] 5.2 8.0 -3.5 5.6
PS [ml/min/ml] 3.4 1.7 6.4 9.3
ve 89 -3.8×105 -2.7×104 91
vp -8.1 -16 -7.7 -16
τp -7.4 23 -22 -0.26
τic 35 -20 -24 25
10◦
Fp [ml/min/ml] -0.93 -0.24 -0.69 0.25
PS [ml/min/ml] 3.6 -18 -6.8 -19
ve 4.6 -11 -8.5 -5.7
vp -0.23 -2.5 5.2 2.5
τp -0.25 -56 -11 -66
τic 62 55 -71 36
20◦
Fp [ml/min/ml] -2.0 -1.1 2.3 1.3
PS [ml/min/ml] 6.6 -5.9 -13 -2.0
ve 2.2 -2.0 -4.0 -0.03
vp -4.9 4.3 9.4 -0.03
τp 12 -12 -25 -5.7
τic -29 -1.0 -64 -1031
Table 5.7: The mean percentage difference (mean over 100 iterations) between the esti-
mates of the WX-2CXM model parameters when the TR or flip angle is raised/lowered by
5% versus its baseline value, for flip angles of 3, 5, 10, and 20◦ and TR of 6 ms.
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TR +5% TR −5% angle +5% angle −5%
3◦
Fp [ml/min/ml] 2.6 0.17 3.0 1.6
PS [ml/min/ml] -18 13 -9.3 -29
ve 94 82 95 97
vp -47 -15 -9.7 -12
5◦
Fp [ml/min/ml] -0.95 1.1 -0.95 0.66
PS [ml/min/ml] -3.5 1.6 14 5.8
ve -1.0 2.6 1.1 0.94
vp 4.6 -5.3 2.3 1.7
10◦
Fp [ml/min/ml] 0.30 -0.82 -1.5 1.2
PS [ml/min/ml] -2.3 -2.5 -4.1 -1.2
ve -0.09 -0.9 -0.18 -0.07
vp 2.1 1.5 2.3 1.7
20◦
Fp [ml/min/ml] 1.1 -0.87 -1.6 1.9
PS [ml/min/ml] 0 -0.77 -1.2 0.21
ve 0.62 -0.54 -0.78 1.1
vp 0.05 -0.02 -0.42 0.65
Table 5.8: The mean percentage difference (mean over 100 iterations) between the esti-
mates of the 2CXM FXL model parameters when the TR or flip angle is raised/lowered by
5% versus its baseline value, for flip angles of 3, 5, 10, and 20◦ and TR of 6 ms.
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TR +5% TR −5% angle +5% angle −5%
3◦
Fp [ml/min/ml] 27 18 -9.6 37
PS [ml/min/ml] -91 24 0.95 -52
ve -200 42 -2.6×104 -900
vp 7.7 4.6 0.53 3.4
5◦
Fp [ml/min/ml] 98 52 53 51
PS [ml/min/ml] 92 78 99 -20
ve -1.9×104 66 -42 34
vp -9.8 -2.3 -1.1 -4.7
10◦
Fp [ml/min/ml] -0.16 2.2 0.99 32
PS [ml/min/ml] 1.7 3.2 -0.18 83
ve 2.0 2.8 -1.3 87
vp -2.1 -0.23 3.0 -45
20◦
Fp [ml/min/ml] -0.04 0.19 -0.43 1.1
PS [ml/min/ml] 1.1 -2.0 -4.6 4.2
ve 0.07 -0.13 -0.43 0.78
vp -1.8 2.1 4.9 -5.7
Table 5.9: The mean percentage difference (mean over 100 iterations) between the esti-
mates of the 2CXM NXL model parameters when the TR or flip angle is raised/lowered by
5% versus its baseline value, for flip angles of 3, 5, 10, and 20◦ and TR of 6 ms.
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noise are given in tables 5.7 (WX-2CXM), 5.8 (FXL), and 5.9 (NXL). Mean estimates
of ve are vulnerable to outliers, as seen in tables 5.7 and 5.9. Figure 5.12 shows
the simulated uptake curves generated using the baseline and perturbed TRs. The
impact of these variations is most pronounced at lower flip angles and in the NXL
(first row of figure 5.12, table 5.9), and so, to minimise the impact of changes in TR
on estimates of Fp, PS, ve, and vp, a larger flip angle should be selected for the DCE
acquisition. Due to the scatter in mean estimates of τv and τic, perhaps caused by
outliers, it is difficult to draw any conclusions about the impact of TR variations on
these parameters.
A 5% variation in the TR is a relatively small variation, and variations of this mag-
nitude could occur in typical DCE MRI protocols due to changes in the FOV or slice
angle necessary to accommodate individual patients. Such a variation has a small
impact on the tracer uptake curves and 2CXM parameter estimates (see table 5.7);
as indicated, the impact is greatest for smaller flip angles.
5.4.5 Simulation results - AIF concentration
The difference in the shape of the uptake curves using the baseline and increased
concentration AIF were investigated for the each of the four flip angles. As expected,
higher AIF concentrations resulted in higher uptake curve concentrations in figure
5.13 (‘baseline’ (∗, •,+) vs ‘perturbed’ (−,−−, · · · ) curves). FXL curves (∗) demon-
strated a prominent first pass peak as compared to NXL curves (•), while WX-2CXM
curves (+) showed a moderate first pass peak.
The impact of variations in AIF concentration was minimised at the NXL and at lower
flip angles; the difference between the baseline uptake curves and those produced
using an AIF with elevated concentration is smallest for the NXL curves in the upper
left as compared to the FXL curves in the lower right plot of figure 5.13. However,
it should be noted that inflow and saturation effects can be problematic for contrast
agent concentrations using data from low flip angles at high arterial contrast agent
concentrations, meaning that, in practice, a lower flip angle may not necessarily
minimise errors in calculated AIF concentration.
Note that, in general, differences in AIF concentration will tend to affect the shape
of the first-pass portion of the uptake curve (immediately after injection) most dra-
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Figure 5.12: Simulated MR signal uptake curves are shown for simulations using an
assumed TR of 6 ms versus using TRs which are raised and lowered by 5%. The effect of
this variation on three water exchange regimes (FXL, NXL, WX-2CXM) is shown for flip
angles of 3, 5, 10, and 20◦, with the lowered TRs shown as solid lines, and the elevated
TRs shown as dashed lines.
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Figure 5.13: Simulated MR signal uptake curves are shown using an AIF with concentra-
tions as measured a patient dataset versus an AIF with twice the vascular concentration of
Gd for flip angles of 3, 5, 10 and 20◦. The effect of this variation on the uptake curves in
three water exchange regimes (FXL, NXL, WX-2CXM) is shown, with the measured AIF
results shown as ∗/+/•, and the increased concentration AIF results shown as solid/dashed
lines.
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matically. This corresponds to an impact on parameters related to this portion of
the curve, such as Fp and vp. While the increased AIF concentration causes the
magnitude of the baseline uptake curves to be elevated relative to the perturbed (2×
concentration) curves, the shape of the tails of the curves are similar, indicating that
parameters related to the shape of the tail of the curve, such as ve and PS, are less
affected by variations in the shape of the AIF than Fp and vp.
5.4.6 Simulation results - compartmental relaxivities
The baseline data assumed the same relaxivity occurred in all tissue compartments
(4.5 /mM/s). As a perturbation or variation on this baseline value, a vascular re-
laxivity of 4.0 /mM/s, and an EES relaxivity of 5.0 /mM/s were used. The uptake
curves in figure 5.14 show that a variation of this magnitude has little impact on the
final parameters and uptake curves in the WX-2CXM and NXL (· · · and −−) at low
flip angles; the baseline and perturbed curves are similar for both the WX-2CXM
and NXL. The impact of variations in relaxivity are more pronounced for the FXL
curves (∗). Variations in the relaxivity also have a greater impact on all of the FXL,
NXL, and WX-2CXM at higher flip angles; the difference between the baseline and
perturbed curves is more pronounced for the curves in the lower right plot of fig-
ure 5.14 as compared to the upper left plot. This is particularly noticeable for the
first pass of the NXL curves. To minimise the impact of variations in contrast agent
relaxivity between tissue compartments, smaller flip angles should be selected.
Variations in compartmental relaxivities affect the shape of both the initial and final
portions of the uptake curve. In figure 5.14, differences in the initial portion of the
uptake curves due to variations in compartmental relaxivities are demonstrated by
differences in the shape of the first portion of the baseline vs the perturbed curves,
particularly noticeable in the 20◦ NXL curves (· · · and •). Variations in the shape of
the tail of the curve are illustrated by the manner in which the baseline and perturbed
curves intersect, as can be observed in the 20◦ FXL curves (∗ and −) in figure 5.14.
5.4.7 Simulation results - precontrast T1
The baseline data use an assumed arterial blood T1(0) of 1.35 s, and a tissue T1(0) of
1.30 s, which was the mean precontrast T1 for the bladder ROI for patient 1 measured
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Figure 5.14: Simulated MR signal uptake curves are shown for simulations using a relax-
ivity of 4.5 /mM/s versus using a vascular relaxivity of 4.0 /mM/s, and an EES relaxivity
of 5.0 /mM/s for flip angles of 3, 5, 10 and 20◦. The effect of this variation on three water
exchange regimes (FXL, NXL, WX-2CXM) is shown, with the 4.5 /mM/s results shown
as ∗/+ /• and the variation shown as solid/dashed lines.
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using a multiple flip angle technique. Four variations were tested: Using a tissue T1(0)
of 1.30 s with raised (1.95 s) and lowered (0.75 s) blood T1(0), and then the assumed
blood T1(0) (1.35 s) with raised (1.90 s) and lowered (0.70 s) tissue T1(0). In figure
5.15, the precontrast starting points for the test data have been shifted to align with
the precontrast baseline data so that the magnitude of the effect can be more easily
seen.
The uptake curves in figure 5.15 show that variations in tissue T1(0)s had a greater
impact on tracer kinetic parameter estimates than variations in arterial T1(0)s; there
is a greater separation between the green tissue curves (· and −) than between the red
arterial curves (∗ and −). The effect of variations in tissue T1(0) was most noticeable
in the FXL (first column) and at low flip angles (first row). Variations in arterial
T1(0) had a smaller impact, which was most pronounced in the NXL (middle column)
and at low flip angles (first row). This suggests that to minimise the impact of errors
in T1(0), higher flip angles should be selected.
5.5 Discussion and Conclusions
Many different factors can affect the results of an analysis process. In the case of the
analysis presented in chapter 4, the results in this chapter show that the choice of
model used for the analysis was an important factor which affected the quality of fits
obtained and the vp estimates presented. The decision to use automatically detected
AIFs also had an impact on vp estimates, but did not change the conclusions of the
analysis. When developing a new protocol, it is important to know what impact
variations in values of input parameters such as TR and flip angle will have on
the parameter estimates, so that these parameters can be optimised. Errors in the
assumed compartmental relaxivities, calculated AIF concentration, and calculated
pre-contrast T1 should also be anticipated, and it is useful to know what impact these
errors have on the acquired uptake curves and tracer kinetic parameter estimates so
that informed decisions can be taken to minimise these errors by choosing appropriate
assumed values, using appropriate analysis methods, or choosing an appropriate flip
angle.
The results in sections 5.4.3 and 5.4.4 consider the impact of variations in parameters
over which the user has some control: TR and flip angle. Section 5.4.3 emphasises
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Figure 5.15: Simulated MR signal uptake curves are shown for simulations using an
assumed an arterial blood T1(0) of 1.35 s, and a tissue T1(0) of 1.30 s versus using raised
and lowered arterial and tissue T1(0)s for flip angles of 3, 5, 10 and 20◦. The effect of
this variation on three water exchange regimes (FXL, NXL, WX-2CXM) is shown, with
the lowered blood/tissue T1(0)s shown as solid lines, and the elevated blood/tissue T1(0)s
shown as dashed lines. Note that changes in the T1(0) will affect the baseline of the uptake
curves; all curves in this figure have been shifted to the same baseline value so that the
impact of the T1(0) variations can be more easily judged.
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that variations in flip angle do have an impact on the final parameter estimates,
signal uptake curves, and water exchange sensitivity of the sequence. Apart from the
large scale variation in flip angle which can be implemented on the scanner, smaller
variations will occur due to differences between the nominal and actual flip angle.
Steps such as B1 mapping can be taken if large variations in the actual flip angle are
anticipated. The results in section 5.4.4 indicate that, for the small variations in TR
which may be necessitated by changes in the FOV, the impact of variations in TR is
small. While the actual value of TR must be accounted for in analysis, the impact
of a 5% variation on the water exchange sensitivity of the protocol is likely minimal.
The preliminary investigations in sections 5.4.5, 5.4.6, and 5.4.7 consider the impact
of variations in parameters over which the user has little control. MR artefacts affect-
ing the measured AIF concentration and measured precontrast T1, and the existence
of unknown and spatially varying relaxivities in the blood and tissue compartments
must be accepted as largely beyond the user’s control in clinical experiments. Fortu-
nately, the preliminary investigations in sections 5.4.5, 5.4.6, and 5.4.7 indicate that
the impact due to small variations in these parameters is likely small. These simu-
lations show the resulting variations in the shape of the signal uptake curve, which
can be used to broadly inform protocol design to minimise these errors (for example,
by taking careful measurements of precontrast T1 and improving spatial resolution
to minimise partial volume effects), or to assist in the choice of sequence parame-
ters which might increase the difference between the FXL and NXL, minimising or
maximising the sensitivity of a sequence to water exchange. Figures 5.13 and 5.14
indicate that impact of variations in AIF concentration and compartmental relaxivi-
ties are minimised at lower flip angles; figure 5.15 indicates that the impact of errors
in precontrast T1 will be minimised at higher flip angles. Thus, if significant water
exchange effects, variations in T1(0), errors in actual flip angle, or dramatic changes
in TR are anticipated, and if the impact of these factors on the tissue uptake curves
is undesirable, a higher flip angle should be chosen. If significant errors in the cal-
culated AIF concentration or assumed compartmental relaxivities are anticipated, a
lower flip angle should be chosen. Thus, there are many conflicting factors to consider
when selecting even a single MRI sequence parameter such as flip angle, and it is to
inform this type of decision that the simulations in this chapter were carried out.
Other parameters apart from the ones considered here can, of course, vary, and will
also have an impact on the final tracer kinetic parameter estimates. Haematocrit,
the fractional blood volume occupied by erythrocytes, will vary slightly between
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individuals, and also between large vessels and small capillaries. In the absence
of individual measurements of arterial haematocrit, a value of 0.42 was assumed
in all calculations involving haematocrit [30]. Flip angle may vary spatially, and the
impact of differences in flip angle between the AIF and the tissue were not considered.
Likewise, differences in relaxivity between the AIF and tissue could also occur, but
were not simulated here.
The overall conclusions of this chapter are twofold. The results in sections 5.1, 5.2,
and 5.3 suggest that the 2CXM with manually defined AIFs can be used to anal-
yse most (8/12) of the bladder cancer patient datasets. For these data, the use of
manually defined AIFs tended to give higher parameter estimates than the use of au-
tomatically detected AIFs, however, the overall conclusions of the analysis remained
the same for either type of AIF. Secondly, the results in section 5.4 suggest that if
it is desirable to maximise the water exchange sensitivity of a SPGR protocol with a
short TR (6 ms), a small flip angle should be used. This will minimise the impact of
variations in AIF concentration and compartmental relaxivities, however, care should
be taken to obtain accurate estimates of precontrast T1s. Conversely, if a sequence
is desired which is insensitive to water exchange, a higher flip angle should be used;
in this case, variations in compartmental relaxivities will have a greater impact and
care must be taken to obtain accurate estimates of AIF concentrations.
The results in sections 5.3 and 5.4.5 are of particular interest as they highlight the im-
pact that the AIF has on the final parameter estimates, which is further investigated
in chapter 6. There are a variety of MRI artefacts to which the AIF is particularly
vulnerable, including partial volume, inflow, and signal saturation, and so it is partic-
ularly important to be aware of potential errors in the calculated AIF concentration.
During the analysis in chapter 4, it became apparent that the AIFs available in the
bladder cancer dataset were likely being affected by partial volume and inflow ef-
fects, and thus investigations were undertaken into whether it was possible to apply
a correction to reduce the impact of these artefacts on the tracer kinetic analysis.
In chapter 6, various correction methods are presented, and their impact on tracer
kinetic parameter estimates compared. The impact of variations in the AIF on DCE
MRI analysis are also investigated in section 7.2, where a protocol sensitised to water
exchange effects is investigated.
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Individually measured patient AIFs are necessary for quantitative parameter esti-
mates in most tracer kinetic models. It is desirable to measure each patient’s AIF
individually because one would like the individual variations in the AIF (due, for
instance, to variations in heart rate, cardiac output, and kidney function), to prop-
agate through the tracer kinetic analysis through to the final parameter estimates.
However, it is difficult to measure AIFs using MR in individual patients due to ef-
fects including partial voluming in arteries, inflow effects due to fast-moving arterial
blood, signal saturation at high contrast agent concentrations, field inhomogeneities,
and difficulties in obtaining accurate precontrast T1 measurements in blood. During
the analysis of the data in chapter 4, it was suspected that one or more of these
effects were likely affecting the AIFs. The results in section 5.3 showed that changes
in the AIF have an impact on the resulting uptake curves and parameter estimates,
and it was decided to investigate possible AIF correction strategies for this dataset.
Because CT and MR data were available for the same patients in this dataset, there
was potential to use the CT AIFs to correct the MR AIFs. The CT AIFs were
acquired with higher temporal and spatial resolution than the MR AIFs, and CT
does not suffer from inflow effects, signal saturation, field inhomogeneities, or most
of the other artefacts that have the potential to affect MR AIFs, making the CT
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AIFs a good basis for correction and comparison with the MR AIFs. Cardiac output
is a promising basis for AIF correction techniques because it is directly related to
arterial blood flow, and thus to the shape of the measured MR arterial input function.
Although a non-imaging measure of cardiac output was not acquired for the patients
in this dataset, cardiac output can be estimated from the area under the first pass
of the AIF as described in section 2.6 (this will be discussed further in section 6.4).
Estimates of cardiac output using the CT and MR AIFs in this dataset suggested
that the MR AIFs were being affected by artefacts, and that CT measures of cardiac
output were a promising basis for correction of the MR AIFs.
In total, four strategies were tested for improving individual MR AIF measurements:
using a group-averaged AIF [30], fitting a functional form and adjusting the equilib-
rium plasma contrast agent concentration to a literature value (‘equilibrium adjusted’
or ‘equilibrium’ AIF) [29], scaling the AIF by the ratio of MR/CT cardiac output
(‘CO scaled’ AIF), and adjusting the baseline signal using a literature technique based
on cardiac output (‘CO adjusted’ AIF) [136]. In order to calculate the cardiac output
from CT, a calibration was performed to ensure accurate conversion to contrast agent
concentration. Details of this calibration are discussed in section 6.4.1.
Fitting to the data was performed as in chapter 4 (see section 4.2). Briefly, all
analysis was done using self-written software in MATLAB (The MathWorks Inc.,
Natick, MA, USA). Fitting to the uptake curves was performed using a bounded
simplex based nonlinear optimisation where the sum of squares of the residuals was
used as a minimisation function. A haematocrit of 0.42 was assumed for calculation
of plasma concentrations from whole-blood signal [30], a relaxivity of 4.5 /mM/s was
assumed for Omniscan [106], precontrast T1 of 1.35 s was assumed for arterial blood
[115, 116], and precontrast T1s for tumour ROIs were calculated using the multiple
flip angle data. Tumour regions were the same as in chapter 4. The manually defined
AIFs discussed in section 5.3 were used throughout this chapter.
6.1 Statistical methods
During the analysis in sections 6.2, 6.3, and 6.4, two-tailed paired t-tests were per-
formed to assess whether the AIF corrections brought the MR parameter estimates
closer to the CT parameter estimates for each parameter. For each of the 4 AIF cor-
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rections, the difference between CT and the MR FXL and NXL parameter estimates
using the corrected MR AIFs were compared with the difference between the CT and
MR AIF parameter estimates using the uncorrected MR AIFs. Reductions in the
mean CT-MR difference were tested using a two tailed paired t-test, and reductions
in the variance were tested using a squared ranks test for equality of variance. To
correct for multiple comparisons, a 2 test Bonferroni correction can be applied to
the p-values in these sections, as the FXL and NXL estimates were tested for each
parameter. Using a two test correction, p=0.01 becomes p=0.02 after correction,
and p<0.05 after correction is considered significant. All results presented include 10
patients (except where noted in section 6.5); patients 9 and 12 were excluded due to
slow tracer uptake.
6.2 Group averaged AIF
It is not always possible to measure reliable AIFs in all patients in a study due to
factors such as data acquisition errors or variations in individual patient physiology.
In cases where an individually measured AIF is not available, one can use a literature
AIF (for example, the population AIF measured by Parker et al. in [30]). However,
it is likely that the patient group in a study will be different from the population used
to create the literature AIF. If the study population is relatively homogeneous in age
and overall health, and the number of patients in the study with measured AIFs is
sufficient, a more relevant group AIF specific to the patient group can be created
by averaging all the measured AIFs in the group. To investigate the impact of this
approach on the final parameter estimates, the concentrations of all 12 manually
defined patient AIFs were averaged and used to create a group AIF. All individual
AIFs are shown with the resultant averaged AIF in bold in figure 6.1.
6.2.1 Group averaged AIF - results
All twelve raw AIFs from the bladder cancer dataset with the group AIF overlaid
are shown in figure 6.1. Using the group averaged AIF to perform 2CXM FXL/NXL
fits to the bladder cancer dataset (using the same ROIs and methods as in chapter
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Figure 6.1: The calculated tracer concentrations from 12 patient AIFs are shown, overlaid.
The group averaged AIF resulting from averaging these 12 AIFs is shown in bold.
4) resulted in the parameter estimates shown in tables 6.1 and 6.7. Estimates of Fp,
vp and ve decreased slightly, relative to the results found using an uncorrected AIF.
The variance in the parameter estimates was generally reduced when using the group
averaged AIF. A reduction in variance could be expected when substituting a group
AIF for individual AIFs, as one source of variation in the data (individual variations
in AIFs) has been eliminated.
The difference between CT and MR parameter estimates can be compared for analysis
using the raw and group AIF using table 6.1. The MR parameter estimates calculated
using a group averaged AIF produced reductions in the mean CT-MR difference for
Fp, PS, and ve and reductions in the variance for vp, as shown in table 6.1. Reductions
in variance were significant for Fp after a 2 × Bonferroni correction. Reductions in the
mean CT-MR difference for Fp and reductions in the variance for vp were significant
before Bonferroni correction, but not afterwards.
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Figure 6.2: The raw AIFs and the AIFs which have been corrected using a group averaged
AIF are shown here for all 12 patient datasets.
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6.3 Adjustment of equilibrium plasma CA concen-
trations
After the initial injection of contrast agent into the patient, the contrast agent circu-
lates around the vasculature and leaks out of blood vessels which allow such leakage.
This circulation and leakage continue for some time, with the shape of the bolus be-
coming increasingly dispersed on each recirculation. Eventually, after several minutes,
the concentration of contrast agent reaches a relatively stable equilibrium concentra-
tion, where peaks and troughs due to individual bolus recirculations are no longer
visible. This equilibrium concentration likely depends on several factors including
renal function and the injected dose of contrast agent.
In patients with normal kidney function, some authors suggest that the equilibrium
concentration of contrast agent in arterial plasma should be roughly equivalent to
literature values for healthy volunteers [29]. If this assumption holds, it is possi-
ble that the variation between the individual’s actual arterial CA concentration and
the literature measurements are smaller than the variations between the actual and
MR-measured concentration caused by MR imaging artefacts. A suitable literature
reference is one in which careful, MR independent measurements of arterial CA con-
centration were made, for example using arterial blood sampling in [137]. Horsfield
et al. have proposed a method of correcting MR AIFs by fitting a functional form
and scaling so that the final concentration matches that measured by Weinmann et
al. [29, 137]. It should be noted that this method is only appropriate for patient
groups with good kidney function, equivalent to that of the healthy volunteers in
[137]. In this thesis, this method will be referred to as the ‘equilibrium adjusted AIF’
or ‘equilibrium AIF’ for shorthand. The bladder AIFs corrected using this method
are shown in figure 6.3.
The functional form the of AIF presented by Horsfield et al. [29] is based on work by
Davenport et al. [138], which describes how the dispersion of the bolus of contrast
agent can be described by a gammavariate. Each recirculation of the bolus involves
the convolution of the gammavariate by the same function shifted in time. The
result of this convolution is another gammavariate. For each recirculation of the
bolus, the total contrast agent present is the contrast agent remaining from the
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Figure 6.3: The raw AIFs and the AIFs which have been corrected by adjusting the final
plasma concentration (the ‘equilibrium AIF’) are shown here for all 12 patient datasets.
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previous recirculations, plus that from the new recirculation, and so the effects of
recirculation require the summation of the gammavariates. For N recirculations of
the bolus (N ≥ 0), Horsfield et al. show that the concentration of contrast in the
vessels is proportional to a summation of gammavariates R(t) [29]:
R(t) =
N∑
j=0
γ(α(j + 1) + j, β, t− jτ) , Nτ < t < (N + 1)τ (6.1)
where α and β are parameters describing the shape of the curve, and τ is the time
needed for the bolus to recirculate through the system. A triexponential decay is
then applied to these summed gammavariates, to account for the effects of leakage
and excretion of the contrast agent. This gives a function of the form:
Cp(t) = k
[
3∑
i=1
Aie
−mit
]
R(t) , Nτ < t < (N + 1)τ (6.2)
Here, Ai and mi are parameters describing the shape of the triexponential decay, k
is a scaling factor related to the area under the first pass of contrast agent, and R is
from equation 6.1. This functional form can be scaled so that the final concentration
matches that measured in [137] by adjusting the scaling appropriately. For a dose D
of contrast agent, if the scaled concentration Cp is 0 for t < 0, Cp(t) is given by [29]:
Cp(t) = D(β(α + 1) + τ)
[
3∑
i=1
Aie
−mit
]
R(t) , Nτ < t < (N + 1)τ (6.3)
This form of the AIF is referred to here as the ‘equilibrium adjusted AIF’.
6.3.1 Equilibrium adjusted AIF - results
All twelve raw AIFs from the bladder cancer dataset with the equilibrium adjusted
AIFs overlaid are shown in figure 6.3. Applying this correction resulted in an increase
in peak and tail concentrations for 5 AIFs, and a decrease in concentration for 7 AIFs.
The percent difference between the peak concentration of the raw and adjusted AIFs
had a mean ± SD of (37 ± 26)%. For the concentrations at 2 minutes after injection,
the percent difference between the raw and adjusted AIF concentrations was (67 ±
24)%.
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Using the equilibrium adjusted AIF to perform 2CXM FXL/NXL fits to the bladder
cancer dataset (using the same ROIs and methods as in chapter 4) resulted in the
parameter estimates shown in table 6.7. Estimates of all parameters, and their as-
sociated variance, decreased relative to the results found using an uncorrected AIF.
A reduction in variance may be associated with the elimination of variation in the
data related to imaging artefacts, and a smoothing of the AIFs (the fitted functional
forms are noise-free).
The difference between CT and MR parameter estimates can be compared for analysis
using the raw and equilibrium adjusted AIF using table 6.2. The MR parameter
estimates calculated using the equilibrium adjusted AIF produced reductions in the
mean CT-MR difference for all parameters, and reductions in the variance for Fp
and vp, as shown in table 6.2. Neither the reductions in the mean difference nor the
reductions in variance were significant either before or after Bonferroni correction.
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6.4 Cardiac output based corrections
As discussed in section 2.6, cardiac output (CO) can vary between individuals for a
number of reasons. It can also be expected that the cardiac output may be directly
related to the observed shape of the AIF. Some groups have suggested that individ-
ual measurements of cardiac output could be used to adjust MR AIFs [139, 136].
Although no independent measurements of cardiac output were available for this
dataset, estimates of cardiac output can be obtained from DCE datasets using the
area under the first pass of the AIF. In the bladder cancer dataset, cardiac output
was found using the Stewart Hamilton equation in the indicator dilution method (see
equation 2.40 of section 2.6). The area under the first pass of tracer through the artery
of interest (AUC) was found by fitting a gamma variate function to the first pass and
integrating the area under the fitted curve. The area under the fitted gamma variate
was used rather than simply the area under the first pass because the area under the
first pass is ambiguous due to the appearance of the subsequent recirculations, and
the first pass of tracer is expected to have the form of a gammavariate function in
the case of a bolus injection [140, 138]. This method was applied to both the DCE
MRI and the DCE CT datasets, to obtain both an MR and a CT estimate of cardiac
output in each patient. In order to calculate the CT CO, the baseline subtracted CT
signal had to be converted to contrast agent concentration using a calibration. This
is discussed in section 6.4.1.
Table 6.3 lists the MR and CT cardiac output estimates in units of L blood/min for
the bladder cancer dataset as found using the indicator dilution method described
above. The discrepancy between the MR CO estimates emphasise the fact that the
MR AIFs are likely affected by artefacts; the MR CO estimates are generally larger
than the CT estimates, which are much closer to the literature value of 6.5 L/min in
healthy adults [80]. The mean (± SD) MR CO for this group was (15.1 ± 9.4)L/min,
which is significantly higher than mean CT CO (5.9 ± 1.6)L/min (p=0.008).
Using the CO estimates from table 6.3, two methods of using the cardiac output
to correct MR AIFs were investigated: a simple linear scaling by the ratio of the
MR/CT cardiac outputs, and a non-linear adjustment as proposed by Zhang et al.
[136]. These methods will be discussed in sections 6.4.2 and 6.4.3.
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patient MR CO CT CO
1 12.7 7.0
2 7.1 4.3
3 10.0 4.1
4 18.8 4.2
5 12.8 7.3
6 4.6 6.7
7 37.3 6.1
8 7.3 9.2
9 14.7 7.5
10 26.1 5.4
11 21.3 4.9
12 9.1 4.9
mean 15.1 5.9
Table 6.3: MR and CT cardiac output estimates in units of L/min for all 12 bladder
cancer patients, as calculated using the Stewart Hamilton equation.
6.4.1 CT calibration
Accurate knowledge of the concentration of contrast agent is required for calculation
of the cardiac output from DCE CT, because the area under the concentration vs
time curve (AUC) must be calculated.
As discussed in section 2.3, the background subtracted DCE CT signal is proportional
to the concentration of contrast agent. The proportionality constant is found by
performing a calibration measurement using the same scan settings as in the DCE
CT protocol, ideally immediately before or after the DCE CT scan to be calibrated.
Because the CT data used in the analyses in this thesis were acquired for a different
study, no calibration was done at the time of acquisition (March 2007 - November
2008). The author undertook a calibration some months later (November 2009). The
phantom used was the standard phantom used for abdominal DCE CT calibration at
the Christie hospital. The phantom is shown in figure 6.4; it consists of a large acrylic
cylinder containing samples of material with varying linear attenuation coefficients
including air, polystyrene, and Teflon. It also contained several empty slots; three of
these slots were used to hold vials with varying dilutions of Omnipaque; the dilutions
were 1:10, 1:100, 1:200 diluted with sterile medical saline, which correspond to 30
mg/ml, 3 mg/ml, and 1.5 mg/ml of iodine, respectively. The phantom was scanned
with the same parameters as used in the DCE CT acquisitions: 120 kV p, 80 mAs,
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Figure 6.4: A CT calibration phantom containing samples with a range of linear attenu-
ation coefficients (acrylic, polystyrene, Teflon, air), as well as vials containing Omnipaque
300 at dilutions of (A) 1:10, (B) 1:100, and (C) 1:200
4×5 mm slices, and a 512×512 reconstruction matrix.
Using the phantom shown in figure 6.4 and plotting HU versus contrast agent concen-
tration, a constant of proportionality of (2.58 ± 0.04) HU/mM was found; data are
shown in figure 6.5. This constant was used to convert the CT signal intensity into
iodine concentration. Although only 3 samples were used to produce this calibration,
this was judged to be sufficient as the samples covered a wide range of concentrations,
and the resulting calibration curve is very linear with little noise or scatter.
It is unknown how the beam spectrum at the time of calibration may have differed
from that at the time of imaging, but the work in [54] suggests that over a shorter
time period (48 weeks) the calibration factor may vary by up to 24%. Ideally, this
calibration would have been performed at the time of scanning.
6.4.2 Scaling by cardiac output
The cardiac output estimated using the Stewart Hamilton equation applied to DCE
MRI AIF data is likely to be inaccurate due to issues such as partial volume effects
and inflow affecting the AIF. However, because a CT estimate of cardiac output
156
Chapter 6. Investigating MR AIF errors and AIF correction
methods by comparison with CT
Figure 6.5: A plot of HU versus concentration of Omnipaque for the phantom shown in
figure 6.4. Error bars are standard deviations over the regions of interest taken in each vial
of contrast agent.
would not suffer from these issues, it could be expected to be more accurate than an
MR estimate of cardiac output. This is illustrated by the CO values in table 6.3. MR
and CT estimates of cardiac output were found using the Stewart Hamilton method,
and the ratio of MR/CT cardiac outputs was used to scale the MR AIF. As shown
in equation 6.4, if the MR AIF is scaled by the ratio of the MR/CT cardiac output,
the (possibly inaccurate) MR cardiac output cancels, giving an area under the scaled
AIF which should depend on the dose of MR tracer and the CT measured cardiac
output. If the CT cardiac output is assumed to be nearer to the patient’s true cardiac
output, the resulting scaled AUC should be closer to the ‘true’ value in the absence
of artefacts affecting the MR AUC.
AUCMR
(
COMR
COCT
)
=
doseMR
COMR
(
COMR
COCT
)
=
doseMR
COCT
(6.4)
The bladder AIFs corrected using this method are shown in figure 6.6.
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Figure 6.6: The raw AIFs and the AIFs which have been corrected by scaling by the ratio
of cardiac output (‘CO scaled’) are shown here for all 12 bladder cancer patients.
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6.4.2.1 Scaling by cardiac output - results
All twelve raw AIFs from the bladder cancer dataset with the CO scaled AIFs over-
laid are shown in figure 6.6. Applying this correction resulted in an increase in peak
concentration for all 12 AIFs. The percent difference between the peak concentration
of the raw and CO scaled AIFs had a mean ± SD of (240 ± 210)%. For the con-
centrations at 2 minutes after injection, the percent difference between the raw and
scaled AIF concentrations was (240 ± 210)%.
Using the cardiac output scaled AIF to perform 2CXM FXL/NXL fits to the bladder
cancer dataset (employing the same ROIs and methods as in chapter 4) resulted in
parameter estimates shown in table 6.7. Mean estimates of PS, Fp, ve, and vp, as
well as their variance, decreased relative to the results found using an uncorrected
AIF. The reduction in variance may be associated with the elimination of variation
in the data related to imaging artefacts affecting the area under the first pass peak
of the MR AIF.
The difference between CT and MR parameter estimates can be compared for analy-
ses using the raw and CO scaled AIFs using table 6.4. The MR parameter estimates
calculated using the CO scaled AIFs produced reductions in the mean CT-MR dif-
ference and reductions in the variance for Fp and vp, as shown in table 6.4. The
reductions in the mean CT-MR difference were significant after Bonferroni correction
for NXL estimates of Fp, FXL estimates of vp, and both FXL and NXL estimates of
PS. Reductions in the mean difference between CT and MR NXL estimates of vp
were significant before Bonferroni correction, but not afterwards. Reductions in the
variance were significant for Fp and vp.
159
Chapter 6. Investigating MR AIF errors and AIF correction
methods by comparison with CT
F
p
v p
P
S
v e
F
X
L
N
X
L
F
X
L
N
X
L
F
X
L
N
X
L
F
X
L
N
X
L
U
n
co
rr
ec
te
d
A
IF
M
ea
n
(M
R
-C
T
)
d
iff
er
en
ce
0.
26
0.
35
0.
10
0.
12
0.
06
7
0.
04
4
0.
05
3
0.
04
6
M
R
-C
T
va
ri
an
ce
0.
08
0.
09
0.
01
0
0.
00
83
0.
01
6
0.
01
7
0.
01
6
0.
01
9
C
O
sc
al
ed
A
IF
M
ea
n
(M
R
-C
T
)
d
iff
er
en
ce
-0
.0
5
0.
28
-0
.0
10
0.
04
4
-0
.0
75
-0
.0
94
-0
.0
94
-0
.0
99
M
R
-C
T
va
ri
an
ce
0.
00
4
0.
00
6
0.
00
09
4
0.
00
12
0.
03
1
0.
03
0
0.
07
4
0.
07
0
R
ed
u
ct
io
n
in
m
ea
n
d
iff
er
en
ce
(p
-v
al
u
e)
0.
25
0
.0
0
3
4
0
.0
0
3
2
0.
04
5
0
.0
1
1
0
.0
0
9
8
0.
09
3
0.
08
1
R
ed
u
ct
io
n
in
va
ri
an
ce
of
d
iff
er
en
ce
(p
-v
al
u
e)
0
.0
0
2
6
0
.0
0
2
6
0
.0
0
4
1
0
.0
1
2
0.
28
0.
33
0.
03
6
0.
06
8
T
ab
le
6.
4:
T
he
m
ea
n
di
ffe
re
nc
e
be
tw
ee
n
M
R
an
d
C
T
pa
ra
m
et
er
es
ti
m
at
es
of
F
p
,
v p
,
P
S
,
an
d
v e
ar
e
gi
ve
n,
w
it
h
va
ri
an
ce
,
to
as
se
ss
w
he
th
er
th
er
e
w
as
an
y
im
pr
ov
em
en
t
in
th
e
ag
re
em
en
t
of
M
R
w
it
h
C
T
af
te
r
M
R
A
IF
co
rr
ec
ti
on
us
in
g
th
e
C
O
sc
al
ed
A
IF
.
P
-v
al
ue
s
ar
e
sh
ow
n
be
fo
re
B
on
fe
rr
on
i
co
rr
ec
ti
on
,
an
d
th
os
e
th
at
re
m
ai
n
si
gn
ifi
ca
nt
(p
<
0.
05
)
af
te
r
a
2
te
st
B
on
fe
rr
on
i
co
rr
ec
ti
on
ar
e
in
di
ca
te
d
w
it
h
bo
ld
fa
ce
.
160
Chapter 6. Investigating MR AIF errors and AIF correction
methods by comparison with CT
6.4.3 Adjustment of baseline signal using cardiac output
Zhang et al. have proposed a method of using measured cardiac output to perform
non-linear adjustments of the pre-contrast AIF signal, effectively constraining the
conversion from signal intensity to contrast agent concentration [136]. The method
works by forcing the area under the first pass of the AIF to obey the Stewart-Hamilton
principle for a dose of contrast agent D and cardiac output CO:
AUC =
D
CO
(6.5)
This involves three steps. First, a gammavariate function is used to fit the first
pass peak of the AIF signal curve, to isolate the first pass from the subsequent
recirculations and determine the AUC. Next, the pre-contrast MR signal intensity
S(0) is adjusted until the MR AUC has the desired value of D/CO. Finally, the
whole signal AIF is shifted to the new baseline S(0) which gives the desired AUC.
The signal AIF is then converted to concentration for use in further analysis. The
adjustment of S(0) is based on the assumption that errors in the measured AIF
are largely due to inaccuracies in S(0) caused by inflow and partial volume effects,
and that the adjustment of S(0) based on the measured CO will ensure the correct
magnitude for the adjusted AIF [136].
To implement this method in the bladder cancer dataset, CT estimates of cardiac
output found using the Stewart Hamilton equation were used to adjust the the pre-
contrast MR signal until the area under the first pass of the MR AIF had the desired
value, which in this case was equal to the dose of MR contrast agent DMR divided
by the CT estimate of cardiac output COCT :
∫
CcorrectedMR (t)dt = AUC =
DMR
COCT
(6.6)
Finally, the MR signal AIF was shifted to the new baseline S(0) giving the desired
AUC.
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Figure 6.7: The raw AIFs and the AIFs which have been corrected by adjusting the
baseline signal to produce agreement with the Stewart Hamilton equation using a CT
measure of cardiac output (‘CO adjusted’) are shown here for all 12 patients.
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6.4.3.1 Adjustment of baseline signal using cardiac output - results
All twelve raw AIFs from the bladder cancer dataset with the CO adjusted AIFs
overlaid are shown in figure 6.7. Applying this correction resulted in an increase
in peak concentration for all 12 AIFs. The percent difference between the peak
concentration of the raw and CO adjusted AIFs had a mean ± SD of (340 ± 300)%.
For the concentrations at 2 minutes after injection, the percent difference between
the raw and adjusted AIF concentrations was (66 ± 51)%.
Using the cardiac output adjusted AIF to perform 2CXM FXL/NXL fits to the
bladder cancer dataset (using the same ROIs and methods as in chapter 4) resulted
in parameter estimates shown in table 6.7. Estimates of PS, Fp, ve, and vp and
their variance decreased relative to the results found using an uncorrected AIF. The
reduction in variance may be associated with the elimination of variation in the data
related to imaging artefacts affecting the area under the first pass peak of the MR
AIF.
The differences between CT and MR parameter estimates can be compared for analy-
sis using the raw and CO adjusted AIFs using table 6.5. The MR parameter estimates
calculated using the CO scaled adjusted AIF produced reductions in the mean CT-
MR difference and reductions in the variance for Fp and vp, and reductions in the
mean difference between CT and MR FXL estimates of PS as shown in table 6.5.
The reductions in the mean CT-MR difference were significant after Bonferroni cor-
rection for Fp, NXL estimates of vp, and FXL estimates of PS. Reductions in the
variance were significant after Bonferroni correction for Fp and FXL estimates of vp.
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6.5 Comparisons with CT before and after AIF
correction
In order to assess whether the AIF corrections altered the results of the analysis
comparing CT with MR, a similar analysis comparing the MR and CT parameter
estimates was performed to that done in sections 4.3 and 5.3: both the MR FXL
and NXL parameter estimates were compared with CT parameter estimates using a
2 tailed paired t-test. In order to aid the comparison with section 5.3, the same 8
patients were included in the means of this table (patients 1, 3, 4, 5, 6, 8, 10, and
11) as in table 6.6. A 2 test Bonferroni correction can be applied to the resulting p-
values, to compensate for the two (FXL and NXL) tests performed on each parameter.
Results are given in table 6.6.
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The results of comparing the analysis using a raw MR AIF with CT in table 6.6
indicate that there are significant differences between CT and MR NXL estimates of
Fp, and the FXL and NXL estimates of vp. For both Fp and vp, the CT/MR difference
is supported by a difference between FXL and NXL estimates of the parameter. There
was also a significant difference between FXL and NXL estimates of PS but there
was no evidence of a difference between CT and MR estimates of PS.
The differences between CT and MR NXL, and between MR FXL and NXL estimates
of vp were maintained after all 4 AIF correction methods. The difference between
CT and MR FXL estimates of vp was maintained when the group AIF or equilibrium
adjustment method was used, but was not significant after the use of the CO based
AIF corrections, as these methods resulted in MR FXL estimates of vp which were
closer to CT.
The differences between MR FXL and NXL estimates of Fp were maintained after
the use of all 4 AIF correction methods. The differences between CT and MR NXL
estimates of Fp were maintained when the group AIF and the equilibrium adjustment
method was used, but the CO based AIF corrections brought MR NXL estimates of Fp
closer to CT and the difference was no longer significant. A difference between CT and
MR FXL estimates of Fp using the raw AIF was observed, but was not significant after
Bonferroni correction (p=0.78). Although the size of the difference decreased after
the use of all 4 the AIF correction methods, the standard deviation also decreased,
and the difference between CT and MR FXL estimates of Fp was significant both
before and after Bonferroni correction using the equilibrium adjustment and the CO
adjustment methods, and before correction using the CO scaling method (p=0.056).
The difference between MR FXL and NXL estimates of PS was not supported by
a difference between CT and MR. However, the difference between FXL and NXL
estimates of PS was maintained by the use of all corrections except the equilibrium
adjustment correction.
No significant differences were observed between CT and MR, or between MR FXL
and NXL estimates of ve after Bonferroni correction.
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6.5.1 Discussion of CT comparisons
The results of the analysis using an unscaled AIF here are the same as those reported
in table 5.4 of section 5.3 (note that these results differ from the results in chapter
4 because that analysis used an automatically detected AIF while the raw AIF used
here is manually defined).
Any changes in the significance of the CT-MR differences in parameter estimates
after AIF correction are of interest because they may indicate that some differences
between CT and MR were an artefactual result of errors in the calculated AIFs, while
other real differences were being hidden by errors in the AIFs.
Some differences were apparent both before and after using the AIF correction meth-
ods. A significant difference between MR FXL and NXL estimates of Fp, vp, and PS,
indicating potential sensitivity to water exchange, was observed both before and after
AIF correction. These potential water exchange sensitivities were supported by dif-
ferences between CT and MR parameter estimates in the case of the NXL estimates
of vp. NXL estimates of Fp were significantly different from CT before correction and
after using the group and equilibrium adjusted AIFs, but the CO based corrections
brought MR NXL estimates of Fp closer to CT and the difference was no longer sig-
nificant (perhaps indicating it was related to an MR artefact affecting the first pass
peak). The same effect was observed for FXL estimates of vp, which were no longer
significantly different from CT after the CO based AIF corrections were applied. FXL
estimates of Fp were marginally different from CT before AIF correction (p=0.078),
and marginally or significantly different after all correction methods.
The fact that a difference between MR FXL and NXL estimates of vp, indicating a
sensitivity of this parameter to water exchange, was supported by a difference between
CT and MR NXL estimates of vp both before and after each of the AIF corrections
suggests that this is a real difference which may be related to water exchange. The
conclusions in section 5.3 (discussing the impact of manual and automatic AIFs on
parameter estimates) are broadly supported here, suggesting that vp and Fp are the
parameters most likely to be affected by water exchange, as shown by differences be-
tween the MR FXL and NXL parameter estimates which are supported by differences
between CT and MR NXL estimates. As before, it is not clear that a non-FXL anal-
ysis is needed, as the only difference between CT and MR FXL parameter estimates
before AIF correction (vp) was not significant or marginally significant after the use
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of the CO based AIF correction methods. However, the presence of marginally sig-
nificant differences (0.05 ≤ p ≤ 0.10) between CT and MR FXL estimates of vp and
Fp suggest that caution should be used when applying an FXL model, and further
investigation is warranted.
6.6 Summary - impact of AIF correction on pa-
rameter estimates
The CT AIFs measured in this dataset appear to be more accurate and less vulnerable
to artefacts than the MR AIFs; this is supported by the CO estimates in table 6.3,
which are artificially elevated for MR. Because the CT data were assumed to be less
affected by artefacts, CT was used as a point of comparison to assess the relative
benefits of the four AIF correction methods investigated in sections 6.2, 6.3, and 6.4.
The parameter estimates obtained using the corrected AIFs were generally lower than
estimates obtained using the raw AIFs, except for vp estimates obtained using the
group averaged AIF, which were slightly elevated. Parameter variance also tended
to decrease; again, estimates of vp obtained using the group averaged AIF were the
only instance in which variance increased. Table 6.7 shows the mean values of the
FXL and NXL parameter estimates of PS, Fp, vp, and ve for all 10 patient datasets
analysed (5 datasets for ve).
To measure the improvement in the agreement of tracer kinetic parameter estimates
with CT after AIF correction, tables 6.1, 6.2, 6.4, and 6.5 show the mean differences
between MR and CT tracer kinetic parameter estimates in row 1, variance in row 2,
the p-value for the significance of the improvement in agreement with CT in row 3,
and the p-value for the significance of the improvement in variance in row 4. The
p-value in row 2 arises from a comparison of the difference between CT and the
raw FXL/NXL results with the corrected CT - FXL/NXL difference using a two
tailed paired t-test. The p-value for the reduction in variance in row 3 arises from
a comparison of the difference between CT and the raw FXL/NXL results with the
corrected CT - FXL/NXL difference using a two tailed squared ranks test for equality
of variance. All p-values can be corrected using a 2× Bonferroni correction (FXL and
NXL estimates of each parameter were tested for fits using each of the 4 corrected
AIFs).
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The results in tables 6.1, 6.2, 6.4, and 6.5 can be summarised according to the AIF
correction as follows:
Use of a population AIF produced reductions in the mean CT-MR difference for
all parameters, and reductions in the variance for Fp and vp. Reductions in the
variance of Fp were significant after Bonferroni correction, while reductions in the
mean CT-MR difference for Fp and variance of vp were significant before but not
after correction.
Use of the CO scaling method produced significant reductions in the mean difference
between CT and MR NXL estimates of Fp, FXL estimates of vp, and both FXL and
NXL estimates for PS. Significant reductions in the variance were seen for Fp and
vp. Reductions in the variance for ve were significant before, but not after Bonferroni
correction.
Use of the CO adjustment method produced significant reductions in the mean CT-
MR difference and reductions in the variance for Fp and FXL estimates of vp. Signif-
icant reductions in the mean CT-MR difference were seen for PS. Reductions in the
variance of ve were significant before Bonferroni correction, but not afterwards.
As seen in section 6.4, the mean MR CO for this group was (15.1 ± 9.4) L/min, while
the mean CT CO was (5.9 ± 1.6) L/min. It was hypothesised that the MR AIFs
might be affected by imaging artefacts. Because these measures of CO are derived
from the area under the first pass of the AIF, it could thus be inferred that the MR
measures of CO might also be affected by imaging artefacts. The fact that the CT
COs lie within the normal range for healthy adults (see section 2.6), while the MR
COs, which are considerably higher, do not, supports this hypothesis, and suggests
that the measured CT AIFs and COs are likely not affected by imaging artefacts
impacting the MR AIFs. Using the CT COs to correct the MR AIFs generally
resulted in AIFs with higher concentrations (see figures 6.7 and 6.6), while using a
group AIF or adjusting the equilibrium plasma concentration had a more variable
effect (see figures 6.1 and 6.3).
The results of comparing the CT and MR parameter estimates before and after AIF
correction indicate that vp and Fp are the parameters which are most sensitive to water
exchange effects, as shown by differences between the MR FXL and NXL parameter
estimates which are supported by differences between CT and MR NXL estimates
(table 6.6). As before, it is not clear that the use of a non-FXL model is warranted for
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analysis of this clinical bladder cancer dataset, as there was generally good agreement
between CT and MR FXL parameter estimates. The only difference between CT
and MR FXL parameter estimates before AIF correction (vp) was not significant
or marginally significant after the use of the CO based AIF correction methods.
However, the presence of marginally significant differences (0.05 ≤ p ≤ 0.10) between
CT and MR FXL estimates of vp and Fp suggest that caution should be used when
applying an FXL model, and further investigation is warranted.
It could be expected that vp and Fp would be the parameters most sensitive to
water exchange, as these ‘vascular parameters’ are strongly influenced by the AIF
and the first pass of contrast agent through the tissue. The first pass is also the
time when there is likely to be the greatest difference in T1s between the EES and
vascular compartments, meaning that this is when water exchange between these
compartments is most likely to be intermediate rather than in the FXL, and thus
that parameters strongly affected by the shape of the first pass are likely to be more
sensitive to water exchange effects.
6.7 Comparison with literature AIFs
Comparing the results of the MR tracer kinetic analysis with CT is one method
of evaluating the benefits of AIF correction. However, there are other methods of
measuring AIF concentrations, and taking samples of arterial blood to measure tracer
concentrations has the advantage that it does not suffer from any imaging artefacts.
In the absence of blood sampling data for these patients, and having already compared
MR and CT results from individual patients before and after AIF correction, it
was of interest to compare the measured and corrected AIFs with AIFs from the
literature taken using arterial blood sampling techniques. Of course, the validity
of any comparison between a patient AIF and a literature AIF taken from healthy
volunteers is vulnerable to physiological differences and variations. However, as a
point of reference, a comparison with literature AIF concentrations gives a general
idea of whether the AIFs being calculated are physiologically reasonable.
Fritz-Hansen et al. injected 8 healthy volunteers (aged 25-32) with a 0.1 mmol/kg
bolus of Gd-DTPA mixed with 80 MBq 99mTc-DTPA (with a 99mTc-DTPA to Gd-
DTPA ratio of < 0.02) in under 10 s. Starting simultaneously with the tracer injec-
172
Chapter 6. Investigating MR AIF errors and AIF correction
methods by comparison with CT
tion, arterial blood samples of 500 µl were taken from a peripheral artery every 2 s
for the first minute and then every 10 s for a further 3 minutes. Blood samples were
evaluated in a gamma counter, and the concentration of Gd-DTPA was calculated
[1]. Using figure 8 from [1], which shows the arterial Gd-DTPA concentrations for the
first 120 s after injection for 6 volunteers, the mean peak and tail concentrations in
plasma for each of the 6 AIFs shown were estimated and averaged to give one mean
peak and tail concentration, which were converted from whole-blood concentrations
to plasma concentrations using an assumed haematocrit of 0.42. The resulting peak
and tail concentrations were 4.66 mM and 0.95 mM , respectively.
In table 6.8, the mean peak and tail bladder patient AIF concentrations from each
correction technique are shown, and the % differences between the mean concentra-
tion and the peak and tail concentrations of 4.66 mM and 0.95 mM from [1] are
shown for reference. Because the tail values in figure 8 of [1] are concentrations given
at 120 s after injection, the tail concentrations listed in table 6.8 are also taken at
120 s after injection.
A single sample t-test was performed to compare all 12 AIF peak and tail concen-
trations to the literature values of 4.66 mM and 0.95 mM respectively. A 2 test
Bonferroni correction can be applied, as the peak and tail concentrations were com-
pared with literature values for each of the correction techniques. Mean peak/tail
concentrations in table 6.8 which are highlighted in boldface indicate concentrations
which are not significantly different from the literature values after a 2× Bonferroni
correction. The raw peak AIF concentrations did not differ significantly from the
literature value of 4.6 mM . However, both peak and tail AIF concentrations were
lower than literature values after the equilibrium adjustment scheme was applied,
and higher than literature values following the CO based corrections.
6.8 Correlation of CT and MR AIF concentrations
It might be expected that patients with high CT AIF concentrations would also have
higher MR AIF concentrations because relative peak concentration should depend
on physiological factors that, ideally, are the same between the MR and CT exami-
nations. However, there is the confounding factor that a standard dose (100 ml) of
CT contrast agent was injected for all patients, while the dose of MR contrast agent
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Uncorrected Group Eq. CO scaled CO adjusted
Peak [mM ] Mean 4.1 4.0 3.3 9.7 11.9
SD [mM ] 2.2 - 0.88 1.8 2.8
range [mM ] 0.90-7.9 - 1.8-4.4 6.8-13 9.1-17
% diff [mM ]
from 4.66 -13 -15 -30 110 160
p-value 0.37 - 0.0002 0.0001 0.0001
Tail [mM ] Mean 1.1 0.98 0.88 3.0 2.4
SD [mM ] 0.4 - 0.09 0.84 0.63
range [mM ] 0.43-1.9 - 0.79-1.1 2.1-4.9 1.7-4.1
% diff [mM ]
from 0.95 18 2.9 -6.8 220 150
p-value 0.0001 - 0.021 0.0001 0.0001
Table 6.8: The mean, standard deviation, and range of the peak and tail concentrations
from the bladder cancer dataset are listed for uncorrected AIFs as well as for AIFs resulting
from each of the four correction techniques. The peak (highest) and tail (average from 118
to 122 s) plasma concentrations are compared with literature peak (4.66 mM) and tail
(0.95 mM) concentrations from [1]. P-values from single sample t-tests are shown before
Bonferroni correction; p-values are highlighted in bold where patient concentrations are not
significantly different from literature values after a 2 × Bonferroni correction.
(0.1 ml/kg) was dependent on body weight; this could potentially interfere with the
expected correlation between CT and MR. To test the hypothesis that CT and MR
AIF concentrations should be correlated, linear correlation analysis was performed to
determine whether there was any correlation between the CT and MR AIF peak/tail
concentrations, either before or after correction. The r2 and p values for each of the
MR/CT correlations are presented in table 6.9.
Significant correlations were found between the CT and MR peak concentrations
before correction, and after the equilibrium adjustment correction, as shown in table
Raw Eq. CO sc. CO adj.
Peak [mM ] r2 0.44 0.49 0.22 0.003
p-value 0.019 0.011 0.12 0.69
Tail [mM ] r2 0.054 0.38 0.46 0.68
p-value 0.47 0.034 0.015 0.0009
Table 6.9: The correlation between the peak and tail concentrations in the MR and CT
AIFs was tested for the bladder cancer dataset before and after the AIF corrections were
applied. Values for correlations (r2) are from a simple linear correlation, p-values are from
2-tailed single sample t-tests (significant correlations indicated in boldface).
174
Chapter 6. Investigating MR AIF errors and AIF correction
methods by comparison with CT
Figure 6.8: The raw AIF and the AIFs which have been corrected by all 4 methods
are shown here for a typical patient AIF: using a group AIF, adjusting the equilibrium
concentration, scaling by the ratio of MR and CT cardiac outputs, and adjusting the
baseline signal using a CT measure of cardiac output. Literature peak (4.66 mM) and tail
(0.95 mM) concentrations [1] are shown as bold horizontal lines.
6.9. Because the CO corrections are based on adjusting the area under the first pass
of the AIF, correlations between CT and MR peak concentrations are not surprising.
The hypothesis that CT and MR AIF concentrations should be correlated was sup-
ported for the first pass peak, but not for the tail of the AIF. The correlation between
CT and MR peak concentrations was lost after applying the CO based corrections.
When considering the correlation between CT and MR AIF concentrations, it must
be noted that the difference in doses may lead to a lack of correlation: a standard
dose (100 ml) of CT contrast agent was injected for all patients, while the dose of
MR contrast agent (0.1 ml/kg) was dependent on body weight.
6.9 Discussion and Conclusions
Figure 6.8 shows a typical example of an AIF before and after correction using each
of the 4 methods from this chapter. Comparisons with CT support the use of car-
diac output based AIF corrections for MR AIFs, as the agreement between CT and
MR parameter estimates improved after AIF correction, and the variance on MR
parameter estimates was reduced. These comparisons suggest that cardiac output
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based AIF corrections can counter the effects of some MR artefacts and improve
AIF measurements. The use of the group AIF produced significant reductions in the
mean CT-MR difference for Fp, and may be used if a measurement of CO cannot be
obtained. The use of the equilibrium adjustment correction did not produce a signif-
icant improvement in the agreement with CT. The cardiac output based corrections
appeared to be the most effective correction schemes, in terms of producing improved
agreement with CT.
It is unknown to what extent the use of CT estimates of cardiac output based on the
area under the concentration curve (rather than a more accurate, non-DCE method
of cardiac output measurement such as the thermodilution or dye dilution method
[141]) influenced these results. Although an independent measure of cardiac output
would have been preferred, none was available for these data. However, the use of
a phase contrast measurement of cardiac output was used to correct the MR AIFs
acquired in chapter 8 with good results. Although no CT data were available for
comparison of parameter estimates before and after correction in chapter 8, reasonable
AIF concentrations and parameter estimates were obtained.
CT and MR peak concentrations were significantly correlated before correction, but
the correlation was lost after applying the CO based corrections. The concentrations
measured at 2 minutes after contrast agent injection were not correlated in the CT
and MR datasets. This may be related to the different doses of contrast agent used:
100 ml of CT contrast agent was injected into each patient, while the MR contrast
agent dose of 0.1 ml/kg was adjusted according to patient weight. At 2 minutes after
injection, the contrast agent appears to have dispersed in the arterial plasma, and
the concentration may depend on the total volume of blood, which varies according
to patient weight. This hypothesis was tested by performing a correlation analysis
between tail concentration and patient weight; no significant correlations between the
concentration of tracer at 2 minutes after injection and patient weight were found,
either for CT or MR. These lack of correlations suggest the presence of artefacts
which may be affecting the measured MR concentrations in a nonlinear way relative
to contrast agent concentration. Although there was no correlation between CT and
MR concentrations before AIF correction, the use of each of the three AIF correction
schemes produced significant correlations between CT and MR tail concentrations.
The comparison of MR AIF concentrations with literature values demonstrates that
the raw and corrected AIFs fall within a reasonable range (where the raw AIFs tend
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to be lower than the literature value and the CO corrected AIFs tend to be higher;
see figure 6.8). While the mean AIF values agreed with the literature values (table
6.8), individual AIFs could have considerably higher or lower concentrations, again,
see figure 6.8. The range and SD values given in table 6.8 also indicate the extent
to which individual AIF concentrations varied. Discrepancies between individual
AIFs and the expected values could indicate artefacts affecting the MR signal, and
provided the initial motivation to explore AIF correction schemes in this chapter. The
discrepancy of the AIF concentrations with literature values both before and after
correction emphasises that comparisons between the bladder patient datasets and
these literature values must be regarded with caution. Differences in bolus injection
speeds between [1] and the present studies would be expected to produce differing
AIF peak concentrations, and differences in the cardiac output and renal function
between healthy young (25-32 years of age) volunteers in [1] and older (53-80 years
of age) cancer patients might be expected to produce differences in the AIF tail
concentrations. These factors are discussed below.
Because a power injector was not used for [1], it is unclear what the injection speed
was for each volunteer. It is stated that the injection was completed in < 10s at
0.1 mmol/kg, implying that it is possible the injection rate used in the present
experiments was more than twice as fast as the rate used in [1]. For instance, the
smallest injected dose in the bladder dataset was 12 ml. At 3 ml/s, this would take
only 4 seconds to inject, rather than up to 10 seconds in [1]. Because a faster injection
speed would be expected to produce higher peak concentrations in the patient AIFs
[142], the elevated concentrations produced by the CO corrections relative to the
literature value (see table 6.8) may be partially due to faster injection rates.
Because glomerular filtration rates (GFRs) were not available for the bladder patient
dataset, and neither GFRs nor cardiac outputs were provided in [1], it cannot be
confirmed that there were significant physiological differences related to cardiac or
renal function between the healthy volunteers used to produce the literature AIFs
and the older cancer patients used to produce the AIFs in this work. However, it
is generally the case that healthy young individuals have better renal function than
older patients [143]. In [143], healthy males aged 25-32 had a median glomerular
filtration rate (GFR) of 121 ml/min/1.73m2. This is substantially greater than the
GFRs expected for older individuals. Healthy males aged 69 (the mean for the blad-
der patients) could be expected to have GFRs of 88 ml/min/1.73m2 [143]. Cancer
patients might be expected to have even lower GFRs than healthy individuals of the
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same age. Because reduced kidney function would be expected to produce higher
AIF concentrations in the tails, the results in table 6.8 which show the older patient
AIFs have higher CO corrected tail concentrations than the literature AIFs may be
partially explained by reduced renal function in this patient group relative to the
healthy volunteers in [1]. Note that the equilibrium AIF correction method is based
on producing agreement with the literature value from [1], eliminating any individual
differences due to variations in renal function; as expected there is agreement between
the tail concentrations of these AIFs and the literature values in table 6.8. The lack
of improvement in agreement of parameter estimates with CT after the equilibrium
AIF correction was applied (as seen in table 6.2) supports the hypothesis that there
maybe differences in patient renal function which are eliminated by the equilibrium
AIF correction, making this method unsuitable for use in individuals whose renal
function may differ from healthy young volunteers.
Although early studies demonstrated a decline in cardiac output with age of approx-
imately 40 ml/min per year in healthy males [77], later studies suggest that the
perceived decline in cardiac output is mainly due to the increased prevalance of dis-
ease in older populations [144, 145]. If we accept this, but assume that the patients
in the study are susceptible to the usual rates of cardiovascular disease, the equation
from [77] estimates that young males aged 25 would be expected to have a cardiac
output 1.8 L/min greater than healthy males aged 69; again, cancer patients might
be expected to have lower cardiac outputs than healthy individuals of the same age.
Reduced cardiac output should lead to higher peak AIF concentrations, again in
agreement with the results in table 6.8.
The comparison between these patient AIF concentrations and the literature concen-
trations taken using blood sampling was performed to assess whether the concentra-
tions being calculated in the corrected AIFs were physiologically reasonable. This
was a concern because the AIF concentrations after correction were substantially
different from the raw AIF concentrations. Although the mean AIF concentrations
agreed with literature values, there was considerable variation amongst individual pa-
tients, and agreement between literature AIFs and corrected AIFs was not observed.
However, it is, as discussed above, reasonable to expect higher concentrations in these
patient AIFs than in the literature AIF used, and the literature comparison supports
the corrected AIFs as being broadly physiologically reasonable.
It may also be the case that the disagreement between the patient AIFs and literature
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AIFs may be due to errors in the analysis of the patient AIFs. The CT calibration
discussed in section 6.4.1 was performed several months after the scans; some inves-
tigators suggest that a CT calibration should be performed after every dynamic CT
scan for accurate conversion to contrast agent concentration [54]. If the calibration
performed several months later gave a calibration factor which did not provide the
correct conversion to contrast agent concentration, this would bias the calculated CT
cardiac outputs, resulting in inaccurate results for the CO adjustment and CO scaling
corrections.
Another factor which may have affected the calculated COs (and thus the results of
the CO adjustment and CO scaling corrections) was the method of CO correction.
Because an independent measure of CO was not available for these data, CO was cal-
culated using the Stewart Hamilton equation. This calculation involves a number of
assumptions. It assumes that the gammavariate fit to the AIF peak correctly charac-
terises the area under first pass peak, isolating it from any subsequent recirculations.
A gammavariate function is generally thought to accurately characterise the AIF re-
sulting from a bolus injection [140, 138], and so this assumption is likely reasonably
accurate if the first pass peak is an accurate reflection of the concentrations involved
(ie not susceptible to any artefacts). Bolus injections are also desirable because the
Stewart Hamilton equation assumes an instantaneous injection; although this is never
possible in practice, if the injection time is short relative to the recirculation time,
the Stewart Hamilton equation should still hold [85]. The Stewart Hamilton method
also assumes that there is no leakage of contrast agent out of the system between the
time of injection and the time of measurement of the curve. In these experiments,
the contrast agent was injected in a peripheral vein, and the concentration curve
was measured in the iliac artery. This means that the bolus of contrast agent was
required to pass through the heart and lungs prior to measurement. Some leakage
of contrast agent is likely to occur during this time, particularly in the lungs [29].
The amount of leakage which occurs would determine the extent to which this would
affect the calculated CO: a 10% leakage would result in an AUC 10% lower than it
would have been had the full dose arrived, which results in a calculated CO which is
overestimated by 10%.
Another assumption of the Stewart Hamilton equation is that the tracer and plasma
are well mixed. This assumption should hold with low molecular weight contrast
agents, but caution should be used with more viscous agents. The equation also
assumes that the system is stationary, ie. that the distribution of transit times of
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tracer particles does not change with time. Although this assumption is violated for
the pulsatile flow produced by the heart, Zierler et al. suggest that if the variations
in transit times are sufficiently rapid around some central value, the assumption that
the system is stationary may still be valid [85].
6.9.1 Conclusions
The use of a group AIF cannot correct for imaging artefacts present in the individual
AIFs, and the equilibrium adjustment technique does not account for differences
in individual physiology which might produce variations in AIF tail concentrations.
The cardiac output based methods of AIF correction used here attempt to account
for both of these issues, being individually based and able to correct for partial
volume and inflow effects. The comparisons with CT in section 6.4 support the
use of cardiac output based AIF correction methods, as the parameter estimates
calculated using CO corrected AIFs showed improved agreement with CT and reduced
variance compared to parameter estimates calculated using the uncorrected AIFs.
Of the available methods for evaluating the benefit of the AIF correction methods,
comparison with CT was seen as the most useful. Because the CT and MR AIFs
were available in the same patients, they should reflect the same physiology, but the
CT AIFs did not suffer the same artefacts as the MR AIFs because CT images the
tracer directly and this CT protocol had higher spatial and temporal resolution as
compared to the MR.
Comparison with a literature AIF was another option for evaluating the effects of the
AIF corrections. As shown in figure 6.8, the CO corrected AIFs tended to have higher
concentrations than the raw or equilibrium adjusted AIFs, and also showed higher
concentrations than literature AIFs from [1]. Although the mean of the peak AIF
concentrations agreed with literature values before correction, there was considerable
variation in individual AIF concentrations. Differences in patient age and physiology
in the bladder dataset as compared to the volunteers used to produce the literature
AIFs could be expected to produce higher AIF concentrations, as observed after the
use of the CO based corrections.
The results in section 6.5 indicate that vp and Fp are the parameters which are
most sensitive to water exchange effects, using both raw and corrected AIFs. It
is unclear whether the use of a non-FXL model is warranted for analysis of this
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clinical bladder cancer dataset, as there was generally good agreement between CT
and MR FXL parameter estimates. However, significant and marginally significant
(0.05 ≤ p ≤ 0.10) differences between CT and MR estimates of vp and Fp suggest
that caution should be used when applying an FXL model.
Of the four AIF correction methods tested, cardiac output based corrections were
the most effective in improving the agreement of MR and CT estimates of Fp, vp
and PS, and reducing the variance in estimates of Fp and vp. In order to measure
water exchange effects, the results in this chapter have shown that it is important to
have accurate and precise estimates of vp and Fp; this may be facilitated with the
use of CO based AIF corrections. Indeed, analysis which is not sensitised to water
exchange effects could also benefit from the improved agreement and correlation of
AIF concentrations with CT and the reductions in parameter variance which the
CO based AIF corrections provide. In conclusion, CO based AIF corrections merit
further investigation as a method of compensation for MR artefacts affecting AIFs.
6.9.2 Summary
The results in this chapter suggest that the MR AIFs used in chapter 4 may have
been suffering from artefacts, but that cardiac output based AIF corrections may
compensate for some of these artefacts, producing reduced variance in parameter
estimates and improved agreement with CT. The use of a group AIF and of an
equilibrium concentration adjustment technique were also investigated, but did not
appear to improve the AIFs as significantly.
The results from chapter 5 emphasised the impact of AIF variations on parameter re-
sults, while the results in chapter 6 suggested a method for correcting AIF variations
due to artefacts. As a result of these findings (chapter 6), the use of a phase contrast
measurement of cardiac output was implemented in order to apply the cardiac output
adjustment technique to the AIFs in chapter 8, a dataset designed to perform prelim-
inary tests of a water exchange sensitised protocol in healthy volunteers. In chapter
7, further simulations are described which also contributed to the development of the
protocol in chapter 8.
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using the WX-2CXM: simulations
In chapter 4, it was established that while intravascular-EES water exchange was
potentially creating a small effect in the clinical dataset analysed, insufficient infor-
mation existed to measure water residence times in these data using the WX-2CXM.
The residence times of water in the vascular, EES, and intracellular compartments
are parameters which would be of clinical interest if they could be easily measured,
as these parameters are directly related to tissue physiology and could be expected
to change in response to some treatments, particularly in oncology [146]. In order to
determine whether it might be possible to measure water residence times using a clin-
ical sequence, the simulations presented in this chapter were performed to determine
the optimal DCE MRI acquisition parameter choices for measuring these parame-
ters. Additionally, these simulations further explore the question of whether water
exchange effects need to be accounted for in standard clinical protocols. The results
of these simulations led to the development of a protocol which would be tested in
healthy volunteers in the parotid gland (see chapter 8).
There were many factors to consider when developing a protocol sensitised to water
exchange. The experience gained from analysing the bladder cancer dataset in chapter
4 motivated and informed this work, and the investigations in chapter 5 led to the
decision to use manually selected AIFs, and allowed an informed awareness of how
assumptions about T1 relaxivity, T1(0), flip angle, and TR might affect the outcome
of WX-2CXM analysis of water exchange sensitised data. Because the parameters for
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the flip angle, TR, and contrast agent injection can be controlled and adjusted in a
DCE MRI protocol, further investigations were performed to optimise these parts of
the protocol for maximum water exchange sensitivity, and potentially measure water
residence times. These investigations are presented in this chapter.
During these investigations, it became apparent that the ability to measure water
residence times without using a specialised sequence was not guaranteed. In the
simulations described below, the scatter and standard deviation on estimates of the
water residence times are large, particularly for τp. However, the simulations also sug-
gest that such measurements may be possible, and indicate which parameter choices
minimise the associated uncertainties in estimating the water residence times.
7.1 Optimisation of flip angle
In a typical SPGR-type DCE MRI protocol, the three most important adjustable
parameters that determine image contrast are TE, TR, and flip angle (α). In any
potentially clinically useful sequence, the TE is constrained to be as small as pos-
sible to minimise T ∗2 effects, and the ‘optimised’ value for TE selected here was the
smallest value allowed by the scanner. Water exchange effects should generally be
more apparent at lower flip angles and longer TRs [120, 59], and so simulations were
run to optimise these two parameters to maximise the difference between the signal
obtained using the FXL and NXL of the 2CXM model, thus maximising the potential
water exchange sensitivity of the sequence.
The maximum possible range of variation produced by water exchange effects using a
particular set of parameters can be found by taking the difference in signal intensities
produced using the FX and NX limits of the model. Maximising this difference should
give a TR/α combination which maximises the sensitivity to water exchange:
Max [SFXL(TR, α)− SNXL(TR, α)]
Analytically, this could be done by finding the root of the partial derivative of the
difference SFXL − SNXL with respect to flip angle and TR
δ (SFXL − SNXL)
δTR δα
= 0 (7.1)
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Plotting out the surface formed by SFXL − SNXL for a range of possible values of
alpha and TR reveals that it is a smooth surface (see figure 7.1). Because this surface
is smooth, with clear maxima and minima, taking the maximum of the SFXL−SNXL
difference gives an estimate of the maximum of the partial derivative, indicating
values for TR and α which maximise the signal difference.
7.1.1 Simulation results - optimal flip angle for maximising
the FXL - NXL signal difference
Figure 7.1 shows the absolute difference between the FXL and NXL signal intensities
for a range of flip angles and TRs, at a timepoint corresponding to the first pass of
contrast agent through the tissue. Although a dual bolus acquisition was planned
(see section 7.2), the signal intensity used to generate figure 7.1 was based on a single
bolus acquisition, to isolate the optimal flip angle for the portion of the acquisition
which, it was hoped, would demonstrate increased water exchange sensitivity.
In an effort to ensure the relevance of these simulations to real patient data, the
manually defined AIF and FXL MR parameter estimates from patient 1 of the blad-
der dataset were used to generate the simulated tissue signal uptake curves. This
dataset was chosen because it had both a good quality AIF and tissue uptake curve,
with minimal motion and AIF artefacts as compared to other datasets. FXL MR
parameter estimates were selected rather than WX-2CXM parameter estimates from
this dataset as the use of the 6 parameter WX-2CXM was not justified for these
data. The parameters used to generate the simulated uptake curves were: Fp = 0.26
ml/min/ml, PS = 0.067 ml/min/ml, ve = 0.14, vp = 0.10, τp = 0.01s, τic = 0.01s.
The choice of 0.01 s for τp and τic was based on an estimate of a small but phys-
iologically possible values for the water residence time, as attempts at WX-2CXM
fitting to the bladder dataset tended to find small (and, as mentioned, unacceptably
variable) estimates of these parameters. A haematocrit of 0.42, tracer relaxivity of
4.5 /mM/s and precontrast tissue T1 of 1.3 s were used to convert between signal
intensity and concentration.
A short TR was needed to ensure good temporal resolution for the dynamic acquisi-
tion. Ideally, sub-second temporal resolution would be used to ensure good charac-
terisation of the first pass peak of the AIF. However, this was not possible while still
maintaining both good spatial resolution and an adequate number of slices to min-
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Figure 7.1: The absolute difference between the signal intensity in the FXL and NXL is
shown, for a range of flip angles and repetition times TR. On the left, the flip angle ranges
from 0 to 90◦ and TR ranges from 0 to 60 ms, while on the right the flip angle ranges from
0 to 40◦ and TR ranges from 0 to 15 ms to show more detail in the range of likely imaging
parameters.
imise inflow effect. A goal of 1-2 s temporal resolution was established, as previous
work [36] suggested that a temporal resolution of less than 2 s was required. A TR
of 2 ms was chosen for these simulations, as previous experience with T1 weighted
DCE MRI protocols on the scanner indicated that a TR in this range would be
needed to achieve the desired temporal resolution. Figure 7.1 shows that while the
SFXL−SNXL signal difference is greater at larger TRs (left), a noticeable increase in
the signal difference is still seen for short TRs (right) for certain flip angles. Taking
the absolute maximum of the surface at TR = 2 ms in figure 7.1, the flip angle which
maximises SFXL − SNXL is 5◦ at a timepoint corresponding to the first pass peak of
the tracer through the tissue.
This result is relatively robust to input parameter variation. In figure 7.2, the input
parameters have been varied to encompass a wide range of values for Fp, PS, ve, and
vp. The parameters used to produce the curves in figure 7.2 are given in table 7.1 for
a TR of 2 ms. It can be seen that the optimal flip angle for maximising SFXL−SNXL
remains relatively stable, regardless of the input parameters. For the range of input
parameters given in table 7.1, the optimal flip angle for maximising SFXL − SNXL
(corresponding to the peaks of the SFXL−SNXL curves in figure 7.2) ranges from 4◦
to 7◦.
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Figure 7.2: The absolute difference between the signal intensity in the FXL and NXL is
shown for a range of input parameters at a repetition time TR of 2.0 ms. The parameter
values used to produce this figure are given in table 7.1.
symbol Fp PS vp ve
[ml/min/ml] [ml/min/ml]
∗ 0.010 40 0.99 0.99
. 0.050 0.25 0.063 0.042
◦ 0.080 0.400 0.080 0.080
−− 0.1 0.014 0.014 0.014
− 0.9 0.009 0.09 0.09
−.− . 1 0.0011 0.02 0.02
Table 7.1: Parameter values used to produce the simulated data for the curves in figure
7.2.
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7.2 Contrast agent injection protocol
In the DCE MRI protocol being developed and optimised for a small pilot study on
volunteers in chapter 8, there would be no opportunity to collect CT data to serve as
a reference unaffected by water exchange. However, it can be seen from the results
in the previous section, and in the literature [120, 59], that low flip angles are most
sensitive to water exchange, while high flip angles are relatively insensitive to water
exchange effects. This suggests that a comparison of two datasets acquired in the
same volunteer, one at a low flip angle and one at a high flip angle, might reveal
differences which are directly related to water exchange. In addition, previous work
suggested that a protocol with multiple flip angles might be useful for measurements
of water residence times [60]. It was thus decided to simulate a protocol using two
bolus injections of contrast agent, where the acquisition following the first bolus would
use a different flip angle than the acquisition following the second bolus.
As stated in section 7.1.1, a flip angle of 5◦ was found to give the greatest separation
between FXL and NXL signals for a TR of 2 ms. A flip angle of 30◦ was chosen for the
‘high’ flip angle portion of the protocol because it was commonly used as the flip angle
in many of the clinical DCE MRI protocols used on the research scanners at the time
the simulations were written. Figure 7.1 shows that, at a TR of 2 ms, the difference
between the FXL and NXL signals is very small at a flip angle of 30◦, suggesting
that this flip angle should give minimal water exchange sensitivity as compared to a
flip angle of 5◦. The difference between the FXL and NXL signal intensity is a factor
of 10 smaller at 30◦ compared to 5◦; for a signal intensity measured at the first pass
peak of contrast agent through the tissue, at a TR of 2ms:
SFXL(5
◦)− SNXL(5◦)
SFXL(30◦)− SNXL(30◦) = 9.6 (7.2)
7.2.1 Order
Once the flip angles had been chosen, the next decision was whether the low flip angle
acquisition should precede the higher flip angle acquisition, or vice versa. Running the
lower flip angle first has the advantage that vascular-EES T1 differences are potentially
greatest after the first bolus injection and before tracer has accumulated in the EES.
Another advantage is that the overall lower concentration of tracer in the tissue
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after the first bolus minimises the risk of signal saturation, which would increase the
difficulty of fitting the data to detect small differences due to water exchange.
Running the higher flip angle acquisition first has the advantage that a useable AIF
would be obtained soon after the initial IR-TFE measurement of pre-contrast T1 (it
was anticipated that the AIF from the lower flip angle acquisition might be compro-
mised by inflow and signal saturation effects). However, if the higher flip angle acqui-
sition was run last, the T1 immediately prior to the second bolus injection would be
extrapolated from the calculated concentration timecourse, and a useable AIF would
still be obtained.
Simulations were run to determine which sequence of flip angles would give the most
accurate estimates of water residence times. Figure 7.3 illustrates sample tissue time-
courses resulting from a protocol in which the 5◦ flip angle was run first, and one in
which the 30◦ flip angle was run first. These timecourses were produced using the
WX-2CXM with normally distributed random noise added at a level of 2% of the
mean signal; this produced tissue uptake curves with a noise level which appeared
similar to what was hoped the new acquisition would produce. The following param-
eters were used to produce the simulated data: Fp = 0.26 ml/min/ml, PS = 0.067
ml/min/ml, ve = 0.14ml/min/min, vp = 0.10 ml/min/min, τp = 0.1 s, τic = 0.5
s. In these simulations, τic was set to be five times larger than τp. It was unknown
what the expected values for the water residence times in the parotid would be, but
literature suggests that τic may be longer than τp [27, 147]. Simulations were also run
using these parameters multiplied by 0.75 and 1.25, to investigate the behaviour of
the simulations over a range of parameter values. These scaled simulation parameters
are given in table 7.2 for reference. As before, the manually defined AIF from patient
1 in the bladder cancer dataset was used to produced the simulated curves.
Figure 7.4 shows histograms representing the parameter estimates resulting from
fitting 100 simulated timecourse data curves similar to the curves in figure 7.3 with
normally distributed random noise added. The simulated curves fitted to obtain
the parameter estimates in figure 7.4 were produced using the raw (not multiplied)
parameter inputs. Histograms are not shown for the simulated curves produced using
lower (×0.75) and higher (×1.25) simulation parameters, but they are broadly similar.
The means, medians, and SD of the parameters resulting from the multiplied data
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Figure 7.3: Sample timecourses are shown illustrating the tissue timecourse resulting from
a dual bolus protocol using a 30◦ flip angle followed by the 5◦ flip angle (A) and a 5◦ flip
angle followed by the 30◦ flip angle (B). Data (◦) are the result of simulations with the raw
(not multiplied) simulation parameters, with normally distributed random noise added.
WX-2CXM fits to the data are shown as solid lines.
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are given in table 7.2.
Using the raw (not multiplied) simulation parameters, the protocol beginning with
the lower flip angle shown in figure 7.4, panel B, produced more precise estimates of
all parameters with a comparable accuracy as shown in table 7.2. This is particularly
important for τp. Most histograms in panel B of figure 7.4 have sharper peaks nearer
to the true value of the parameters used to produce the simulated curves than do the
histograms in panel A, and lower standard deviations. In particular, estimates of the
water residence times τv and τic are more precise using the protocol in panel B. When
examining the means and standard deviations in table 7.2, it should be noted that
the distributions of these parameter estimates are not necessarily normal, as shown
in the histograms in figure 7.4.
When the simulation parameters were raised or lowered (×0.75 or ×1.25), the pro-
tocol beginning with a lower flip angle no longer produced more precise estimates
of all parameters. However, the median estimates remained more accurate than the
protocol beginning with a higher flip angle for Fp, ve and vp. Estimates of the water
residence times τp and τic remained more precise using the protocol beginning with
the lower flip angle. For all three simulated datasets, τp proved difficult to estimate,
demonstrating a skewed distribution and wide scatter. Estimates of τic showed a more
accurate mean and lower SD than estimates of τp in table 7.2. The fitted parameter
estimates in these simulations, particularly ve and τv, are vulnerable to outliers, as
seen in table 7.2.
The results indicate that a protocol beginning with the lower flip angle acquisition
may give slightly more accurate parameter estimates, and may be particularly useful
for estimating τic.
190
Chapter 7. Measuring water residence times using the WX-2CXM:
simulations
Figure 7.4: Parameter estimates resulting from WX-2CXM simulations with noise (100
simulated timecourses) are shown as histograms. The results from the dual bolus protocol
with the 30◦ flip angle followed by the 5◦ flip angle are shown in A, while the results from
the dual bolus protocol with the 5◦ flip angle followed by the 30◦ flip angle are shown
in B. The true parameter values used to produce the simulated curves are the raw (not
multiplied) values, and are shown as black vertical lines in each histogram. The parameters
Fp and PS are in units of [ml/min/min]; τp and τic are in units of [s], and ve and vp are
unitless.
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7.2.2 Contrast agent dose
Along with the order in which the two parts of the protocol would be run, the total
injected dose of contrast agent can also be optimised. Although, in theory, any dose
could be used, in order to simplify contrast agent dose calculations at the scanner,
simulations were created specifying either two full dose boluses at the standard dose
of 0.1 ml/kg, or two half dose boluses at 0.05 ml/kg of contrast agent.
Depending on the tracer uptake and washout characteristics, injecting two full dose
boluses would potentially risk saturating the MR signal in the AIF, tissue, or both,
in the second part of the acquisition [148]. However, the use of two full dose bo-
luses might lead to better estimates of water residence times due to the greater
intercompartmental T1 differences produced by higher tracer concentrations, partic-
ularly between the intracellular and EES compartments. Using two half dose boluses
would minimise signal saturation concerns, but simulations were needed to determine
whether sufficient intercompartmental T1 differences would be induced to detect water
exchange effects.
Figure 7.5 shows the SPGR signal intensity curves plotted for 5◦ and 30◦ with a TR
of 2 ms and a tracer relaxivity of 3.6 /mM/s. The AIF measured by Fritz-Hansen
et al. in [1] with the highest concentration shows a peak plasma concentration of
approximately 7 mM , and tail concentration of approximately 1 mM . The curves
in figure 7.5 demonstrate that any AIF acquired at 5◦ is likely to experience signal
saturation, whether a standard dose or two half dose boluses are used, assuming
maximum possible peak concentrations of 8 mM and 6 mM for the standard and
half dose boluses, respectively. The 5◦ SPGR signal curve at these concentrations
is relatively insensitive to changes in contrast agent concentration. The 30◦ curve,
meanwhile, shows good sensitivity to contrast agent concentration at these points
with little risk of signal saturation. The risk of signal saturation in the AIF is thus
not a deciding factor in whether to choose a full or half dose bolus, as the AIF
from the 5◦ acquisition will likely be saturated in either case. However, at the lower
concentrations which might be observed in the tissue (1-2 mM), the risk of signal
saturation in the 5◦ acquisition is more of a concern. Signal saturation in the tissue
would increase the difficulty in fitting the data for quantitative analysis, potentially
undermining the usefulness of the 5◦ acquisition for detecting small water exchange
effects. The 5◦ curve in figure 7.5 indicates that a reduced dose of contrast agent
would decrease the risk of signal saturation in the tissue, and that a half dose bolus
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Figure 7.5: SPGR signal curves are plotted with arbitrary scaling against concentration
of contrast agent to demonstrate the risk of signal saturation at 5◦ and 30◦ for a TR of 2
ms.
of contrast agent should be used if tissue concentrations are anticipated which might
produce signal saturation in a 5◦ acquisition.
As shown in figure 7.6 and table 7.3, the use of a standard dose bolus tended to
produce estimates of τic and τp which were more precise than the estimates obtained
using a half dose bolus. For Fp, PS, ve, and vp, the histograms in panel A of figure
7.6 have a lower spread than the histograms in panel B; the peaks in both panel A
and B show a comparable accuracy for both doses. When examining the means and
standard deviations in table 7.3, it should be noted that the distributions of these
parameter estimates are not necessarily normal, as shown in the histograms in figure
7.4.
When the simulation parameters were raised or lowered (×0.75 or ×1.25), the use of
a standard dose bolus still tended to produce parameter estimates which had a lower
standard deviation than those found using a half dose bolus, as seen in table 7.3. The
accuracy of the medians was comparable at both doses, although, as with the raw
(not multiplied) parameter estimates, the use of a standard dose bolus produced more
precise estimates of the water residence times τp and τic. Although the distributions
of τp were skewed with high scatter, they were more accurate with lower SD when
using a standard dose bolus. The median values of τic tended to be closer to the
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Figure 7.6: Parameter estimates resulting from WX-2CXM simulations with noise (100
simulated timecourses) are shown as histograms. The results from the dual bolus protocol
with the 5◦ flip angle followed by the 30◦ flip angle using a standard dose bolus are shown in
A, while the results using a half-dose bolus are shown in B. The true parameter values used
to produce the simulated curves are the raw (not multiplied) values, and are shown as black
vertical lines in each histogram. The parameters Fp and PS are in units of [ml/min/min];
τp and τic are in units of [s], and ve and vp are unitless. Note that the τp histogram in panel
B has been truncated and rebinned over an interval from 0 to 1 s to better illustrate the
distribution.
simulated values when using a half dose bolus. The fitted parameter estimates in
these simulations, particularly ve and τv, are vulnerable to outliers, as seen in table
7.3.
As there were some concerns about signal saturation using two full dose boluses at
low flip angles, it was decided that two half dose boluses would be used for the final
protocol, since the accuracy of parameter estimates obtained would be comparable.
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7.3 Discussion and Conclusions
The development of a protocol to estimate water residence times in volunteers faced
three issues: an uncertain ability to measure water residence times, a lack of a ref-
erence dataset unaffected by water exchange, and difficulties in AIF measurement
at low flip angles. The simulations in this chapter suggest that a protocol with two
bolus injections could address each of these issues. Such a protocol would allow the
acquisition to have multiple flip angles including a low flip angle during the first pass
of contrast agent through the tissue when water exchange effects are expected to have
the greatest impact, followed by a high flip angle during the second bolus to enable
the measurement of an AIF with minimal inflow and saturation effects. Although
a reference dataset completely unaffected by water exchange would still not be ob-
tained, the comparison of the parameter estimates from the low flip angle and high
flip angle boluses should highlight differences due to water exchange at different flip
angles, ensuring some information about water exchange can be gained even if water
residence times cannot be estimated.
Simulations suggest that a dual injection protocol employing a 5◦ acquisition for the
first bolus and a 30◦ acquisition for the second bolus would be optimal for monitoring
water exchange effects and potentially measuring water residence times. A half dose
bolus was chosen rather than a full dose bolus to minimise the likelihood of signal
saturation while giving parameter estimates of a comparable accuracy. Although
longer TRs could be expected to increase the water exchange sensitivity of the data,
a short TR must be used to ensure adequate temporal sampling of the AIF. The
simulations indicate that a TR of 2 ms appears to still allow estimates of τic.
7.4 Summary
The simulations in this chapter guided the development of a DCE MRI acquisition
designed to measure water exchange effects using two half dose bolus injections of
contrast agent using a lower (5◦) flip angle to monitor the first bolus and higher (30◦)
flip angle to monitor the second bolus. TRs were chosen as short as possible so that
a high temporal resolution (< 2 s) could be achieved for good AIF sampling; the
choice of a 2 ms TR in these simulations indicated that the lower flip angle should
be set at 5◦.
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In the next chapter, the results of implementing this acquisition in a DCE MRI
protocol imaging the parotid in healthy volunteers are presented.
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Applying the WX-2CXM to assess
water exchange effects in the
parotid gland
8.1 Introduction
In chapter 7, simulations were performed to find the optimal flip angle and contrast
agent injection protocol for a sequence which would be sensitised to water exchange.
A dual angle, dual injection protocol was developed, which would allow the water ex-
change sensitised portion of the timecourse to be compared with the higher flip angle
(water exchange insensitive) portion of the timecourse. This was done to allow for
a quantitative comparison of water exchange effects in the sensitised and insensitive
portions of the timecourse.
Quantitative DCE MRI is most commonly used to characterise tumour tissues. Be-
cause the protocol used in this chapter was a preliminary protocol, the decision was
made to test it in healthy volunteers rather than oncology patients. In the absence
of tumour tissues, a healthy tissue from the body was needed which would have mea-
surable vascular, intracellular, and EES compartments, with sufficiently permeable
vasculature that contrast agent extravasation and equilibration would occur within
the 5-10 minutes planned for each DCE MRI acquisition. These characteristics were
necessary to allow quantitative DCE MRI analysis to be performed using the WX-
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2CXM. The parotid was chosen as the tissue of interest to test this protocol because
other investigators in the department had successfully imaged the parotid in healthy
volunteers as part of a separate investigation (see [73]), and found the tissue charac-
teristics suitable for DCE MRI analysis. The parotid is highly vascularized, demon-
strates good contrast agent leakage, and has measurable (non-negligible) vascular and
EES fractions. The parotid is also a good organ to use for DCE imaging because its
location in the skull minimises motion, and allows surface coils to be used which can
increase the SNR and temporal resolution over the use of volume coils.
The experiments in the present chapter were carried out to test two hypotheses. The
first hypothesis was that the lower flip angle portion of the DCE MRI timecourse
would be more sensitive to water exchange than the higher flip angle portion, and
that evidence of water exchange effects could be revealed by differences between
the high and low flip angle portions of the timecourse. The second hypothesis was
that fitting the full dual angle, dual injection timecourse might allow estimates of
water residence times to be made for each of the vascular, intracellular, and EES
compartments. Both of these hypotheses were supported by the preliminary results
of the experiments as discussed in this chapter.
8.2 Materials and Methods
Eight volunteers between the ages of 21 and 59 (mean: 32 ± 12 years) were imaged
on a 1.5 T Philips Intera scanner using the Philips SENSE 18 element neurovascular
coil. An ECG-gated quantitative flow (Q-Flow) phase contrast sequence was run
to acquire flow measurements over one cardiac cycle in the ascending aorta. The
Q-Flow sequence is a single slice, fast field echo (FFE) type sequence which encodes
flow parallel to the slice encode direction and allows phase subtraction calculations
of flow. The imaging plane for the Q-Flow sequence was aligned perpendicular to the
ascending aortic artery by an experienced radiographer (Neal Sherratt), using survey
images in all three planes to ensure perpendicularity of the slice with the vessel. Flow
compensation and concommitant gradient correction were applied by the scanner
[149]. The sequence had a flip angle/TR/TE of 10◦/5.4/3.2 ms, 1.25×1.25 mm
reconstructed voxels, one 8 mm slice perpendicular to the ascending aorta, SENSE
factor of 2, Venc of 200 cm/s. Retrospective cardiac synchronisation was used to
reconstruct the 75 flow measurements over one cardiac cycle.
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Next, a high resolution T2-weighted turbo spin echo (TSE) sequence was acquired
for ROI definition. This sequence had a flip angle/TR/effective TE of 90◦/6216/120
ms, FOV of 180×180×75 mm, 256×200 matrix, 0.70×0.88 mm reconstructed voxels,
25×3 mm slices, TSE factor of 15.
Five inversion recovery TFE (IR-TFE) sequences were run to acquire a pre-contrast
T1 map, with five points along the inversion curve. These sequences had a flip
angle/TR/TE of 12◦/2.8/1.01 ms, shot interval between inversion pulses of 4000
ms, echo train length of 51, SENSE factor of 3, FOV of 180×180×75 mm, 176×147
matrix, 1.02×1.02 mm reconstructed voxels, 25×3 mm slices, inversion times of 80,
250, 1000, 2500, 3900 ms.
The dynamic acquisition consisted of three series of 3D T1-weighted spoiled gradient
echo fast field echo (FFE) acquisitions, which differed only in the flip angles used. The
TR/TE was 2.94/1.07 ms, SENSE factor of 3, and the geometry was the same as for
the IR-TFE (FOV of 180×180 mm, 176×147 matrix, 1.02×1.02 mm reconstructed
voxels, 25×3 mm slices). Ten dynamic volumes were acquired at 30◦, followed by
230 volumes at 5◦, followed by 230 volumes at 30◦ with a temporal resolution of
2.2 s. The first ten dynamic volumes at 30◦ were added for the calculation of AIF
concentration after the first volunteer was scanned, and it was noted that inflow
effects were compromising the AIF during the 5◦ timecourse to such a degree that
the accurate calculation of the AIF during the 30◦ timecourse was key. Due to
gradient heating restrictions, no more than 100 volumes could be packaged into one
sequence, and so there was a small (< 4s) gap between the 100th and 101st, and 200th
and 201st acquisitions of the latter two series. One bolus of Dotarem (gadoterate
meglumine, Guerbet, Aulnay-sous-Bois, France) was injected using a power injector
at a dose of 0.05 ml/kg and rate of 3 ml/s during the acquisition of the tenth volume
of the latter two series. See figure 8.3 for an illustration of the three phases of the
DCE MRI timecourse.
8.2.1 Analysis
Because this protocol was designed to test the sensitivity of a clinical protocol to
water exchange, the 6 parameter WX-2CXM model described in section 3.5, and its
FX and NX limits, were used for model fitting to the signal intensity DCE MRI
timecourse. As before, the FXL and NXL models gave estimates of Fp, PS, ve, and
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vp, while the WX-2CXM also gave estimates of τp, and τic.
Signal intensity was converted to contrast agent concentration using a relaxivity of
3.6 /mM/s for Dotarem [106]. A precontrast T1 of 1.35 s and haematocrit of 0.42
for arterial blood were assumed for all calculations involving the conversion of signal
intensity to plasma concentration [30]. As in chapter 4, all fitting was done in Matlab
(The MathWorks Inc., Natick, MA, USA) using a bounded simplex based nonlinear
optimisation where the sum of squares of the residuals was used as a minimisation
function.
8.2.1.1 ROI selection
Parotid glands were outlined on post-contrast dynamic images by the author, with
reference to the high resolution T2-weighted TSE images. ROI analysis (rather than
voxelwise analysis) was performed on the mean signal of these ROIs, to improve
SNR. For this reason, it was important that the ROIs selected contained reasonably
homogeneous tissue. The parotid ROIs were trimmed to exclude voxels which may
have contained non-glandular tissue, such as brain, skull, cerebrospinal fluid, major
arteries, veins, or nerves. Because considerable inter-volunteer heterogeneities were
observed in the contrast agent uptake curves resulting from these regions, the use of
the trimmed ROIs was compared with smaller ROIs consisting of 4×4 voxels (two
regions of 4×4 voxels, one in each of the right and left parotid glands). The observed
inter-volunteer heterogeneities in the shape of the contrast agent uptake curves were
observed for both sizes of ROIs (see figure 8.1), and so the trimmed regions were
chosen for use in all further analysis, as they provided better SNR than the 4×4
voxel ROIs, but were less likely to suffer partial volume effects than the untrimmed
full-parotid ROIs. Figure 8.1 shows an example comparing the contrast agent uptake
curves from two volunteers, demonstrating differences in the shape of the curves which
persisted when both the larger, trimmed ROIs, and the smaller 4×4 ROIs were used.
Due to restrictions on the scanner, the dynamic timeseries had to be split into blocks
of (at most) 100 scans. It was noted that the first volume (or timepoint) acquired
in a new block of scans showed a higher signal intensity relative to the prior and
subsequent volumes. No dummy scans were performed prior to each dynamic run,
and so the higher signal in the first scan of each block is a likely indication that the
magnetisation had not yet reached a steady state during this timepoint [150]. The
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Figure 8.1: Contrast agent uptake curves are shown for two volunteers which demonstrate
different uptake characteristics. The uptake characteristics are maintained over different
spatial scales of regions: trimmed whole parotid (left), and 4×4 voxels (right).
first volume acquired in each block was thus excluded from all further analysis. This
effect is particularly noticeable in the 5◦ portion of the acquisition, and can be seen
in figure 8.3 at timepoints 11, 111, and 211 (arrows).
8.2.1.2 Rician noise correction
It is recognised that the noise distribution in MR magnitude images is Rician (rather
than Gaussian) [151]. A simple correction can be applied to compensate for this [152].
The correction makes almost no detectable difference to the signal intensity at high
SNRs, but a noticeable difference at low SNR where noise dominates the detected
signal. A Rician correction was applied to all of the magnitude signal intensity data,
but the correction had little impact apart from the precontrast 30◦ data, which was
generally the noisiest portion of the dynamic acquisition. This Rician correction of
the pre-injection data impacted the S0 calculation (see equation 8.2), eliminating the
bias which would have been introduced by assuming Gaussian noise in the magnitude
images [151].
If SAV G is the mean signal intensity found by averaging the precontrast timecourse,
and σS is its standard deviation, the Rician corrected signal intensity SR is given by
[151]:
SR =
√
|S2AV G − σ2S| (8.1)
Separate values for σS and mean preinjection Rician corrected signal SR were calcu-
lated for each of the three portions of the acquisition shown in figure 8.3. In the case
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Figure 8.2: A typical slice from a high resolution T2 weighted image is shown with the
trimmed parotid ROI shown in white. The ROI is shown at the same resolution as T1
weighted dynamics, and has been trimmed to remove non-glandular tissues, including visible
veins and arteries.
of the preinjection signal used in the calculation of S0, SAV G was taken as the aver-
age of the preinjection timepoints (excluding the first timepoint as noted in section
8.2.1.1), and σS was the standard deviation of these timepoints. For the remainder
of the dynamic series, SAV G(t) was taken to be the mean signal from the ROI, and
σS was taken to be the value calculated from the precontrast signal relevant to the
portion of the timecourse being analysed. As previously noted, this correction had no
noticeable effect at higher (postcontrast) SNRs, due to the small size of σS relative
to SAV G.
8.2.1.3 Contrast agent concentration calculation
Several steps in the 2CXM fitting require conversion of the uptake timecourse from
signal to concentration. In order to perform this conversion using a SPGR/FFE-type
sequence, a value of S0 is required (see section 3.5). The value for S0 depends on
factors such as proton density, receiver gain, and other scanner settings. If the scanner
settings are altered, the value of S0 will change accordingly. Despite efforts to prevent
changes in any of the settings, some settings affecting S0 were automatically modified
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Figure 8.3: A sample contrast agent uptake timecourse is shown to illustrate the three
different phases of the DCE MRI acquisition in this protocol. First, 10 timepoints were
acquired at 30◦ (×, light shading), followed by 230 timepoints acquired at 5◦ (∗, medium
shading), and a further 230 timepoints acquired at 30◦ (o, dark shading). Due to scanner
restrictions, a maximum of 100 timepoints could be acquired in a block. It can be seen in
this figure that the first timepoint acquired in several of the blocks shows a higher signal
intensity relative to the prior and subsequent volumes, particularly in the 5◦ portion of the
timecourse (see timepoints 11, 111, 211, with arrows).
by the scanner during the acquisition of the three flip angles in the dynamic timeseries.
As a result, a separate value for S0 had to be used for each of the three sections of the
dynamic timeseries (the 10 pre-contrast timepoints at 30◦, 230 timepoints at 5◦ and
230 timepoints at 30◦). Figure 8.3 shows the three different phases of the acquisition
for which S0 was calculated.
For a SPGR-type sequence, if the signal intensity S and T1 relaxivity are known at the
timepoint for which S0 is needed, S0 can be calculated using equation 3.32. Generally,
S0 is assumed to be constant throughout a DCE MRI acquisition. However, for this
protocol it was found that S0 differed for each of the three flip angles (α) used. Thus,
three S0 values (S0i) were calculated using the following equation:
S0i =
S(ti)
sinα 1−e
−TR/T1i
1−cosα e−TR/T1i
(8.2)
For the 5◦ portion of the acquisition, the T1 maps generated by the IR-TFE images
were used to find the precontrast value for T1(t) in equation 8.2, and the first 10 images
(excluding the first timepoint) of the 5◦ timecourse acquired prior to contrast agent
injection were used to calculate the baseline signal S(t) in equation 8.2. This value for
S0 was used to calculate the 5
◦ concentration timecourse. For the 30◦ portion of the
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acquisition, the pre-injection T1 was found by averaging the T1(t) values in the final
ten timepoints of the 5◦ portion of the acquisition (at this point, T1(t) was relatively
stable), and S(t) was calculated by averaging the signal intensity over the first ten
preinjection/postcontrast timepoints acquired at 30◦ (excluding the first) for use in
equation 8.2. The resulting value for S0 was used to calculate the 30
◦ concentration
timecourse. Note that the baseline signal intensities S(t) were corrected for Rician
noise as outlined in section 8.2.1.2.
In the case of the AIFs, because the signal was compromised by inflow effects, a
different method was used to calculate the concentration for the 30◦ portion of the
data. At the beginning of the DCE series, 10 timepoints were acquired at 30◦ prior
to the 5◦ timecourse, in order to aid in the calculation of the 30◦ AIF. The signal
from these first 10 timepoints was averaged (again, excluding the first timepoint) and
an assumed precontrast blood T1 of 1.35 s was used to calculate the S0 for the first
10 timepoints. This value for S0 used for the calculation of the concentration in the
final (30◦) portion of the acquisition, along with a T1 corrected for any discrepancy
between the tail of the 5◦ and the start of the 30◦ portion of the timecourse.
The inflow effects compromised the 5◦ AIF to such a degree that it was unusable,
and due to the unphysiologically low concentrations calculated for the 30◦ AIFs, it
was suspected that these AIFs also likely suffered some combination of inflow and
partial volume effects. After the raw concentration AIFs were calculated as described
here, the CO estimate calculated using the Q-Flow data was used to perform a CO
correction on the 30◦ AIF (see below, section 8.2.1.4).
8.2.1.4 AIF selection and correction
Arterial input functions were obtained using manually defined regions of 1-3 voxels
in one slice clearly showing each of the right and left internal carotid arteries. The
slice for AIF definition was selected in the distal portion of the imaging volume (one
slice with the clearest section of internal carotid chosen from slices 21-24) to minimise
inflow effects. The final slice in the volume was not chosen for AIF definition due
to B1 concerns. Although the external carotid arteries are the feeding arteries for
the parotid glands, the internal carotids were selected for AIF extraction because
of their larger size, to minimise partial volume effects. The AIF is not expected to
differ significantly between the internal and external carotids as they branch from
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the common carotid at the upper border of the thyroid cartilage, which is reasonably
close to the parotid. In the case of one volunteer (volunteer 8), it was not possible
to obtain a good quality AIF from the carotids; this dataset was excluded from all
further analysis.
The raw extracted AIFs had obvious inflow effects in the 5◦ portion of the acquisition
- the peak concentrations were much reduced as compared to the same AIFs in the
30◦ portion of the acquisition, to the point where no visible peak was present in many
of the datasets (see figure 8.4). At the same time, although the shape of the 30◦ AIFs
was consistent with expectations, inflow effects were also suspected to be affecting
the concentrations (elevated signal intensities were observed in the carotids in the
lower slices of the volume). To compensate for inflow effects while still maintaining a
dual-bolus AIF, the cardiac output (CO) adjustment correction described in section
6.4.3 [136] was applied to the 30◦ portion of the AIF; this corrected AIF was copied
and shifted in time to create a 5◦ AIF as follows. First, the CO adjustment technique
was applied to the 30◦ portion of the AIF using the Q-Flow estimates of CO. These
results are discussed further in section 8.3. The CO adjustment shifted the corrected
AIF to a baseline concentration of 0 mM . This AIF was copied directly into the 5◦
portion of the timecourse. The concentration in the last 10 timepoints of this AIF
was averaged, and used to shift the CO adjusted AIF upwards; this shifted AIF was
copied into the 30◦ portion of the timecourse, so that the concentration in the tail of
the 5◦ portion of the timecourse would match the concentration at the start of the 30◦
portion. Note that because the second bolus of gadolinium was injected before the
first bolus had completely cleared from the circulation, the concentration of tracer
before the second bolus is greater than 0 mM .
An example of the raw AIF and the AIF resulting from this correction process is
shown in figure 8.4. This figure demonstrates both the impact of inflow effects on
the AIF, and the effectiveness of the CO adjustment. Inflow effects are particularly
noticeable in the 5◦ portion of the acquisition; the first bolus injection is highly
suppressed and unusable, while the second bolus injection has high concentrations
considering the reduced dose (0.05 ml/kg). Once the AIF resulting from the second
bolus injection has been corrected using the CO adjustment technique, and copied
into the initial part of the timecourse, the resulting dual bolus AIF demonstrates a
more typical shape, and concentrations more in line with literature values for both
AIF peaks.
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Figure 8.4: The raw AIF from volunteer 3 is shown to demonstrate the impact of inflow
effects on the AIF, and the effectiveness of the CO adjustment. The AIF from the first
bolus injection acquired at 5◦ is highly suppressed and unusable, and so the second bolus
acquired at 30◦ was used for CO adjustment. The elevated concentration observed in the
second bolus of the raw 30◦ AIF (◦) was reduced by CO adjustment; this corrected AIF
was copied into the initial part of the timecourse to produce the dual bolus CO adjusted
AIF shown here (•).
8.2.1.5 CO estimation
Segment (Einer Heiberg and MedvisioAB, Lund, Sweden [153]) software was used to
place ROIs in the ascending aorta, plot flow, and estimate cardiac output using the
Q-Flow data. Note that other analysis in this thesis was performed using Matlab
(The Math-Works Inc., Natick, MA, USA) software written by the author unless
otherwise specified.
ROIs were placed in the ascending aorta using magnitude Q-Flow images. Segment
software was used to fit the ROI to the whole cross section of the lumen of the carotid
artery at each of the 75 timepoints acquired through the cardiac cycle. Segment
was then used to calculate the through-plane velocity of the blood from the phase
difference images, and integrate the velocity over the area of the ROI to obtain a
value for flow at each point during the cardiac cycle. Flow was then plotted over
the whole cardiac cycle, and the area under this curve was integrated to obtain a
value of net flow and cardiac output in units of litres of blood per minute (see section
2.2.2 for an illustration of a flow curve and further discussion of cardiac output
calculations). Figure 8.5 shows an example of a Q-Flow magnitude and phase image
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Figure 8.5: The magnitude (left) and phase (middle) images from the Q-Flow data are
shown for a typical volunteer. The ROI used the calculate flow is shown in blue, in the
ascending aorta. The resulting flow curve (left) is plotted over one cardiac cycle.
from one volunteer; the ascending aorta ROI is shown in blue on these images, and
the resulting flow curve over one cardiac cycle is plotted in the left panel.
8.2.1.6 Statistics
One dataset (volunteer 8) was excluded from analysis because it was not possible to
obtain a useable AIF from this dataset. 2CXM analysis provided estimates of Fp,
vp, and PS in the remaining 7 datasets. It was not possible to obtain estimates of
ve in datasets 3, 4, or 6 from fits to the 5
◦ data. However, as was seen in chapter 4,
estimates of other parameters may still be obtained where the fit fails to provide a
reasonable estimate of ve (0 < ve < 1 ). Thus, all statistical testing of the 5
◦ data
used estimates of Fp, vp, and PS from 7 datasets, and estimates of ve from 4 datasets.
Similarly, the WX-2CXM fitting of the full timecourse (both 5◦ and 30◦) was unable to
provide estimates of ve or τe in the volunteer 3 dataset. Because the water residence
times τi are interdependent, none of the water residence times are reported from
dataset 3. Results from the full WX-2CXM include estimates of Fp, vp, and PS
from 7 datasets (volunteers 1-7), and estimates of ve, τp, τic, and τe from 6 datasets
(volunteers 1, 2, 4-7)
Comparisons of parameter estimates resulting from fitting the 5◦ and 30◦ data were
performed using two tailed paired t-tests (section 8.4.3). Although non-parametric
testing (the Mann-Whitney test) was considered for the ve comparisons, the small
number of ve estimates rendered this option inappropriate: the Mann-Whitney test
cannot show significance for less than 4 samples (p is always > 0.05) [154]. Normal
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volunteer heart rate CO age weight
[bpm] [L/min] [years] [kg]
1 60 5.6 21 70
2 57 5.6 27 65
3 63 6.0 25 80
4 45 4.8 29 74
5 83 6.3 33 55
6 80 8.1 33 75
7 71 3.7 59 80
8 57 3.6 28 52
Table 8.1: Estimates of heart rate and cardiac output in the ascending aorta using the
Q-Flow MR data with ECG gating, for all 8 volunteers. Ages and weights are also given,
for reference.
plots of ve were roughly linear, and so t-tests were applied and the results are shown
for ve. The p-values for ve comparisons, as with all of the statistical results in this
chapter, must be judged with due consideration of the small number of samples.
F-tests were used to determine whether the full 6 parameter WX-2CXM was signif-
icantly better than the 4 parameter FXL or NXL models for fitting each of the 5◦,
30◦, and full timecourses; these results are discussed in section 8.4.1.
Comparisons of peak and tail AIF concentrations with literature values were per-
formed using single sample t-tests. A 2 test Bonferroni correction was applied to
all p-values, since both peak and tail concentrations were tested. These results are
discussed in section 8.3.2.
8.3 Results: CO corrected AIFs
Cardiac output estimates for all 8 volunteers were obtained from the MRI Q-Flow
data as outlined in section 8.2.1.5. Mean heart rate and CO estimates are given in
table 8.1. The mean heart rate and cardiac output (± SD) for the group were (65
± 13) bpm and (5.5 ± 1.5) L/min, respectively, which are physiologically reasonable
and lie within the normal range [81, 82, 77, 155].
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Peak [mM ] Tail [mM ]
raw CO adj. raw CO adj.
1 0.956 3.26 0.474 1.37
2 4.43 4.65 0.562 0.548
3 11.3 4.32 1.13 0.525
4 4.14 3.52 0.971 0.792
5 6.91 2.48 1.07 0.421
6 6.00 3.27 0.751 0.432
7 9.43 6.20 1.14 0.792
Table 8.2: The peak and tail (2 minutes post-injection) concentrations are given for 7 raw
and CO adjusted AIFs. Note that volunteer 8 has been excluded due to a lack of useable
AIF on MRI.
8.3.1 CO correction of AIFs
Using ROIs in the internal carotid arteries, the signal timecourse was extracted and
converted to contrast agent concentration. Cardiac output estimates obtained using
the Q-Flow data were used to apply the cardiac output adjustment correction out-
lined in 6.4.3 [136]. The raw timecourses were observed to have highly variable first
pass peak concentrations, while the CO adjustment produced peak concentrations
which were more consistent across the volunteers and more physiologically plausible
as compared with literature values [1] (see section 8.3.2). This suggests that, despite
best efforts, the raw AIFs from these data suffered inflow effects. It also supports the
use of the CO adjustment technique as a method of AIF correction. All seven raw
and CO adjusted AIFs are shown in figure 8.6. As seen in table 8.2, the mean, SD,
and range of raw AIF concentrations are reduced by the CO adjustment: raw AIFs
have peak concentrations ranging from 0.96 to 11.3 mM (mean: 6.2 ± 3.5 mM),
while the CO adjusted AIFs have peak concentrations of 2.5 to 6.2 mM (mean: 4.0
± 1.2 mM).
8.3.2 Comparison with literature
As in section 6.7, several versions of the AIFs were investigated for use in this anal-
ysis. The raw and CO adjusted AIFs have already been described. Additionally,
a group AIF was created by aligning the peaks of the raw AIFs and averaging the
concentration timecourses. The group AIF is shown in figure 8.7. The peak and
2 minute post-injection concentration for the group AIF are given in table 8.3, for
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Figure 8.6: Raw and CO adjusted AIF contrast agent concentration curves are shown
for all seven volunteers. Raw AIFs (∗) demonstrate first pass concentrations which are
generally higher than CO adjusted AIFs.
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comparison with the raw AIF, CO adjusted AIF, and literature values.
Table 8.3 shows the mean peak and tail AIF concentrations for the raw, group,
and CO adjusted AIFs, and the % differences between the mean concentration and
the peak and tail plasma concentrations of 4.66 mM and 0.95 mM from [1]. As
in [1], tail concentrations are calculated at 120 s after injection (mean from 118 to
122 s). Both the group and CO adjusted AIF showed peak concentrations which
were closer to literature values than the raw AIFs; this was not the case with the
tail concentrations. The raw, population, and CO adjusted AIFs all showed lower
concentrations at 2 minutes after injection than the literature value, which may be
due to the half-dose bolus used here.
A single sample t-test was performed to compare the AIF peak and tail concentrations
to the literature values of 4.66 mM and 0.95 mM respectively. A 2 test Bonferroni
correction was applied, as both the peak and tail concentrations were compared with
literature values. None of the peak or tail concentrations in table 8.3 are significantly
different from the literature values, indicating that there is good agreement between
the concentrations seen in AIFs and the values in [1], despite the lower dose of
contrast agent used here (0.05 ml/kg here, which is half of the 0.01 ml/kg dose in [1]).
However, there is a considerable range in the AIF concentrations seen for individual
volunteers in table 8.3, motivating the use of the CO adjustment technique. The use
of the CO adjustment reduced the range of peak AIF concentrations, and improved
the agreement with the values from the literature.
The fact that the calculated tail concentrations and CO adjusted peak concentra-
tions are lower than the literature values is likely related to the lower dose of contrast
agent used here. Although halving the dose of contrast agent while maintaining the
injection rate should not affect the AIF peak height at the site of injection (because
the concentration of the bolus is fixed), the increase in dispersion effects for a smaller
bolus may reduce the peak height. The tail concentrations are expected to be more
significantly affected by halving the dose (because for the same total volume of plasma
the amount of contrast agent has been halved), and indeed, there is a greater discrep-
ancy between the literature value and the tail concentration of the volunteer AIFs
than between the literature value and the peak concentration in table 8.3.
Figure 8.7 shows an example of a raw AIF which has been corrected using the CO
measured using phase contrast MR (volunteer 4, CO of 4.6 L/min). The horizontal
lines in the figure indicate the peak and 2 minute post-injection concentrations from
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Uncorrected Group CO adjusted
Peak Mean [mM ] 6.2 4.8 4.0
SD 3.5 - 1.2
range 0.96-11 - 2.5-6.2
% difference from 4.66 [mM ] 32 2.5 -15
p-value 0.29 - 0.18
Tail Mean [mM ] 0.87 0.84 0.70
SD 0.28 - 0.33
range 0.47-1.1 - 0.42-1.4
% difference from 0.95 [mM ] -8.1 -12 -26
p-value 0.48 - 0.09
Table 8.3: The mean, standard deviation, and range of peak and tail concentrations from
the 7 parotid volunteers are listed for uncorrected AIFs as well as a population AIF and CO
adjusted AIF. The peak (highest) and tail (average from 118 to 122 s) plasma concentrations
are compared with literature peak (4.66 mM) and tail (0.95 mM) concentrations from [1]
using a two tailed paired t-test. None of the peak or tail concentrations are significantly
different from literature values.
[1]. In this case, the CO AIF correction improves the agreement of the raw AIF peak
concentration with literature value.
8.4 Results: Tracer kinetic parameter estimates in
the parotid
Because of the dual bolus nature of the acquisition, there were three uptake curves
which could be fitted: the 5◦ timecourse after the first injection, the 30◦ timecourse
after the second injection, and the full timecourse including both the 5◦ and 30◦
uptake data. The WX-2CXM, as well as its limits (FXL and NXL) were fitted to all
three of these timecourses.
8.4.1 F-test: full 6 parameter WX-2CXM
In order to determine whether the use of the full 6 parameter model was justified,
F-tests were performed comparing fits using 6 parameter WX-2CXM with its limits
(FXL and NXL) for each of the three portions of the acquisition. These fits, as with
all subsequent analysis in this chapter, were performed using the individual (CO
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Figure 8.7: The raw AIF (∗), group AIF (.), and the AIF which has been corrected by
adjusting the baseline signal to produce agreement with the Stewart Hamilton equation
using a phase contrast measure of cardiac output (‘CO adjusted’) (+) are shown here for
one volunteer (volunteer 4). Horizontal lines indicate the mean peak (4.66 mM) and 2
minute post-injection (0.95 mM) plasma concentrations from [1].
adjusted) AIFs.
Table 8.4 shows the p-values resulting from F-tests comparing the WX-2CXM with
either the FXL (first 3 columns) or the NXL (last 3 columns). The null hypothesis is
that the 4-parameter limit provides a better fit than the WX-2CXM, so a p < 0.05
indicates that the null hypothesis has been rejected, and the WX-2CXM provides a
significantly better fit to these data; these entries have been highlighted in boldface.
A p > 0.05 indicates that we cannot reject the null hypothesis and the WX-2CXM
does not provide a significantly better fit than the 4 parameter model. A table entry
of −1 indicates that an invalid F-statistic was found and the null hypothesis cannot
be rejected. For example, F < 0 would occur if the WX-2CXM fit had a higher
sum of squared residuals than the FXL. Because the FXL is a nested model of the
WX-2CXM which can be derived from the WX-2CXM, in theory, the sum of squared
residuals for the WX-2CXM should always be ≤ than for the FXL. The fact that a
higher sum of squared residuals is found in some instances indicates that the fitting
algorithm has arrived at a local minimum in the parameter space. Efforts should be
made to avoid this occurrence when applying F-tests, to avoid invalid F-statistics.
The p-values in table 8.4 can be used to select a model for fitting the data. Table
8.5 lists these models for fitting each of the three portions of the acquisition for each
volunteer. Table 8.5 is related to table 8.4 as follows: in cases where p < 0.001 for F-
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WX-2CXM vs FXL WX-2CXM vs NXL
volunteer 5◦ 30◦ full 5◦ 30◦ full
1 p<0.0001 -1 -1 -1 0.015 p<0.0001
2 -1 0.99 0.62 0.62 0.00088 p<0.0001
3 -1 -1 0.0029 p<0.0001 0.89 p<0.0001
4 -1 -1 p<0.0001 0.92 -1 p<0.0001
5 p<0.0001 -1 -1 p<0.0001 0.99 0.22
6 p<0.0001 -1 p<0.0001 p<0.0001 0.10 0.0032
7 p<0.0001 p<0.0001 p<0.0001 p<0.0001 0.0017 p<0.0001
Table 8.4: The results of F-tests comparing the suitability of the 6 parameter WX-2CXM
with its limits (FXL and NXL) for fitting the 5◦, 30◦, and dualbolus timecourses. The
null hypothesis is that the 4 parameter model provides a better fit than the WX-2CXM;
entries in boldface indicate cases in which the null hypothesis has been rejected and the
alternative hypothesis (that the WX-2CXM provides a significantly better fit) has been
accepted. Entries of -1 indicate instances where an invalid F-statistic was found (eg. F < 0).
tests against both the FXL and NXL, the full 6 parameter model is selected. In cases
where the WX-2CXM does not provide a significantly better fit, the 4-parameter with
the lower summed squared errors is selected.
8.4.1.1 Discussion: F-test results
The results in tables 8.4 and 8.5 support the hypothesis that the 5◦ data are more
sensitive to water exchange than the 30◦ data, as the full WX-2CXM provides a
significantly better fit to the 5◦ data more often than the 30◦ (when comparing
with the 4-parameter models, the WX-2CXM provides a significantly better fit in
3 instances in the 5◦ data and only one instance for the 30◦ data). There may be
some additional information about water exchange present in the full timecourse as
the WX-2CXM provides a significantly better fit in 2 instances when fitting the full
timecourse where the FXL is selected when fitting the 5◦ data (datasets 3 and 4).
Although the 30◦ data are less sensitive to water exchange than the 5◦ data, some
information about water exchange may still be present. However, the results in table
8.5 suggest that there is insufficient information about water exchange to support the
use of a 6 parameter model when fitting data acquired with a flip angle of 30◦.
Table 8.5 suggests that water exchange is likely not in the NXL in the parotid, as the
NXL is rarely the selected model; the only instance is for volunteer 1 in the 5◦ data.
Additionally, the fits to the full timecourse in figure 8.8 demonstrate that while the
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volunteer preferred model
5◦ 30◦ full
1 NXL FXL FXL
2 FXL FXL FXL
3 FXL FXL WX-2CXM
4 FXL FXL WX-2CXM
5 WX-2CXM FXL FXL
6 WX-2CXM FXL WX-2CXM
7 WX-2CXM WX-2CXM WX-2CXM
Table 8.5: The model for fitting each portion of the contrast agent uptake timecourse (5◦,
30◦, or full timecourse) is listed for each volunteer, as selected using nested F-tests. The
models were selected using nested F-tests; p-values listed in table 8.4.
FXL and WX-2CXM consistently provided fits with low summed squared residuals,
the NXL failed to fit the data in 2 cases.
Another conclusion which can be drawn from the results in tables 8.4 and and 8.5 is
that the use of the full WX-2CXM is supported in these data. For the data which
are expected to be more sensitive to water exchange (either the 5◦ or full timecourse
), the WX-2CXM is suitable for fitting 5/7 datasets (columns 1 and 3 of table 8.4).
The parameter estimates resulting from these fits will be presented in section 8.4.2.1.
8.4.2 Results: WX-2CXM, FXL, and NXL fits to the data
Even after trimming ROIs to remove non-glandular tissue from the parotid ROIs such
as blood vessels, nerves, and other tissues, there was considerable heterogeneity in the
shape of the contrast agent uptake curves amongst the volunteers, as demonstrated
in figure 8.8. This heterogeneity in the shape of the curves in figure 8.8 is reflected in
the range of the resulting parameter estimates in tables 8.6, 8.7, and 8.8. However,
despite this heterogeneity, the WX-2CXM and FXL models provided excellent fits
to the data, with low summed squared errors and no noticeable systematic fitting
errors.
The NXL model was unable to provide a fit with summed squared errors comparable
to the FXL and WX-2CXM fits, and failed to fit the data for volunteers 1 and 4.
Evidence of this can be seen in figure 8.8. In addition to having a much higher sum
of squared errors than the FXL and WX-2CXM fits to the data for volunteers 1 and
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1 2 3 4 5 6 7
PS [ml/min/ml] 0.042 0.11 0.0059 0.017 0.28 0.025 0.013
Fp [ml/min/ml] 0.22 0.64 0.28 0.20 0.65 0.45 0.61
vp 0.072 0.16 0.23 0.15 0.051 0.23 0.24
ve 0.074 0.16 5.3×1010 0.12 0.26 0.13 0.64
Table 8.6: Parameter estimates resulting from fitting the FXL of the WX-2CXM to the
full timecourse data for all 7 datasets.
1 2 3 4 5 6 7
PS [ml/min/ml] 0.015 0.0034 0.0035 12 0.0065 0.0058 0.0049
Fp [ml/min/ml] 1.8 0.54 0.29 0.025 0.37 0.51 0.79
vp 0.086 0.30 0.26 0.21 0.27 0.29 0.33
ve 1.3 0.75 0.76 0.88 0.75 0.72 0.70
Table 8.7: Parameter estimates resulting from fitting the NXL of the WX-2CXM to the
full timecourse data for all 7 datasets.
4, these two failed NXL fits shown in figure 8.8 resulted in the highest values for ve
in table 8.7 (in the case of volunteer 1, ve > 1).
The general unsuitability of the NXL for fitting the data was predicted by the model
selection results in section 8.4.1, and is also evident in table 8.7, where the fractional
volumes ve and vp have a sum which is greater than 1 for all fits.
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Figure 8.8: The signal uptake curves for the parotid ROIs in the 7 volunteers. WX-
2CXM, FXL, and NXL fits to the full timecourse are shown for all 7 datasets. The resulting
parameter estimates are given in tables 8.8, 8.6, and 8.7.
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Mean SD
Fp [ml/min/ml] 0.46 0.23
PS [ml/min/ml] 0.06 0.05
vp 0.19 0.06
ve 0.14 0.09
τp [s] 0.47 0.99
τic [s] 5.20 9.5
τe [s] 0.13 0.21
Table 8.9: Mean WX-2CXM parameter estimates for Fp, vp, and PS, (7 datasets) and
ve, τp,τic, and τe (6 datasets, volunteer 3 excluded). Means are calculated using the data
shown in table 8.8.
8.4.2.1 Results: WX-2CXM fits and water residence times
Good fitting of the full WX-2CXM to the tissue signal curves was observed without
evidence of systematic fitting errors for all 7 datasets, as shown in figure 8.8. The
parameter estimates from WX-2CXM fits to all 7 datasets are given in table 8.8.
Parameter estimates were averaged from datasets 1-7 to give the group means for Fp,
vp, and PS in table 8.9. Because it was not possible to obtain reasonable estimates of
ve (0 < ve < 1) or τe from dataset 3 using the WX-2CXM, this dataset was excluded
when taking the mean of ve, τp , τic and τe in table 8.8. These parameters are not
strongly linked to Fp, vp, and PS: although it was not possible to estimate ve or τe,
reasonable estimates of the other parameters were still obtained, and so it is possible
to include dataset 3 when taking the mean for Fp, vp, and PS. This is shown in
table 8.8, where estimates of Fp, vp, and PS for dataset 3 lie within the range of
the estimates found for the other datasets. This is also supported by the simulation
results in section 7.2, which demonstrate that estimates of Fp, vp, and PS remain
accurate despite the presence of outliers for ve and τp in these simulations.
8.4.3 Results: FXL-NXL differences in the 5◦ and 30◦ time-
courses
The results of fitting the FXL and NXL models to both the 5◦ and 30◦ timecourses
are shown in figures 8.9 and 8.10. Mean parameter values are given in tables 8.10 and
8.11. Both the figures and tables show estimates of Fp, vp, and PS from datasets 1-7,
while estimates of ve are only shown from datasets 1, 2, 5 and 7 in this section. This
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Figure 8.9: Estimates of Fp, vp, PS (7 datasets), and ve (4 datasets) from fitting the FXL
and NXL to the 5◦ timecourse. Group means are shown as horizontal bars; these values are
summarised in table 8.10. Fp and PS are in units of [ml/min/ml]; vp and ve are unitless.
is because the FXL fits to the 5◦ timecourse failed to provide reasonable (0 < ve < 1)
estimates of ve for dataset 3, and the NXL fits failed to provide reasonable estimates
for datasets 4 and 6, leaving datasets 1, 2, 5, and 7. However, ve is not strongly
linked to the other parameters - it is still possible to obtain reasonable estimates of
other parameters even if ve cannot be estimated. In this case, it was still possible to
use the estimates of Fp, vp, and PS from datasets 3, 4 and 6, and so estimates of
these parameters are given for 7 datasets in tables 8.10 and 8.11.
The FXL and NXL parameter estimates were generally similar; however, there were
significant differences between FXL and NXL estimates of vp and Fp in the 5
◦ time-
course (vp: p=0.005, Fp: p=0.02), seen in figure 8.9. There were also differences
between FXL and NXL estimates of vp in the 30
◦ timecourse (p=0.02), seen in figure
8.10.
Because the 5◦ portion of the acquisition was designed to have an increased sensitivity
to water exchange, it was hypothesised that there would be a greater FXL-NXL
difference in this portion of the timecourse. This is supported by the results in figure
8.11. The difference between the parameter estimates resulting from FXL and NXL
fits to the 5◦ and 30◦ are shown here for 7 datasets for Fp, vp, PS. Because it was
222
Chapter 8. Applying the WX-2CXM to assess water exchange
effects in the parotid gland
Figure 8.10: Estimates of Fp, vp, PS (7 datasets), and ve (4 datasets) from fitting the
FXL and NXL to the 30◦ timecourse. Group means are shown as horizontal bars; these
values are summarised in table 8.11. Fp and PS are in units of [ml/min/ml]; vp and ve are
unitless.
not possible to obtain estimates of ve for 3 datasets when fitting the 5
◦ portion of the
timecourse, results are shown only for the remaining 4 datasets for ve (datasets 1, 2,
5, and 7). As seen in figure 8.11, there is a significantly greater FXL-NXL separation
for the 5◦ timecourse than for the 30◦ timecourse for the parameters vp and ve (vp:
p=0.0005, Fp: p=0.015).
These results lend further support to the findings in section 8.4.1, which suggested
that the 5◦ timecourse showed more potential sensitivity to water exchange than the
30◦ timecourse, due to the greater frequency with which the full WX-2CXM was
suitable for fitting the 5◦ data as compared to the 30◦ data.
8.5 Discussion and Conclusions
When the dual injection, dual angle protocol was created for this data acquisition, it
was hypothesised that the 5◦ portion of the timecourse would show increased water
exchange sensitivity as compared to the 30◦ portion. The results in section 8.4.3
support this hypothesis. The separation between the FXL and NXL results is related
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Figure 8.11: The difference between the FXL and NXL parameter estimates as calculated
in the 5◦ and 30◦ portions of the timecourse is given for each of Fp, vp, PS (7 datasets),
and ve (4 datasets). Fp and PS are in units of [ml/min/ml] while vp and ve are unitless.
Group means are shown as horizontal bars; these values are summarised in tables 8.10 and
8.11. Significant differences between the 5◦ and 30◦ results are indicated with an asterisk.
Mean SD p-value
Fp FXL 0.36 0.15
[ml/min/ml] NXL 0.87 1.1
FXL-NXL -0.50 0.99 0.21
PS FXL 0.046 0.048
[ml/min/ml] NXL 0.22 0.46
FXL-NXL -0.17 0.47 0.36
vp FXL 0.15 0.037
NXL 0.27 0.041
FXL-NXL -0.12 0.047 0.0005
ve FXL 0.14 0.06
NXL 0.055 0.17
FXL-NXL 0.084 0.20 0.021
Table 8.10: Mean 2CXM FXL and NXL parameter estimates for Fp, vp, PS (7 volunteers)
and ve (4 volunteers) resulting from fitting the 5◦ portions of the timecourse. P-values are
from two tailed paired t-tests comparing FXL and NXL parameter estimates; significant
values are shown in boldface. See figure 8.9 for individual parameter estimates.
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Mean SD p-value
Fp FXL 0.32 0.39
[ml/min/ml] NXL 0.51 0.80
FXL-NXL -0.19 0.41 0.26
PS [ml/min/ml] FXL 0.18 0.19
[ml/min/ml] NXL 0.064 0.064
FXL-NXL 0.11 0.16 0.12
vp FXL 0.042 0.030
NXL 0.053 0.029
FXL-NXL -0.011 0.0095 0.021
ve FXL 0.048 0.076
NXL 0.036 0.028
FXL-NXL 0.012 0.064 0.15
Table 8.11: Mean 2CXM FXL and NXL parameter estimates for Fp, vp, PS (7 volunteers)
and ve (4 volunteers) resulting from fitting the 30◦ portion of the timecourse. P-values are
from two tailed paired t-tests comparing FXL and NXL parameter estimates; significant
values are shown in boldface. See figure 8.10 for individual parameter estimates.
to the potential water exchange sensitivity of the data, and a greater separation was
observed in the FXL and NXL parameter estimates from the 5◦ timecourse: significant
differences between FXL and NXL estimates of ve were seen in the 5
◦ timecourse
which were not seen in the 30◦ timecourse, and the 5◦ timecourse demonstrated a
significantly greater FXL-NXL difference than the 30◦ timecourse for both vp and ve.
This result agrees with the the expected increase in water exchange sensitivity at lower
flip angles, as demonstrated by the simulations in section 5.4.3 which showed a greater
separation between the FXL and NXL at 5◦ than at higher flip angles. The results
of the F-tests in section 8.4.1 also support the hypothesis that the 5◦ timecourse is
sensitive to water exchange, and further, suggest that the 30◦ timecourse is likely
insensitive to water exchange effects, as the full WX-2CXM was only selected for
fitting 1/7 of the 30◦ datasets while 3/7 of the 5◦ datasets were best fit using the
WX-2CXM. Most quantitative DCE MRI analysis is currently performed in the FXL
(disregarding water exchange effects); the present results do not indicate a need to
alter this practice for flip angles above 30◦.
Recalling the results of section 4.3, and making links with section 8.4.3, the largest
difference between the FXL and NXL in both sections was seen for vp. The results
in section 8.4.3 thus lend support to the hypothesis that the vp differences observed
between CT and MR in chapter 4 were related to water exchange. Because vp is
affected by variations in the AIF, the time lapse between the MR and CT acquisitions,
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and differences in the MR and CT temporal resolution and injection protocols might
have led to some ambiguity as to whether the vp differences observed in chapter 4
were related to AIF issues rather than water exchange. However, the results in 8.4.3
were produced by comparing timecourses designed to have differing water exchange
sensitivities, acquired in the same individual using the same injection protocol within
a time of 17 minutes. The persistant vp differences seen first in section 4.3 and
then again in section 8.4.3 suggest that these vp differences are related to real water
exchange effects in the DCE MRI data. However, it was not possible to measure
water residence times in the data from chapter 4, nor from fitting the 30◦ timecourse
in section 8.4.3, suggesting that although water exchange may have some effect on
DCE MRI acquired at flip angles of 20-30◦, the use of the full WX-2CXM is not
warranted at these higher flip angles.
8.5.1 Water residence times
A further hypothesis which was proposed when this DCE MRI protocol was designed
was that it might be possible to measure water residence times in all compartments.
The first successful use of the WX-2CXM to fit data acquired in vivo, and the result-
ing parameter estimates (shown in tables 8.8 and 8.9) support this hypothesis, and
demonstrate the success of the protocol design. Both the WX-2CXM used here, and
the resulting estimates of water residence times are novel: the preliminary estimates
of the water residence times in table 8.9 are, to the author’s knowledge, the first esti-
mates of all 3 compartmental water residence times measured using DCE MRI in the
same tissue. The results show the first signs that measurements of the compartmental
water residence times may be possible using clinical DCE MRI protocols.
To the author’s knowledge, there are no available literature values for the vascular,
intracellular, and EES water residence times in the parotid. Although there are a
broad range of water residence times quoted in the literature obtained using MR
methods, these values depend strongly on the tissue type being investigated. This is
unsurprising, considering the likely affect of varying cell size, type, and density on
the water residence times. Literature values for intracellular water residence times
range from tens of milliseconds to several seconds [147]: values of 0.05 s have been
found in glioma cells using diffusion MR spectroscopy [146], 0.3 s in breast lesions
using DCE MRI [156], and 2.2 s in normal esophageal tissue using DCE MRI [157].
Measurements of intravascular residence times are less common; Wacker et al. found
226
Chapter 8. Applying the WX-2CXM to assess water exchange
effects in the parotid gland
an intravascular water residence time of 0.27 s in human myocardium using steady
state contrast MRI [158]. Although the literature values for τp and τic are smaller
than the values from table 8.9 (τp = (0.47 ± 0.99)s, τic = (5.20 ± 9.5)s ), the
differences between these experimental results and the literature values may be related
to the considerable physiological differences between the parotid gland and these other
tissues, or to experimental differences.
It should be noted that many of existing (NMR and diffusion MRI-based) techniques
for measuring water residence times are not suited for use in a clinical setting, due to
time or hardware constraints, or the use of high doses of contrast agent. The ability
to measure water residence times as part of a clinical DCE MRI protocol could prove
extremely valuable, as the compartmental water residence times are directly and
quantitatively related to tissue anatomy and physiology in a way which many other
MR parameters are not. While commonly quoted parameters such as Ktrans, IAUC,
and kep may be relatively easy to measure, they have an ambiguous relationship to
the underlying tissue physiology [159]. Changes in water residence times should be
closely linked to changes in cell size and water content, which are linked to common
treatment responses such as cell swelling, apoptosis, inflammation, and changes in
perfusion.
The mean estimates of water residence times in table 8.9 are associated with large
standard deviations. However, an examination of the estimates of water residence
times in individual volunteers in table 8.8 reveals that the large standard deviation in
table 8.9 is due to the non-normal distribution of water residence times. Volunteers
1 and 2 have very low estimates of τp and τe as compared with volunteers 4-7, while
volunteers 6 and 7 have high estimates of τic which skew the mean and increase the
calculated standard deviation shown in table 8.9. The simulations in section 7.2
show that fitted estimates of τp are particularly vulnerable to outliers, which may be
partly responsible for the wide range of water residence time estimates in table 8.8.
This emphasises the need for validation of the water residence times. Independent
estimates of precision and reproducibility (such as those performed in [160]) of water
residence times are needed to determine the true extent of intra-individual differences.
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8.5.2 WX-2CXM parameter estimates: literature compar-
isons
The parotid gland is a complex tissue containing a large number of acinar cells and
ducts dedicated to saliva production. The relatively large volume of acinar cells,
ducts, and the acinar lumen may explain the relatively greater value for the intra-
cellular water residence time compared to the vascular or EES water residence times
seen in table 8.9. This result is supported by the relatively small EES fractions in
table 8.9 (ve 0.14 ± 0.09). If the assumption of ve+vp+vic = 1 holds, the majority of
the remaining tissue space (1− 0.14− 0.19 = 0.67) may be considered ‘intracellular’,
or otherwise inaccessible to the contrast agent.
Estimates of quantitative tracer kinetic parameters in the parotid are given in [161].
However, this analysis is based on a model that uses parameters which are difficult
to compare with the 2CXM. Juan et al. used a two compartment model to estimate
values for A, Kel and k21. Although k21 can be related to PS/ve, Juan et al. note that
the values for k21 were the most susceptible to noise and had the largest variation of
the parameters estimated. Juan et al. estimated a value of (6.1 ± 5.3) [/min] for k21
in controls, while the mean value of PS/ve can be calculated using the values from
table 8.9 as (0.43 ± 0.45) [ml/min/ml]. The disagreement between k21 from [161]
and the value for PS/ve from 8.9 may be related to the different models used for the
analysis. It should also be noted that Juan et al. used normalised signal intensity
rather than calculated T1 values for conversion to contrast agent concentration, and
did not directly measure AIFs, instead using a monoexponential decay of plasma
tracer concentration. It should also be noted that there is evidence that poor temporal
resolution and SNR may bias DCE MRI parameter estimates [162, 36, 142], and so
differences in the temporal resolution in the acquisitions of [161] (10.4 s) and in the
present study (2.2 s) should also be considered.
Roberts et al. used an extended Kety type model (see section 3.4) to estimate ve and
vp in the parotid glands of patients and volunteers [73]. In healthy volunteers, mean
estimates for vp and ve were (0.03 ± 0.01) and (0.23 ± 0.04) respectively [73]. The
mean values of vp and ve in table 8.9 are (0.19 ± 0.06) and (0.14 ± 0.09). While
the values for ve from [73] agree with the values from table 8.9 within one SD, the
values for vp do not. The WX-2CXM estimates for vp from table 8.9 are higher
than those in [73]. The total distribution volume for the contrast agent ve + vp is
similar for both studies (0.26 in [73] and 0.33 in table 8.9). The difference in models
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used in [73] and this analysis may be partly responsible for the discrepancy between
estimates for ve and vp; note also that Roberts et al. used an automated method
of AIF detection rather than directly defining the ROI to create the AIF. In the
comparison of the 2CXM and extended Kety models in the bladder cancer dataset
in section 5.2, the use of the 2CXM results in a higher value for vp (see table 5.3),
as seen in the comparison of the values for vp in table 8.9 and [73]. Evidence that
the extended Kety model underestimates vp relative to the 2CXM is also shown in
[99]. Poor temporal resolution and SNR may bias DCE MRI parameter estimates
[162, 36, 142], and so differences in the temporal resolution in the acquisitions of [73]
(6.2 s) and in the present study (2.2 s) are another a potential source of disagreement
between the parameter estimates.
8.5.3 WX-2CXM parameter estimates: individual results
Examining the individual parameter estimates found in table 8.8 reveals that some of
the parameter distributions are skewed by outliers, increasing the standard deviations
quoted in table 8.9.
In particular, datasets 1 and 3 have very low estimates of PS, and outlying estimates
of ve and τe as compared to the other 5 datasets. It appears that for these datasets,
underlying issues with the AIFs may be contributing to these atypical parameter
estimates. As shown in figure 8.6, the raw AIF from dataset 1 had extremely low
concentrations. Even after applying the CO adjustment corrections to this AIF, the
peak concentration is among the lowest in table 8.2, and the tail concentration is
the highest, indicating there may be some remaining artefacts affecting this AIF
which the CO corrections were unable to compensate for. However, neither the AIF
concentrations nor the parameter estimates for this dataset warranted the exclusion
of these data from analysis, and estimates of Fp, vp, and τic are within the range
of the other datasets. It should also be noted that, because τe is calculated using
ve, the small value for ve in this dataset is directly related to the small value for τe.
However, ve should not affect estimates of Fp or vp, and these parameters are not
outliers in table 8.2. In the case of dataset 1, the F-test selected the FXL rather than
the WX-2CXM, and the estimates of PS in table 8.6 are closer to the other datasets
than the estimates in table 8.8.
In the case of dataset 3, the estimate for ve was unrealistically large (> 1), indicating
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that it was not possible to estimate ve in this dataset. The raw AIF had very high peak
and tail concentrations. Although these seem to have been adjusted by the CO AIF
correction, discrepancies between the rate reduction in contrast agent concentration
in the AIF and uptake can contribute to difficulties in estimating ve [101]. As with
dataset 1, the inability to estimate ve also implies an inability to estimate τe, as
seen in table 8.8. In the case of dataset 1, the estimate of ve was still within the
bounds of possible values for ve (0 < ve < 1), and so this dataset was retained for the
calculations in table 8.9. However, for dataset 3, because the values for ve and τe were
outside the bounds of possible values for these parameters (ve > 1 and τe < 0), and
τic is very large, these estimates of ve and the water residence times were excluded
when calculating the means in table 8.9. As with dataset 1, despite the inability
to estimate ve, estimates of Fp, PS, and vp were still within the bounds for these
parameters, and so estimates of these parameters were included in the means in table
8.9.
Dataset 7 mirrors the effects seen in dataset 3, but to a much lesser degree. Low
estimates of PS, and high estimates of ve and τic were found for this dataset. Again,
this may be linked with high concentrations in the raw AIF, underscoring the impor-
tance of accurate individual AIF measurements, and minimising artefacts affecting
the AIF.
8.5.4 Limitations
The data in this chapter constitutes a preliminary study on a protocol which is under
development. As such, there are several limitations of this study which should be
addressed in future investigations.
The present study imaged parotid glands in a small number of healthy volunteers,
in an effort to asses the impact of water exchange on clinical DCE protocols used
in oncology. There are obvious differences both in the tissue of interest (parotid
versus tumour) and the patient population (young healthy volunteers versus elderly
patients) between this preliminary investigation and the intended use of the proto-
col. A larger study including oncology patients should be carried out to test the
preliminary conclusions outlined here and measure water exchange effects in a more
clinically realistic setting.
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The AIF calculation described in section 8.2.1 involves the replacement of the AIF
in the 5◦ timecourse with that in the 30◦ timecourse, due to the severe impact of
inflow on the lower flip angle data. This decision was made because the form of the
AIF is expected to be very similar over the course of 17 minutes in young healthy
volunteers. However, variations in the AIF may be expected in elderly patients,
and it would be desirable to acquire useable AIFs from both bolus injections. In
an abdominal acquisition, the use of coronally oriented slices running parallel with
the aorta could help alleviate this problem, as a coronal FOV can help to saturate
the inflowing blood, reducing partial volume effects in an aortic AIF. This was not
possible in the carotid, as partial volume effects were a concern in this smaller vessel,
and it was also a concern that in some volunteers a coronal FOV running parallel to
the carotids might not optimally intersect both the carotids and the parotid glands.
Because the water residence times estimated here show such a large variation between
individuals, it cannot be stated that these are conclusive measurements. Further
refinements to this protocol could be made to increase the water exchange sensitivity,
perhaps lengthening the TR and optimising the flip angle accordingly, while still
maintaining a good temporal resolution and SNR. The number of volunteers imaged
in this preliminary study is too small to draw firm conclusions about water residence
times in the parotid, and it would be of interest to run this protocol in a larger
group of volunteers may be allow more precise measurement of water residence times.
However, validation of these water residence times is also required, perhaps via the
use of diffusion MRI or in vitro MR techniques. Reproducibility studies should also be
carried out, to determine the relative contributions of differences between individuals
and measurement errors to the variation in estimates of water residence times. As
there is a lack of available literature regarding quantitative DCE MRI in the parotid,
independent validation of the other tracer kinetic parameters (Fp, vp, ve) estimated
in this chapter should also be performed in the parotid, using other techniques.
8.6 Summary
The protocol used in this chapter draws upon the work reported in the preceding
chapters. The analysis of the bladder dataset in chapter 4 suggested that water
exchange may have some effect on estimates of vp, and motivated the development
of a DCE MRI protocol which was more sensitive to water exchange to investigate
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these findings. The results in chapters 4 and 5 suggested parameters which might
be optimised in a newly developed protocol to make it more or less sensitive to
water exchange. The AIF corrections investigated in chapter 6 provided a means
of correcting the artefacts affecting the AIFs in the protocol from this chapter. The
simulations in chapter 7 led to the choice of the optimal flip angles and contrast agent
injection protocols for the acquisition in this chapter.
The dual injection, dual flip angle DCE MRI acquisition in this chapter was designed
to test two hypotheses: that the lower flip angle portion of the DCE MRI timecourse
would be more sensitive to water exchange than the higher flip angle portion, and
that fits to the full timecourse might allow estimates of water residence times to
be made for each of the vascular, intracellular, and EES compartments using the
WX-2CXM. Both of these hypotheses were supported. The results in this section
8.4.3 suggest that the 5◦ portion of the DCE MRI timecourse was more sensitive
to water exchange than the 30◦ portion, and additionally, when considered along
with the results in section 8.4.1, suggest that it may not be necessary to account
for water exchange effects in DCE MRI analysis when using a T1 weighted SPGR
type sequence with a 30◦ flip angle. The second hypothesis, that this acquisition
might allow estimates of compartmental water residence times, was also supported.
The results in this chapter demonstrate the first successful use of the WX-2CXM, and
the resulting estimates of the mean compartmental water residence times are given in
table 8.9: τp = (0.47± 0.99) s, τic = (5.20± 9.5) s, and τe = (0.13± 0.21) s. The large
standard deviations on these estimates suggest either that there is a large variation
in water residence times in the parotid between individuals, or that these parameters
were not precisely estimated in the current protocol (and not normally distributed).
In either case, it should be noted that these are preliminary estimates only, and the
number of individuals imaged is too small to make any generalised conclusions. It
is likely that further refinements to the DCE MRI protocol are needed to provide
reliable and accurate estimates of water residence times.
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9.1 Summary and conclusions
The investigations of issues related to the measurement of the effects of water ex-
change on quantitative DCE MRI analysis in this thesis were motivated by contro-
versy in the literature over whether these effects should be accounted for in clinical
DCE analysis. As MR technology and DCE analysis become more sophisticated, the
data are of higher quality than they were previously, and the analyses are able to
measure a greater number of parameters related to the underlying tissue physiology.
As a result, assumptions in DCE modeling which would previously have had unde-
tectable or insignificant effects on the results of DCE analysis are becoming more
significant. It is important to understand the ways in which assumptions can affect
quantitative DCE analysis (such as the assumption of FXL water exchange which has
been made in the past), and to be aware of situations in which such assumptions may
not hold and the related effects, such as water exchange, may need to be accounted
for.
This thesis was motivated by two hypotheses. The first hypothesis was that water
exchange has a quantifiable effect on clinical T1 weighted DCE MRI tracer kinetic
parameter estimates, which may allow measurements of the water residence times in
tissue. The second hypothesis was that the importance of water exchange in clinical
DCE MRI analysis could be gauged by comparing clinical DCE MRI data (which
may be affected by water exchange to an unknown extent) with clinical DCE CT
data (which are not affected by water exchange) and with a modified DCE MRI
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protocol which is sensitised to water exchange.
In order to investigate water exchange effects on clinical data, a tracer kinetic model
which incorporates water exchange effects must be used. The development of a new
model incorporating water exchange effects, the WX-2CXM, begins in chapter 3.
Chapter 3 then continues with an exploration of the nested models which are related
to the WX-2CXM, including the 2CXM, 1CM, extended Kety, and uptake models.
The WX-2CXM and its fast and no exchange limits are used for analysis of DCE
data throughout the thesis. The use of these models is supported by the high quality
fits provided to a variety of data, and the absence of systematic fitting errors.
Once the WX-2CXM had been developed, analysis of a clinical dataset was carried
out to determine whether water exchange effects could be detected. The availability
of a clinical dataset where bladder cancer patients had been imaged using both DCE
MRI and DCE CT provided a valuable opportunity to compare DCE MRI results
with the ‘gold standard’ of DCE CT results which are unaffected by water exchange.
The use of the same model to analyse both DCE MRI and DCE CT allowed a direct
comparison of parameter estimates obtained from the same tumours imaged using
each of the two modalities. The bladder cancer dataset analysed in chapter 4 did
not contain sufficient information about water exchange to fit the WX-2CXM. While
fitting the fast and no exchange limits of the WX-2CXM revealed that water exchange
was potentially affecting tracer kinetic estimates of vp, it did not support the use of
the full WX-2CXM in these data.
The analysis in chapter 4 did not provide absolute confirmation on whether clinical
DCE MRI data was sensitive to water exchange, and so, having compared the DCE
MRI with DCE CT data which was not sensitive to water exchange, the natural
extension was performing a comparison with data which was deliberately sensitised
to water exchange. This comparison was carried out in chapter 8. However, in order
to ensure this comparison provided the necessary information, a number of other
issues first needed to be addressed.
Aside from water exchange, there are a number of other factors which can influence
DCE MRI analysis. In chapter 5, the impact of variations in input parameters such
as TR, flip angle, relaxivity, and pre-contrast T1 were explored. The use of nested
F-tests to determine the most appropriate model was introduced, and the results of
using manually defined AIFs were compared with results found using automatically
detected AIFs. The investigations in this chapter provided a better understanding
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of the other factors affecting the analysis in chapter 4, and provided some guidance
for considerations in designing a protocol sensitised to water exchange. One factor
which emerged as being particularly important to DCE analysis, but also particularly
vulnerable to inaccuracies due to MRI artefacts was the arterial input function. It
became clear that inaccuracies in the AIF could introduce biases in the data, and
that the artefacts affecting the AIFs should be minimised to ensure accurate results.
Four AIF correction methods were tested in chapter 6 in order to explore the options
for improving the accuracy of AIFs which were known to be affected by MR artefacts.
The results of these tests indicated that correction techniques using measurements of
cardiac output could be used to significantly improve the quality of MRI AIFs when
the improvement in the results was judged by comparison with DCE CT.
A further question which needed to be addressed before acquiring DCE MRI data
which was sensitised to water exchange was which parameters in the clinical sequence
could be altered to maximise (or minimise) the water exchange sensitivity of the ac-
quisition. The simulations in chapter 7 guided the choice of the optimal flip angle,
TR, and contrast agent injection protocol to be used in the creation of a DCE pro-
tocol which was sensitised to water exchange but still clinically feasible. The result
was a dual flip angle, dual injection protocol which was expected to provide some
additional sensitivity to water exchange over the clinical protocol used in chapter
4. Preliminary testing of this DCE protocol was carried out in 8 healthy volun-
teers. The parotid glands were imaged because, in the absence of tumour tissue, the
parotid glands provided an environment which had the necessary characteristics for
DCE analysis which might enable fitting of the 6 parameter WX-2CXM, in particular,
tracer leakage, measurable vp and ve, and very little motion.
The results of analysing the data from the volunteers imaged using the sensitised
DCE protocol are presented in chapter 8. Because the protocol consisted of two
portions with differing sensitivities to water exchange, it was possible to compare the
results and conclude that the low flip angle portion provided an increased sensitivity,
as compared to the portion which used a 30◦ flip angle which would be more typical
of a clinical acquisition. The WX-2CXM was successfully fitted to the data, and
preliminary estimates of water residence times in the vascular, intracellular, and EES
were found for the first time in the parotid.
Most clinical DCE MRI analysis currently uses an FXL type model (assuming neg-
ligible water exchange effects). Neither the results in chapter 4 nor the results in
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chapter 8 indicate that non-FXL model is necessary for DCE MRI data acquired
at a flip angle above 20◦. Water exchange may potentially have some effect on vp
and Fp estimates at these flip angles, and while further investigation is warranted,
because the effects observed in this work did not significantly impact FXL parameter
estimates it cannot be stated that the general use of a non-FXL model is required.
The work in this thesis yielded several novel findings. To the knowledge of the author,
the results in chapter 4 are the first quantitative estimates of Fp, ve, vp, and PS in
bladder tumours using DCE MRI. The publication of these results in this thesis and
in [110] provides the first literature reference for MR estimates of flow, permeability,
and fractional compartmental volumes for this tumour type. The results in chapter
8 are also novel, both because of the acquisition used and the parameter results
obtained. The acquisition represents the first use of a dual bolus dual flip angle DCE
MRI acquisition to investigate water exchange effects, and the quantitative parameter
estimates obtained are the first to characterise water residence times in the parotid
gland using DCE MRI. The WX-2CXM is a novel model, and estimates of Fp, ve,
vp, PS, τp, τe, and τic in the parotid gland reported in chapter 8 represent its first
published use. The WX-2CXM provides several advantages over other commonly
used DCE MRI models. Firstly, it has a simple structure which facilitates its use
as the parent model for several other simplified models including the 2CXM, 1CM,
extended Kety, and uptake models, as shown in chapter 3. This allows it to be adapted
to a variety of tissues and acquisition types. The WX-2CXM provides the ability to
estimate not only the more commonly reported parameters Fp, ve, vp, and PS, but
also the water residence times in the EES, vascular, and intracellular compartments,
which are not provided by other DCE MRI models neglecting water exchange effects.
The in vivo data in chapter 8 represent a range of shapes of tissue uptake curves,
and the ability of the WX-2CXM to provide high quality fits to this range of uptake
curves without systematic fitting errors demonstrates its versatility, suggesting that
it may provide good fits in a variety of tissues and further investigation is warranted.
In the context of the current literature discussing the impact of water exchange on
T1 weighted DCE MRI, the findings in this thesis should be of interest as the WX-
2CXM represents a new approach to the issue. The work of Springer et al. forms
a substantial part of the current literature on the topic of water exchange and its
impact on T1 weighted DCE MRI, and the ‘shutter-speed models’ proposed by this
group have been used in several different tissues including rat thigh muscle [119], a
rat gliosarcoma model [26], and clinically identified breast lesions [156]. While the
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work of Springer et al. has raised interest in the issue of water exchange in the
context of DCE MRI, the models used in these papers differ from the WX-2CXM
in two important ways. The shutter-speed models in [26, 119, 156] are based on the
combination of a Kety model of tracer kinetics with the diffusion Bloch equations.
This thesis has shown that the extended Kety model is subject to systematic fitting
biases and thus is not appropriate for some tissues. Additionally, implementations of
these models have relied upon the assumption that the tissue T1 may be approximated
by the longer relaxation component [55, 156], which may not always hold [60]. The
WX-2CXM was formulated to address these issues, providing a new approach to
evaluating water exchange effects free from assumptions about fast and slow tissue
T1 components. Further investigation is needed to compare the two approaches, and
to evaluate their relative utility in clinical analyses.
The overall conclusions of the thesis were that water exchange effects likely do not
need to be accounted for in current clinical T1 weighted DCE MRI protocols such as
the bladder cancer protocol in chapter 4. The first hypothesis of the thesis, that water
exchange effects have a quantifiable impact on typical clinical DCE MRI analysis, was
not supported. However, the second hypothesis, that water exchange effects could
be detected by comparison with DCE CT and with a sensitised DCE MRI protocol,
was supported. These comparisons confirmed that subtle water exchange effects are
present, even in clinical data, and in the future it may be possible to measure water
residence times, which could provide a valuable insight into tissue physiology and
would be of interest in DCE cancer imaging.
9.2 Future work
The conclusions of this thesis, that water exchange effects are measurable but likely
do not affect current clinical DCE MRI protocols similar to the one used in chapter
4, present a number of opportunities for future work. In particular, if measurements
of tissue water residence times are to be made clinically feasible, future work should
focus on the refinement and optimisation of a DCE protocol which would allow more
precise measurements of these parameters. Protocols are becoming available which
allow direct measurements of T1 at each DCE timepoint, and the impact of such
protocols on the reduction of uncertainties in DCE analysis related the the calculation
of T1 based on a pre-contrast measurement should be evaluated. Ideally, a future
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protocol should have improved spatial resolution to minimise partial volume effects,
improved temporal resolution to minimise temporal undersampling of the AIF, and
longer TR to maximise water exchange effects. It would also be desirable to test the
effect of increasing the dose of contrast agent on the measurement of water residence
times, as the simulations in section 7.2 indicated that more precise estimates might
be obtained at higher doses of contrast agent.
The accurate measurement of MRI AIFs is fundamental to accurate DCE analysis,
and DCE protocols (particularly those attempting to measure subtle water exchange
effects) should focus on minimising artefacts such as inflow and partial volume that
may affect AIFs. Although cardiac output based AIF correction methods can help
improve AIF accuracy and precision, eliminating the source of artefacts affecting
the AIF concentrations is a far better solution. For example, the use of a coronal
or sagittal acquisition oriented parallel to the artery can help to reduce AIF inflow
effects as the region of RF excitation in this orientation will affect the inflowing blood
before it enters the field of view [114, 163]. As already mentioned, DCE protocols
with improved spatial and temporal resolution would improve the data quality, and
the possible impact of injecting higher doses of tracer should also be evaluated. The
AIF comparisons with the literature values from [1] suffered from differences in the
injection protocol and demographics, and any future evaluations of MR AIF accuracy
would benefit from the acquisition of AIF measurements using both DCE MRI and
blood sampling or radiotracer techniques to provide a gold standard for validation of
the DCE MRI AIF measurements.
Simultaneously with the development of water exchange sensitised DCE MRI pro-
tocols, validation of DCE MRI estimates of water residence times must be made,
perhaps using diffusion MRI or in vitro MR techniques, or radiolabelling. In vitro
tissue models could provide a controlled environment for varying the size of the tis-
sue compartments, and contribute to the understanding of the effects of cell swelling
and breakdown on the water residence times. The preliminary estimates of water
residence times in chapter 8 are interesting, but may be too variable to draw any firm
conclusions, especially considering the current lack of validation. As demonstrated
by the lack of available literature values for parameter estimates in both bladder tu-
mours and the parotid, other parameter estimates including Fp, vp, ve, and PS also
require validation in vivo. Histological techniques may be able to provide estimates of
vp and ve [164], while
15O PET can provide estimates of flow and vp [165, 166]. DCE
CT can also be used to validate DCE MRI estimates of tracer kinetic parameters, as
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demonstrated in this thesis. A validation study comparing DCE MRI with DCE CT
using the same contrast agent, with improved temporal and spatial resolution in the
MR protocol as compared to the protocol in chapter 4 would be of interest.
The conclusions in this thesis regarding the impact of water exchange are specific
to the tissues and DCE protocols used here. Investigations using the 2CXM and
WX-2CXM should be carried out in other tumours, organs, and tissues to explore
the impact of water exchange in other clinical situations. Although the DCE protocol
used in chapter 4 is fairly typical, DCE MRI is becoming increasingly popular, and
there are a range of clinical protocols in use. The WX-2CXM could be modified for use
with other MRI protocols, and investigations into water exchange effects detectable
using other DCE MRI protocols should be made.
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